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An EGF gradient induces the equipotent C. elegans vulval precursor cells 
(VPCs) to assume the 3˚-3˚-2˚-1˚-2˚-3˚ pattern of cell fates. EGF triggers the LET-
60/Ras-LIN-45/Raf-MEK-2/MEK-MPK-1/ERK canonical MAP kinase cascade to 
induce 1˚ fate and synthesize of DSL ligands for the lateral Notch signal. In turn, 
LIN-12/Notch induces neighboring cells to become 2˚. In response to lower dose 
of EGF signal, LET-60/Ras switches effectors to use the RGL-1/RalGEF-RAL-
1/Ral modulatory signaling cascade to promote 2˚ fate in support of LIN-12. The 
goals of this research are to define principles by which signaling networks function 
and to identify an effector cascade downstream of RAL-1. RAL-1 signals through 
EXOC-8/Exo84, an established Ral binding partner, GCK-2, a CNH domain-
containing MAP4 Kinase, and PMK-1/p38 MAP kinase to promote 2˚ fate. We also 
show that RGL-1 plays opposing and genetically separable roles in VPC fate 
patterning. RGL-1 promotes 2˚ fate via canonical GEF-dependent activation of 
RAL-1 and 1˚ fate via a non-canonical GEF-independent activity. Our genetic 
epistasis experiments are consistent with RGL-1 functioning in the modulatory 1˚-
promoting AGE-1/PI3-Kinase-PDK-1/PDK-AKT-1/Akt cascade. Animals without 
RGL-1 experience 15-fold higher rates of VPC patterning errors compared to the 
wild type. Yet VPC patterning in RGL-1 deletion mutants is not more sensitive to 
environmental perturbations. We propose that RGL-1 functions as a “Balanced 
Switch” that orchestrates opposing 1˚- and 2˚-promoting modulatory cascades to 
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decrease developmental stochasticity. To investigate how LET-60/Ras switches 
effectors to promote different cell fates, we used CRISPR to tag endogenous LIN-
45/Raf and RGL-1/RalGEF proteins. We found that they are recruited to different 
subcellular compartments during VPC induction. LIN-45 is recruited to the 
basolateral membrane in presumptive 1˚ cells. RGL-1 is recruited to the apical 
membrane in presumptive 2˚ cells, and this localization depends on functional 
LET-60. We hypothesize that RGL-1 apical localization in the VPCs is mediated 
by phosphorylation or scaffold proteins. Our studies delineate a novel Ral-
dependent developmental signaling cascade, bifunctional RGL-1 as a “Balanced 
Switch”, and LET-60 effector segregation mechanism in vivo, thus providing 
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INTRODUCTION AND LITERATURE REVIEW 
 
C. elegans vulval development 
 
The C. elegans vulva is a textbook system for the study of developmental 
biology and signal transduction. The completed vulva is an epithelial tube that 
connects the uterus to the outside of the hermaphrodite: the vulva mediates egg-
laying and mating with males. Importantly from the perspective of a developmental 
geneticist, the vulva is dispensable for viability. In vulvaless hermaphrodites, self-
fertilized eggs hatch within the mother to produce live progeny. Consequently, this 
system is amenable to genetic manipulation, with genetic perturbations resulting 
in visible phenotypes such as Multivulva (Muv) and Vulvaless (Vul) (Horvitz and 
Sulston, 1980). 
During early larval development, the six vulval precursor cells (VPCs; also 
known as the Pn.p cells, P3.p-P8.p) are generated to form the vulval equivalence 
group. These cells are roughly equipotent, with any VPC capable of assuming any 
of the three potential VPC fates, 1˚, 2˚, or 3˚ (called primary, secondary, or tertiary). 
The VPCs are induced during the third larval (L3) stage. After initial patterning, 
the 22 daughter cells (eight cells from P6.p and seven cells from each P5.p and 




Figure 1. 1 The C. elegans vulva in L4 stage and young adult stage animal. 
The DIC images are captured by Dr. Rasmussen from Dr. Reiner lab. (white scale 
bar = 10 µm in the DIC images) A. The black arrow indicates a vulva in the L4 
stage animal. B. The black arrow indicates a vulva in young adult stage animal.  
 
 
anteroposterior mid-point, between the nose and tail of the hermaphrodite, at the 
ventral midline (Figure 1. 1).  
In this review I focus on the signaling network that governs developmental 
patterning of VPCs fates. Other important features of vulval development are 
outside the scope of this review, and are covered elsewhere (Sternberg, 2005). 
For example, generation of the VPCs and establishment of competency occur 
before the events are not described in this chapter. The timing of vulva 
development is controlled by the well-studied heterochronic system (Euling and 
Ambros, 1996). Generation of VPC lineages is relatively under-studied, beyond a 
sketch of a transcriptional gene regulatory network (Inoue et al., 2002; Inoue et 
al., 2005; Ririe et al., 2008). Polarity of 2˚ vulval lineages is controlled by 
overlapping Wnt systems (Inoue et al., 2004; Kidd et al., 2015; Minor et al., 2013). 
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Vulval morphogenesis is also relatively under-studied, though an interesting start 
has been made (Farooqui et al., 2012; Mok et al., 2015; Pellegrino et al., 2011). 
 
VPC fate patterning 
 
Pattern formation of the C. elegans vulval cell fates has proved to be an 
excellent model for the study of cell-cell communication. A confluence of research 
in the C. elegans VPCs, the Drosophila R7 photoreceptor, and mammalian cell 
culture and biochemistry led to the first consensus description of an intercellular 
signal, from ligand to nucleus. This signal is EGF (Epidermal Growth Factor)-
EGFR (EGF Receptor) signaling through the Ras proto-oncogene activation of 
the Raf-MEK-ERK canonical MAP kinase cascade, which is the main 1˚-
promoting signal in VPC patterning. Also of great impact was the characterization 
of the Notch receptor signaling system, which is the main 2˚-promoting signal in 
VPC fate patterning. Thus, VPC patterning holds a central place in the history of 
cell-cell signaling research in both development and cancer (Egan et al., 1993; 
Greenwald and Rubin, 1992). Here I discuss an undated view of the signaling 





Figure 1. 2 Overview of the C. elegans VPC fate patterning. The six naïve 
VPCs are numbered P3.p through P8.p. P6.p receives high level of inductive 
signal because of its closest distance from the anchor cell. P5.p and P7.p receives 
low level of inductive signal and lateral signal from the P6.p. P5.p, p6.P, and P7.p 
adopt vulval fate and develop vulva after three time of cell division. P3.p, P4.p, 
and P8.p receive insufficient inductive and lateral signal and adopt nonvulval fate 
fused with surrounding hpy7 hypodermis.  
 
 
The vulval equivalence group consists of six equipotent VPCs, arranged 
anteriorly-to-posteriorly along the ventral midline. These specialized cells are part 
of the epithelium (termed the “hypodermis” in C. elegans). During the L3 stage, 
the final pattern of fates emerges: 3˚-3˚-2˚-1˚-2˚-3˚. The 1˚ and 2˚ cells are induced 
vulval fates: these VPCs go on to form the vulva after characteristic cell division 
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lineages. The 3˚ cells are the “uninduced” or “ground” cell fate: they divide once 
and then fuse with the surrounding syncytial epithelium (Figure 1. 2; Sulston and 
Horvitz, 1977). This pattern occurs with 99.8% accuracy and the resulting cell 
lineages are invariant (Braendle and Felix, 2008). This pattern is induced by a 
signal from the Anchor Cell (AC), part of the somatic gonad, plus signals amongst 
the VPCs (Kimble, 1981; Sulston and White, 1980). Ablation of gonad during L1 
stage, or the AC before the L3 stage, caused all VPCs to adopt 3˚ fate and fail to 
develop the vulva. The first detectable event of AC induction is positioning of the 
VPCs relative to the AC. P6.p, the presumptive 1˚ cell, becomes centered next to 
the AC (Grimbert et al., 2016). Classical developmental biology experiments 
followed by decades of molecular genetics analysis has led to three non-
exclusionary mechanistic models that describe VPC fate patterning. Here I 
discuss the signaling network that generates the pattern of VPC fate. 
 
The Morphogen Gradient Model. 
 
Combining cell lineage analysis with ablation of selected cells with a laser 
microbeam revealed the presence of cell-cell signaling events between the AC 
and VPCs and among VPCs (Horvitz and Sulston, 1980; Kimble, 1981; Sternberg 




Figure 1. 3 The Morphogen Gradient Model. The equipotent VPCs are patterned 
by graded morphogen, LIN-3/EGF from the anchor cell (AC) through the activation 
of the receptor, LET-23/EGFR.   
 
 
Additionally, an extensive collection of mutations was generated that perturbed 
patterning in distinctive ways (Ferguson and Horvitz, 1985; Ferguson et al., 1987; 
Greenwald et al., 1983). From an elegant combination of these approaches arose 
the Morphogen Gradient Model (Figure 1. 3).  
The AC induces equipotent VPCs to assume their fate. P6.p, the VPC closest 
to the AC, nearly always becomes 1˚ (Sulston and Horvitz, 1977; Sulston and 
White, 1980). Isolated VPCs (generated by ablation of other VPCs with a laser 
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microbeam) assume 1˚ or 2˚ fate based on distance from the source of signal: 
VPCs close to the AC become 1˚, while those distal from the AC become 2˚ 
(Sternberg and Horvitz, 1986). This observation led to the model that it is dose of 
a “morphogen” signal that dictates VPC fate. Yet this model does not preclude 
cell-cell signaling among VPCs. 
lin-3 and let-23 are essential for 1˚ fate, and encode proteins similar to EGF 
and EGFR, respectively (Aroian et al., 1990; Hill and Sternberg, 1992). LIN-3 is 
expressed in the AC during the induction of VPCs at L2 to L4 stages and is 
required in the AC for VPC induction (Gonzalez-Serricchio and Sternberg, 2006; 
Hill and Sternberg, 1992; Liu et al., 1999). Ectopic expression of LIN-3 is sufficient 
to induce VPCs in the absence of gonad, indicating that LIN-3 is also sufficient to 
induce 1˚ fate (Hill and Sternberg, 1992). Again in isolated VPCs, 1˚ or 2˚ fate was 
induced by LIN-3 and LET-23 signaling dose, manipulated by genetic or 
transgenic means (Katz et al., 1995; Katz et al., 1996). The presence of a gradient 
was later validated visually using a transgenic molecular marker. The egl-17::gfp 
transcriptional fusion is a 1˚ fate marker that expresses GFP in induced 1˚ cells 
(Berset et al., 2001; Burdine et al., 1998). A more sensitive Pegl-17::cfp::lacZ 
transcriptional reporter revealed a transient flash of CFP in induced 2˚ cells. This 
weaker signal is sustained in the 2˚ lineages when negative regulators of 1˚ 
signaling are perturbed (Yoo et al., 2004; Yoo and Greenwald, 2005). 
Taken together, these results indicate that a spatially graded signal is 
detected by VPCs: this “Morphogen Gradient” contributes to the 3˚-3˚-2˚-1˚-2˚-3˚ 
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VPC fate pattern, the morphogen is the EGF ortholog LIN-3, and its receptor is 
the EGFR ortholog LET-23 (Kenyon, 1995). Yet these results were difficult to 
reconcile with the subsequent flood of molecular identification of genes identified 
in mutant screens for Vul and Muv mutants (Ferguson and Horvitz, 1985; 




Figure 1. 4 The Sequential Induction Model. In the response to the LIN-3/EGF, 
LET-23/EGFR activates LET-60/Ras-LIN-45/Raf-MEK-2/MEK-MPK-1/ERK 
signaling cascade to promote 1˚ fate. LET-23-mediated inductive signal induces 
DSL/Notch ligands transcription in the presumptive 1˚ cell. The DSL induces LIN-
12/Notch activation in the neighboring presumptive 2˚ cells.  
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The Sequential induction Model. 
 
Molecular genetic characterization of core signaling components necessary 
for VPC patterning argued that patterning occurred 1˚ first, then 2˚. This model is 
called the Sequential Induction Model (Simske and Kim, 1995; Figure 1. 4). 
Extensive mutant screens identified genes that are necessary and sufficient for 1˚ 
and 2˚ fate (Ferguson and Horvitz, 1985; Ferguson et al., 1987; Greenwald et al., 
1983). Molecular cloning and analysis of these genes, plus epistatic ordering of 
genes into pathways, identified a major (necessary and sufficient) cascade for 
inducing primary 1˚ fate. Via the SEM-5/Grb adaptor and SOS-1/Sos Ras 
exchange factor, LET-23 activates the LET-60/Ras-LIN-45/Raf-MEK-2/MEK-
MPK-1/ERK canonical MAP kinase cascade to induce 1˚ fate (Beitel et al., 1990; 
Chang et al., 2000; Clark et al., 1992; Han et al., 1990; Han et al., 1993; Kornfeld 
et al., 1995a; Lackner et al., 1994; Wu et al., 1995). Screens for suppression of 
the Muv phenotype caused by activated LET-60/Ras discovered proteins now 
accepted as components of Ras-Raf-MEK-ERK signaling: SOC-2/SUR-8 is 
thought to function as a scaffold for LET-60/Ras-LIN-45/Raf (Selfors et al., 1998; 
Sieburth et al., 1998) and KSR-1 is thought to function as a scaffold for LIN-
45/Raf-MEK-2/MEK-MPK-1/ERK (Kornfeld et al., 1995b; Sundaram and Han, 
1995). Thus, this highly conserved cascade in necessary and sufficient to induce 
1˚ fate. Subsequent studies in humans have connected human RASopathies, 
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spectrums of congenital defects, with causative molecular etiologies that serve to 
weakly activate the Ras-Raf-MEK-ERK cascade (Bustelo et al., 2018). 
Critical for the induction of 2˚ fate is the Notch ortholog, LIN-12 (Greenwald 
et al., 1983), which mediates the lateral signal from presumptive 1˚ cell to 
presumptive 2˚ cells (Sternberg, 1988; Sternberg and Horvitz, 1989). Three DSL 
Notch ligands, LAG-2, APX-1 and DSL-1, are synthesized in the presumptive 1˚ 
cell in response to inductive signal. These ligands are redundantly required to 
laterally signal the neighboring P5.p or P7.p to become 2˚ cells (Chen and 
Greenwald, 2004; Zhang and Greenwald, 2011).  
Genetic mosaic experiments showed expression of let-23(+) in P6.p, but not 
in P5.p and P7.p, supports normal vulva induction (Koga and Ohshima, 1995; 
Simske and Kim, 1995). Strikingly, genetic mosaic analyses indicated that LET-
23 function is required to induce 1˚ but not 2˚ fate (Koga and Ohshima, 1995; 
Simske and Kim, 1995). Coupled with the synthesis of DSL ligands for LIN-12 in 
presumptive 1˚ cells, these results are consistent with a different model for VPC 
fate patterning. The Sequential Induction Model proposes that the VPC that 
receives the strongest LIN-3 dose because 1˚, then signals its neighbors to 
become 2˚. This stepwise signaling – first 1˚, then 2˚ – was considered to be 








A key mechanism by which the VPCs are accurately patterned is what we 
term “Mutual Antagonism”. Though they start as equipotent, initially specified 
VPCs alter their signaling network to exclude signals that promote the opposing 
fate. This feature of the signaling network likely reduces conflicting signals, and 
thus the rate of VPCs committing to inappropriate or ambiguous cell fates. In turn, 
by decreasing formation of aberrantly patterned vulvae, this network feature likely 
increases the reproductive fitness of the animal. 
Multiple lines of evidence point to an antagonistic tension between 
presumptive 1˚ and 2˚ cells (illustrated in Figure 1. 5). Prior to induction in L2 and 
early L3 stages, all six VPCs express LIN-12 (Levitan and Greenwald, 1998; 
Wilkinson and Greenwald, 1995). Upon induction, in the developing 1˚ cell LIN-12 
is internalized and degraded (Deng and Greenwald, 2016a; Levitan and 
Greenwald, 1998; Shaye and Greenwald, 2002, 2005). The mechanism of LIN-12 
down-regulation is as yet unknown, but it depends on the MPK-1/ERK 1˚-
promoting target, SUR-2 of the Mediator complex (see below). 
In addition, the 1˚-promoting LET-23-LET-60-LIN-45-MEK-2-MPK-1 
canonical MAP kinase cascade is inhibited in specified 2˚ cells, P5.p and P7.p. 
After induction, transcription of the ERK phosphatase, LIP-1, is induced by LIN-
12/Notch signaling in these cells (Berset et al., 2001). The egl-17 gene is a 




Figure 1. 5 Mutual Antagonism. There are antagonistic mechanisms that 
prevent a specific VPC from adopting a wrong cell fate. In the presumptive 1˚ cell, 
LIN-12/Notch, a 2˚-promoting signal, is blocked by LET-23/EGFR-mediated signal 
through internalization and degradation of the Notch receptor. In the presumptive 
2˚ cells, the Notch target gene, lip-1, is transcribed upon LIN-12 activation. The 
1˚-promoting MPK-1/ERK is inhibited through dephosphorylation by the ERK 
phosphatase LIP-1/MPK.  
 
 
transcription factor (Burdine et al., 1998; Tiensuu et al., 2005). In wild-type VPCs, 
a transient pulse of egl-17 transcriptional reporter can be observed in presumptive 
2˚ cells (Yoo et al., 2004). In the absence of LIP-1 and other LIN-12 transcriptional 
client genes, the lst genes, dpy-23 and ark-1 (see below), the signal from the egl-
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17 reporter persists (Berset et al., 2001; Yoo et al., 2004). In addition to LIP-1, the 
DEP-1 receptor tyrosine phosphatase, predicted to inhibit LET-23 activity, is 
expressed in 2˚ cells after induction to antagonize the 1˚-promoting signal (Berset 
et al., 2005).  
An additional mechanism that may fit conceptually into the Mutual 
Antagonism category is the concept of “Balanced Switches” (Chapter 3; Shin et 
al., submitted). We found that RGL-1 harbors genetically separable and 
antagonistic functions. As demonstrated in mammalian cells (Feig, 2003) and 
validated in C. elegans, the canonical GEF function of RalGEF is activated by Ras 
and stimulates activation of Ral; in VPCs this is a modulatory 2˚-promoting activity. 
Of signaling cascades defined in VPC fate patterning, an AGE-1/PI3K-PDK-
1/PDK signal, with the DAF-18/PTEN lipid phosphatase as a negative regulator, 
has been shown to promote 1˚ fate in a modulatory capacity (Nakdimon et al., 
2012). We showed that AKT-1/Akt likely also functions in this cascade (Shin et al., 
submitted), thus constituting a classic PI3K-Akt signaling cascade. Our genetic 
epistasis data are consistent with RGL-1 performing a GEF-independent function 
as a scaffold of PDK-1 and AKT-1. Such a function was originally described in 
mammalian cells for the RalGEF, RalGDS (Hao et al., 2008; Tian et al., 2002). 
RGL-1 appears to participate in antagonistic 1˚-promoting and 2˚-promoting 
activities. We term this phenomenon the “Balanced Switch”. By deleting RGL-1, 
we appear to abolish the activity of both modulatory cascades, with no net change 
in the balance of 1˚ and 2˚ signals. But animals without RGL-1 display a 15-fold 
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higher error rate in VPC patterning. The “Balanced Switch”, exemplified by RGL-
1, may define a novel category of Mutual Antagonism (Shin et al., submitted; 
Chapter 3).  
Thus, in response to signaling cascades necessary for 1˚ and 2˚ fate, each 
cell type enacts programs to exclude promotion of the competing cell fate. A series 
of orphan 1˚- and 2˚- antagonizing “modifier genes” have been identified, but not 
placed functionally in the VPC patterning network (Greenwald, 2005; Sundaram, 
2005). These gene products could provide yet additional layers of Mutual 
Antagonism mechanisms. Perturbation of multiple antagonistic mechanisms 
confers patterning errors, suggesting that, collectively, these Mutual Antagonism 
mechanisms are critical for accurate VPC fate patterning. 
 
Reconciling the Sequential Induction and Morphogen Gradient models. 
 
The “Sequential Induction” model does not explain how graded EGF signal 
promotes 2˚ fate or varying levels of LIN-3 and LET-23 signaling dose result in 
different signaling outcomes. This contradiction remained in the field for 16 years 
(Kenyon, 1995). However, work from our lab reconciled these two models by 
showing that graded LIN-3-LET-23 signaling promotes 2˚ fate through a LET-60 
switching effectors. In contrast to the LET-60-LIN-45-MEK-2-MPK-1 cascade that 




Figure 1. 6 Reconciling the Sequential Induction and Morphogen Gradient 
models. The Morphogen Gradient Model and Sequential Induction Model were 
reconciled by the study done by Zand et al., 2011. The LET-23/EGFR-LET-
60/Ras-LIN-45/Raf-MEK-2/MEK-MPK-1/ERK promotes 1˚ fate. In the response to 
the graded LIN-3/EGF, LET-23 activates LET-60/Ras-RGL-1/RalGEF-RAL-1/Ral 
to induce 2˚ fate in support of LIN-12/Notch. 
 
 
Ral signal promotes 2˚ fate as a positive modulator in support of LIN-12 (Zand et 
al., 2011; Figure 1. 6). RalGEF-Ral is a proto-oncogenic non-canonical Ras 
effector in human cells (reviewed in Gentry et al., 2014; Kashatus, 2013). We 
further investigated downstream of RAL-1 and found that RAL-1 signals through 
EXOC-8/Exo84-GCK-2/MAP4K-PMK-1/p38 MAPK to promote 2˚ fate (Chapter 2). 
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Yet while LET-60 effector switches from LIN-45/Raf to RGL-1/RalGEF, we do not 
understand the mechanism of effector switching.  
Isolated VPCs distal from the AC were originally shown to frequently assume 
2˚ fate (Katz et al., 1995; Katz et al., 1996; Sternberg and Horvitz, 1986). Yet since 
LIN-12 is theorized to be essential for assuming 2˚ fate (Greenwald et al., 1983), 
it was unclear how these isolated VPCs were induced to become 2˚ cells. A 
resolution of this contradiction is that a combination of low dose LIN-3 and 
autocrine signaling by DSL Notch ligands could induce distal and isolated VPCs 
to assume 2˚ fates (Hoyos et al., 2011). While it is unclear how this signaling 
mechanism intersects with sequential induction and morphogen gradient signaling 
mechanisms, a plausible model is that all three mechanisms collaborate to 
spatially induce, reinforce, and restrict 2˚ fate induction, thereby increasing 
patterning fidelity. 
 
Trafficking-dependent Regulation of Receptor Localization and Function 
 
In addition to the importance of intercellular spatial relationships in VPC fate 
patterning, intracellular spatial localization of signals within VPCs has been found 
to have critical importance. After LET-23 was identified to be an ortholog of the 
EGF receptor (Aroian et al., 1990) and function cell autonomously in the 
presumptive 1˚ cell, P6.p (Hoskins et al., 1996; Koga and Ohshima, 1995; Simske 
and Kim, 1995), over-expressed GFP fusion proteins and antibody staining 
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suggested that LET-23 is localized to plasma membrane, with particularly strong 
localization to junctions (Kaech et al., 1998; Simske et al., 1996; Whitfield et al., 
1999). Subsequent analysis with lower copy number transgene zhIs35[let-
23::GFP + unc-119(+)] suggests that LET-23 expression is dynamically regulated 
during VPC patterning (Haag et al., 2014). Our results analyzing CRISPR-
mediated tag, LET-23::mKate2, supports this observation (H. Shin and T. Duong, 
personal communication; Chapter 4). These observations, plus many genetic 
results and our cell biological results (see Chapter 4), argue that subcellular 
localization of LET-23/EGFR and perhaps LIN-12/Notch provide critical regulatory 
axes to control the VPC fate patterning signaling network. 
 
LET-23 basolateral localization system. 
 
The C. elegans VPCs are polarized epithelial cells that are connected by 
adherens junctions (Chisholm and Hardin, 2005). Through these junctions, the six 
VPCs are tightly connected in the ventral midline in a single row. And, the cell 
junctions generate separated spatial domains of each VPC: the apical and 
basolateral plasma membranes of each VPC. Lipids and transmembrane proteins 
are potentially segregated by these adherens junctions, thus creating potentially 
distinct signaling domains.  
Localization of LET-23 to the basolateral plasma membrane of VPCs is 
necessary for 1˚ fate induction. A critical genetic tool for this discovery was the 
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let-23(sy1) mutation, which introduces a premature stop that truncates the last six 
residues of the receptor. let-23(sy1) animals are vulvaless through lack of 1˚ 
induction, but are unaffected for other phenotypes regulated by LET-23, like 
development of the excretory duct cell or fertility (Aroian et al., 1990; Aroian and 
Sternberg, 1991). The sy1 mutation causes LET-23 to be mis-localized to the 
apical membrane of VPCs, suggesting that the 1˚-promoting signal occurs at the 
basolateral surface, closest to the AC (Simske et al., 1996). Mutations in lin-2, lin-
7, and lin-10 similarly caused a Vul phenotype without impacting other LET-23 
dependent developmental events. LIN-2, LIN-7, and LIN-10 encode orthologs of 
CASK, Veli, and Mint, respectively, and form a protein complex to localize LET-
23 to the basolateral membrane of VPCs (Hoskins et al., 1996; Kaech et al., 1998; 
Kim, 1997; Simske et al., 1996; Whitfield et al., 1999). LIN-2 has a CaM kinase 
domain, a calmodulin-binding domain, and a PDZ domain, a SH3 domain, and a 
guanylate kinase domain (Kim, 1997). LIN-7 has a single PDZ domain (Simske et 
al., 1996). LIN-10 has a two PDZ domains and a phospho-tyrosine binding domain 
(PTB) (Kaech et al., 1998). Of particular note is LIN-7, whose PDZ domain may 
recognize the PDZ recognition sequence in the C-terminus of LET-23 that is 
removed by the let-23(sy1) mutation that causes inappropriate apical localization 
of LET-23. Taken together, these results indicate that the 1˚-promoting signal of 
LET-23 occurs at the basolateral surface, and requires the LIN-2/-7/-10 complex 
to proper localization. 
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A genetic screen for identification genes required for proper localization of 
LET-23::GFP identified ERM-1 (Ezrin/Radixin/Moesin). ERM-1 may function to 
keep LET-23::GFP sequestered in basolateral compartments, thus influencing 
trafficking, and ERM-1 is thought to function independently of LIN-2/-7/-10 (Haag 
et al., 2014). Thus, multiple axes of spatial regulation likely impact LET-23 
signaling. 
 
Negative regulators of LET-23 function through endocytosis, trafficking, and 
degradation. 
 
A series of negative regulators of the LET-23 1˚-promoting signal may control 
endocytosis and intracellular trafficking of LET-23. Reduced function alleles of 
unc-101 were discovered as suppressors of the let-23(sy1) vulvaless phenotype 
(Lee et al., 1994). UNC-101 encodes a medium chain of the clathrin-associated 
complex AP-1. In a computational screen for genes with LAG-1 binding sites that 
are putative LIN-12 transcriptional targets, DPY-23 was found to antagonize the 
1˚-promoting signal (Yoo et al., 2004). DPY-23 has also been implicated in 
endocytosis of other signaling cascades, including Wnt (Pan et al., 2008). In 
mammalian cells, the ortholog of DPY-23, which is a subunit of the clathrin 
Adaptor Protein Complex 2 (AP-2), functions in the degradation of EGFR (Letunic 
et al., 2002; Rapoport et al., 1997).  
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C. elegans AGEF-1 is homologous to mammalian BIG1 and BIG2 ArfGEFs 
(guanine nucleotide exchange factors for the Arf family of small GTPases), which 
are involved in secretory trafficking between trans-Golgi, endosomes and plasma 
membrane through AP-1 recruitment (Casanova, 2007; Ishizaki et al., 2008; 
Manolea et al., 2008; Morinaga et al., 1996; Skorobogata et al., 2014). Mutant C. 
elegans AGEF-1 suppressed the vulvaless phenotype of let-23(sy1) and lin-
2(e1309), suggesting that AGEF-1 functions as a negative regulator of LET-23 
signaling; ARF-1.2 and ARF-3, potential GTPase substrates of AGEF-1, are also 
implicated as negative regulators of LET-23 (Skorobogata et al., 2014). The 
basolateral localization of LET-23 in LIN-2 mutant is partially restored by AGEF-1 
mutant. This result suggests that AGEF-1 represses LET-23 basolateral 
localization in VPCs.  
Mutations in SLI-1 (Suppressor of Lineage defect) were identified as 
suppressors of the vulvaless phenotype of let-23(sy1) (Jongeward et al., 1995; 
Yoon et al., 1995). SLI-1 is the C. elegans ortholog of Drosophila D-Cbl and the 
mammalian proto-oncogene, c-Cbl (Yoon et al., 1995), and its paralogous 
relatives Cbl-b and Cbl-c. Like other Cbl family members, SLI-1 has four-helix 
bundle (4H), EF hand, SH2 domain, RING finger domain, SH3 motifs, and two 
YXN motifs (Yoon et al., 2000; Yoon et al., 1995). Mammalian c-Cbl functions as 
an E3 ubiquitin ligase. c-Cbl interacts with a broad set of signaling proteins 
harboring a phospho-tyrosine consensus sequence, mostly EGF Receptor 
Tyrosine Kinase (Mohapatra et al., 2013; Thien and Langdon, 2001). c-Cbl can 
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function to trigger proteasome-dependent degradation of EGFR via 
polyubiquitylation, or endosomal trafficking and recycling via monoubiquitylation 
(Joazeiro et al., 1999; Levkowitz et al., 1999). A plausible target site by which SLI-
1 inhibits LET-23 is through binding to putative phospho-tyrosine site 2 (out of 8 
in the LET-23 cytoplasmic region), which has been shown to be a negative 
regulatory site (Lesa and Sternberg, 1997). Whether this negative regulation is via 
degradation or subcellular trafficking is unknown. 
Mammalian Rab5 and Rab7, Rab family small GTPases, regulate early 
endosome and late endosome, respectively (Ceresa, 2006). Rab5 promotes 
EGFR internalization, while Rab7 regulates EGFR trafficking from late 
endosomes to lysosomes (Barbieri et al., 2000; Dinneen and Ceresa, 2004; 
Lanzetti et al., 2000; Martinu et al., 2002; Tall et al., 2001). The ortholog of 
mammalian Rab7, C. elegans RAB-7 was shown to be a negative regulator of 
LET-23: the rab-7 mutant suppressed the vulvaless phenotype of let-23(sy1) and 
lin-2(e1309) (Skorobogata and Rocheleau, 2012). In the RAB-7 mutant, LET-
23::GFP is localized at both the apical membrane and the basolateral membrane 
in P6.p. And, the LET-23::GFP is accumulated in the endocytic vesicles 
suggesting that RAB-7 regulates LET-23 trafficking.  
ARK-1 encodes the Ack-related cytoplasmic tyrosine kinase containing SH3 
and CRIB (Cdc42/Rac interactive binding) domains (Hopper et al., 2000). The 
ARK-1 mutant suppresses vulvaless phenotype in let-23(sy1), lin-2, lin-7, and lin-
10 mutants and confers a synthetic Muv phenotype in double mutant 
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combinations with mutations in sli-1 or unc-101, suggesting that ARK-1 
redundantly inhibits LET-23 (Hopper et al., 2000). The ark-1 gene was identified 
as a potential transcriptional target of LIN-12 (Yoo et al., 2004), suggesting that 
ARK-1 antagonizes LET-23 specifically in 2˚ cells, perhaps to prevent 
inappropriate 1˚-promoting signal in 2˚ cells. 
 
Negative and spatial regulation of LIN-12. 
 
At L2 through early L3 stage before inductive signal starts, LIN-12 protein 
was shown to be equally expressed in VPCs. Specifically, LIN-12 was shown to 
be localized to the apical plasma membrane (Levitan and Greenwald, 1998; 
Shaye and Greenwald, 2002). However, the LIN-12 expressed only in 2˚ cells and 
their daughter cells after the VPC fate specification (Levitan and Greenwald, 1998; 
Shaye and Greenwald, 2002). This suggests that LIN-12 is down-regulated by 
inductive signal in presumptive 1˚ cell. LIN-12 may be negatively regulated by 
internalization and degradation mechanisms. SEL-2 has been shown to be a 
negative regulator of LIN-12 in 1˚ cell (de Souza et al., 2007). In SEL-2 mutant, 
LIN-12 was localized at the basolateral membrane in VPCs, indicating that SEL-






Upstream and downstream transcriptional regulators in VPC fate patterning 
 
Changes in transcriptional regulation is central to most developmental 
processes. In VPC induction, controlled expression of the LIN-3 ligand in the AC 
patterns the VPCs, which have themselves undergone a prolonged 
developmental program that includes migrations and competency (Sternberg, 
2005). Downstream of inductive signaling lie transcriptional events that execute 
initial 1˚- and 2˚-specific fate programs. Here I briefly review known transcriptional 
programs upstream and downstream of the VPC signaling network. 
 
Upstream: repression of LIN-3 expression by the synMuv genes. 
 
The synthetic multivulva (synMuv) phenotype was discovered by accident in 
screens for defective vulval formation: two genes are required to be mutated in 
order to have Muv phenotype, while neither single gene mutant shows normal 
vulva induction (Ferguson and Horvitz, 1985). Initial examples discovered by 
accident were the lin-8; lin-9 and lin-15A/B double mutants, each of which were 
shown to comprise mutations in two distinct genes. The synMuv classes A and B 
were subsequently populated by further screens for the synMuv phenotype in non-
Muv single mutants (Ceol and Horvitz, 2004; Ceol et al., 2006; Ferguson and 
Horvitz, 1989). Subsequent analyses found many more synMuv genes, and 
argued that even double mutants among the class B mutants confer the synMuv 
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phenotype at high temperature (Andersen et al., 2008). Some synMuv genes may 
fall into a third class, Class C (Ceol and Horvitz, 2004). 
SynMuv genes are thought to antagonize LIN-3/EGF-LET-23/EGFR signaling. 
The synMuv mutant combination conferred a Muv phenotype that was suppressed 
by reduction of let-23 function (Ferguson et al., 1987). Early genetic mosaic 
experiments suggest that the synMuv lin-15A/B genes function in the 
hypodermal/epithelial cells surrounding the VPCs, leading to the model that the 
collection of synMuv genes defined a third pathway that inhibited vulval induction 
(Herman and Hedgecock, 1990). Consistent with these results, mosaic analysis 
and use of heterologous promoters indicated that the lin-35 synMuv gene 
functions in hypodermis to repress vulval induction (Myers and Greenwald, 2005). 
Critically, depletion of lin-3 by RNAi demonstrated that the phenotype caused by 
mutation of synMuv genes requires LIN-3. Mutation of synMuv genes increases 
LIN-3 expression in hypodermal cells, and ectopic expression of LIN-3 from 
hypodermal cells was sufficient to confer a Muv phenotype (Cui et al., 2006). Of 
critical importance was the identification of a dominant synMuv A mutation, lin-
3(n4441), in the promoter of lin-3. smFISH experiments indicated that 
transcription of lin-3 is tightly regulated spatially, but in synMuv mutants is 
derepressed show expression in the surrounding hypodermal cells (Saffer et al., 
2011). Consequently, a consensus model has emerged that the synMuv genes 
function collectively to repress the promoter of the lin-3 gene, thus spatially 
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restricting LIN-3 expression to the AC and robustly limiting the inductive signal to 
a precise point source. 
Accordingly, many synMuv genes encode transcriptional and/or epigenetic 
regulators (reviewed in (Fay and Yochem, 2007). For example, some of synMuv 
A group genes encode proteins that contain a zinc-finger-like THAP domain (Clark 
et al., 1994; Davison et al., 2011; Huang et al., 1994). The synMuv B group genes 
have homology with mammalian proteins that are involved in chromatin 
remodeling, transcription repression, and histone modification (Andersen and 
Horvitz, 2007; Ceol and Horvitz, 2001; Couteau et al., 2002; Lu and Horvitz, 1998; 
Poulin et al., 2005; Solari and Ahringer, 2000; Unhavaithaya et al., 2002). A 
combination of direct transcriptional repression and gene epigenetic repression is 
thought to impose strict spatial restriction of the LIN-3 inductive signal. Less well 
understood is the role of four LIN-3 splice variants/isoforms and the potential role 
of the ROM-1/Rhomboid protease in propagation of the inductive signal (Dutt et 
al., 2004; Pu et al., 2017; Van Buskirk and Sternberg, 2007).  
 
Downstream: 1˚- and 2˚-promoting transcriptional complexes. 
 
Screens for mutants conferring a Muv defect identified the genes lin-1 and 
lin-31. By genetic epistasis both were found to function downstream in the 1˚ 
induction signaling cascade (Beitel et al., 1995; Ferguson et al., 1987; Miller et al., 
1993). LIN-1 is an ETS/ELK-1-like transcription factor, which is frequently found 
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as a downstream ERK target in mammalian cells (Hart et al., 2000). Strong lin-1 
alleles confer an excess 1˚ phenotype that is insensitive to upstream pathway 
activity, leading to the model that MPK-1/ERK represses LIN-1 activity, which in 
turn represses 1˚ fate. This model was validated by gain-of-function mutations in 
lin-1 that confer a vulvaless phenotype, and which identify C-terminal repressive 
MPK-1/ERK phosphorylation sites (Fantz et al., 2001; Jacobs et al., 1998). The 
transcriptional targets of 1°-promoting signaling are egl-17 and LIN-12/Notch 
ligands, DSL ligands encoded by lag-2, apx-1, and dsl-1 (Burdine et al., 1998; 
Chen and Greenwald, 2004). 
LIN-31 is a winged helix transcription factor orthologous to mammalian HNF-
1 and Drosophila Forkhead (Miller et al., 1993); in modern nomenclature, FoxB. 
Similar to LIN-1, LIN-31 is also phosphorylated by MPK-1/ERK, and a putative 
LIN-31-LIN-1 heterodimer is disrupted by this phosphorylation. Over-expression 
of non-phosphorylatable LIN-31 repressed vulval fates, consistent with this model 
(Tan et al., 1998). But subsequent CRISPR knock-ins of phosphodefective and 
phosphomimetic mutations in the same putative MPK-1 sites failed to alter VPC 
patterning, so regulation of LIN-31 may be more complex (Dickinson et al., 2013). 
Yet in contrast to LIN-1, disruption of LIN-31 function confers both Muv and Vul 
phenotypes: the vulval lineages of lin-31 mutants could be described as 
randomized, with any VPC assuming any fate. (Miller et al., 1993; Tan et al., 1998). 
Consequently, LIN-31 is perceived as a critical determinant of all three potential 
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VPC fates, but its regulation and interactions with other transcriptional machinery 
is still not understood. 
SUR-2/Med23 and LIN-25/Med24 are important for 1˚ fate induction and were 
identified, respectively, based on suppression of activated LET-60/Ras and a Vul 
phenotype. SUR-2 and its partner LIN-25 are subunits of the multi-subunit 
transcriptional Mediator complex, and function downstream of or parallel to MPK-
1 in VPCs (Nilsson et al., 1998; Nilsson et al., 2000; Singh and Han, 1995; Tiensuu 
et al., 2005; Tuck and Greenwald, 1995) Through use of diverse cofactors to 
generate a variety of distinct complex types, the Mediator complex functions to 
bridge tissue-specific transcription factors and RNA polymerase II, as well as 
potentially integrating inputs of various transcriptional enhancers and repressors 
(Allen and Taatjes, 2015). Mammalian Elk1, an ortholog of LIN-1, interacts with 
the MED23/Sur2 in an ERK-dependent manner (Stevens et al., 2002), validating 
the model of MPK-1 repression of LIN-1 and the role of SUR-2/LIN-25 and the 
Mediator complex in VPC induction. SUR-2 and the Hox protein LIN-39, which is 
required for VPC competence (Guerry et al., 2007; Maloof and Kenyon, 1998; 
Wagmaister et al., 2006), likely collaborate to promote transcription of the lateral 
signaling genes lag-2, which encodes a DSL ligand for LIN-12/Notch (Zhang and 
Greenwald, 2011). Genetic analyses suggest that various subtypes of the 
Mediator complex, particularly the CKM module, function to set activity thresholds 
and discriminate between MPK-1/ERK 1˚- and LIN-12/Notch 2˚-promoting 
signaling activity, thus providing a key integration point between the VPC signaling 
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network and precise transcriptional execution of VPC fates (Grants et al., 2016; 
Underwood et al., 2017). 
In parallel to these transcriptional mechanisms are EOR-1 and EOR-2 (EGL-
1 suppressor, Di-O uptake defective, Raf enhancer), which also functions together 
downstream of MPK-1 to positively regulate vulva induction (Howard and 
Sundaram, 2002). The EOR-1 encodes a BTB and C2H2 Zinc finger protein and 
the EOR-2 is a binding partner of EOR-1 (Howard and Sundaram, 2002; Howell 
et al., 2010).  
Notch receptors are unusual, in that they comprise the entirety of their signal 
transduction cascade, from the plasma membrane to the nucleus. Specifically, 
upon ligand binding and activation, a series of proteolytic cleavage events 
released the intracellular domain (ICD) of Notch receptors, including LIN-12, 
which then translocates to the nucleus. There, the ICD functions as a 
transcriptional co-activator (Struhl et al., 1993); reviewed in (Greenwald, 2005; 
Greenwald and Kovall, 2013). 
A critical advance in C. elegans Notch biology was the discovery that the two 
nematode Notch receptors, GLP-1 and LIN-12, share functional redundancy in 
certain processes. The double mutant conferred a distinctive first stage (L1) larval 
arrest dubbed the LAG phenotype (LIN-12 and GLP-1; Lambie and Kimble, 1991). 
Screens for this phenotype identified two additional genes in the Notch system, 
LAG-1 and LAG-3 (LAG-2 encodes a shared LIN-12 and GLP-1 DSL ligand; Tax 
et al., 1997). LAG-1 encodes the nematode ortholog of Drosophila Suppressor of 
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Hairy (Su(H)) and mammalian CBF1, established DNA-binding proteins. Like 
Su(H)/CBF1, LAG-1 binds a conserved consensus target sequence, RTGGGAA 
(Christensen et al., 1996). LAG-1 binds the ICD, and together they can activate 
transcription (Roehl et al., 1996). LAG-3 (a.k.a. SEL-8) is a Glutamine-rich protein 
similar to Drosophila mastermind that forms a complex with LAG-1 (Doyle et al., 
2000; Petcherski and Kimble, 2000). Together, these proteins and the ICD likely 
form a ternary complex that regulates transcription of tissue-specific client genes. 
Using a more refined consensus binding sequence from other systems 
(YRTGTGAA; “Lag binding sequence (LBS)”) potential target genes of Notch 
signaling were identified computationally. Candidates were validated by RNAi 
depletion and promoter::GFP transcriptional fusions Thus, the Notch target genes 
such as dpy-23, lst-1, 2, 3, and 4, mir-61, were identified. Collectively, these genes 
appear to function to antagonize 1˚-promoting signals, contributing to the Mutual 
Antagonism Model. Target genes that promote 2˚ fate have not yet been identified, 
suggesting that they share redundant functions (Yoo et al., 2004; Yoo and 
Greenwald, 2005). 
 
Transcriptional reprogramming of the VPC signaling network 
 
Prior to induction of naïve VPCs, expression of promoter::GFP fusions is 
typically uniform. Soon after induction, however, expression levels of many 
promoters, particularly of modulatory genes, is dynamically regulated. This 
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reprogramming contributes to key mechanisms of VPC fate patterning, such as 
mutual antagonism (see above), and thus represents plasticity of the signaling 
network that accompanies initial specification of fates. Furthermore, we posit that 
reprogramming of the expression of modulatory signals helps reinforce initial 
patterning, so VPCs can commit to their fate decisions while mitigating conflicting 
signals, or “noise”, can could introduce developmental error. 
Mostly, transcriptionally reprogrammed genes have been identified as 
negative regulators of 1˚-promoting signal, or computationally discovered as 
transcriptional targets of the LIN-12/Notch lateral signal. Whether the latter are 2˚-
promoting or anti-1˚ is difficult to determine by existing genetic assays, since the 
two signals are mutually antagonistic. The restriction of gene expression to 
specific VPC lineages reinforces the final commitment and fidelity during VPC fate 
patterning. Here I describe the examples of transcriptional reprogramming in VPC 
fate patterning.  
Reporters for LIN-12/Notch target genes are expressed consistently in VPCs 
at the early L3 stage, before VPC fate patterning has happened. However, at late 
L3 stage, typically before the first cell division, expression from reporters is 
excluded from the 1˚ but not the 2˚ cell/lineage. Reporters are expressed strongly 
in 2˚ cells after VPC fate patterning (Figure 1. 7A). For example, the 2˚-promoting 
ral-1 gene, LIN-12/Notch target genes dpy-23, lst-1, 2, 3, and 4, and 1˚-
antagonizing genes lip-1 and dep-1 all showed this transcriptional expression 
pattern in VPCs (Berset et al., 2001; Berset et al., 2005; Yoo et al., 2004; Zand et  
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Figure 1. 7 Expression pattern of transcription of either 2˚-promoting and 1˚-
antagonizing or 1˚-promoting genes in VPCs. Transcriptional reprogramming 
is shown by promoter GFP fusion in VPCs. A. 2˚-promoting RAL-1 and 1˚-
antagonizing LIP-1, DEP-1, DPY-23, LST-1, -2, -3, and -4 are transcribed in both 
1˚ and 2˚ cells at early L3/before induction. However, they are transcriptionally 
down-regulated in 1˚ cells, but still expressed in 2˚ cells and their daughters at late 
L3 and 2-cell stage. B. 1˚-promoting PXF-1 is transcribed in 1˚ and 2˚ cells at early 
L3 stage. The transcription of PXF-1 persists in the daughters of 1˚ cell at 2 cell 
stage. However, PXF-1 transcription is negatively regulated in the daughters of 2˚ 
cells at 2-cell stage.  
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al., 2011). Strikingly, after induction, expression from these reporters was 
excluded from the presumptive 1˚ cell, but persisted strongly in presumptive 2˚ 
cells.  We speculate that such transcriptional reprogramming of these genes 
reinforces 1˚-antagonizing and/or 2˚-promoting function, thereby better 
demarcating cell fate signaling and increasing developmental fidelity in the system. 
An exception to this observation is highlighted by the ligands for the lateral 
2˚-promoting signal mediated by LIN-12/Notch: transcriptional reporters for apx-1, 
dsl-1, and lag-2 are expressed in the presumptive 1˚ cell in response to inductive 
signal and repressed in non-1˚ cells (Chen and Greenwald, 2004; Zhang and 
Greenwald, 2011). That their reporter expression reflects that otherwise expected 
for 1˚-promoting genes is consistent with their cell non-autonomous role as the 
ligands for the LIN-12/Notch lateral signal. This observation is an important 
validation of the Sequential Induction Model, and may be the exception that 
proves the rule for transcriptional reprogramming. 
Transcriptional reporters for 1˚-promoting genes also reveal initially 
consistent expression that dynamically changes after induction. But in this case 
the induction reflects reprogramming consistent with initial specification to 
promote 1˚ fate (Figure 1. 7B). A different modulatory signaling axis, that of PXF-
1/RapGEF signaling to the very close LET-60/Ras sibling, RAP-1/Rap1, promotes 
1˚ fate in parallel to LET-60 (Rasmussen et al., in revision). CRISPR-tagged 
endogenous RAP-1 is expressed ubiquitously, and GFP expressed from a 
transgenic promoter fusion of pxf-1 showed uniform expression in all VPCs at 
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early L3 stage before VPC fate patterning. However, after induction, pxf-1 reporter 
GFP expression was excluded from 2˚ cells and increased in 1˚ cells at the Pn.px 
stage. This result is consistent with transcriptional reprogramming of PXF-1 
expression restricting activation of 1˚-promoting RAP-1 to the 1˚ cell while 
abrogating the activation of RAP-1 in 2˚ cells. Consequently, we hypothesize that 
PXF-1-RAP-1 functions as a spatially refined positive feedback loop to promote 
1˚ fate. 
Transcriptional reporters for the egl-17 gene reveal an expression pattern that 
reflects the putative morphogen gradient: reporter expression is absent prior to 
induction, then after induction is high in presumptive 1˚ cells and faint and 
transient in presumptive 2˚ cells (Burdine et al., 1998; Yoo et al., 2004). Mutations 
in lip-1 and dep-1, negative regulators of the 1˚-promoting cascade, cause the egl-
17 reporter to persist in 2˚ cells (Berset et al., 2001; Berset et al., 2005; Yoo et al., 
2004). Yet this reporter is likely not a reporter for 1˚ fate, but rather a direct 
transcriptional target of LIN-1/ELK1, downstream of MPK-1/ERK (Tiensuu et al., 
2005). EGL-17 is an ortholog of mammalian FGF, and its secretion by the 
presumptive 1˚ cell helps the migrating SM cells home in on the A-P midpoint of 
the animal (Burdine et al., 1997). 
The regulation of genes at the transcriptional level does not necessarily 
reflect expression of protein at the translational level. For example, the 
promoter::GFP transcriptional fusion of ral-1 showed dynamic changes in levels 
during VPC induction (Zand et al., 2011). In contrast, the endogenously tagged 
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RAL-1 by CRISPR appears to be expressed consistently throughout VPC 
development, and localized to the plasma membrane in all VPCs (Shin et al., 
2018). How do we reconcile these differences? One possibility is that transgenic 
promoter fusions mis-express GFP in a pattern that does not reflect endogenous 
protein expression. However, transcriptional changes may not dramatically impact 
stable endogenous protein with low turnover. But transcriptional changes coupled 
with other layers of post-transcriptional and post-translational changes may still 
collectively impact signaling outputs, and thus restrict signaling activity to certain 
cell types and exclude signals from others. We hypothesize that the observed 
transcriptional reprogramming is functionally significant, and contributes to the 
fidelity of the VPC patterning system. 
Environmental and genetic regulators and variability 
Changes in the environment could represent one of the main perturbations to 
the fidelity of a developmental system. Errors in VPC patterning can result in 
decreasing progeny. Thus, the result of VPC fate patterning is related to 
reproductive success and evolutionary fitness. The C. elegans VPC fate 
patterning is precise and robust process. The VPC fate patterning has 99.8% rate 
of accuracy with variable environmental conditions (Braendle and Felix, 2008). 
The fidelity of VPC fate patterning is controlled by signaling network, mainly 1˚-
promoting Ras and 2˚-promoting Notch signals. Therefore, perturbation of these 
35 
signals can provoke variation of VPC fate patterning with increased error rate 
(Braendle and Felix, 2008). This system has also been used to assess the impact 
of heterogeneity in polymorphic wild C. elegans isolates (Grimbert and Braendle, 
2014; Sterken et al., 2017). Mutual Antagonism and the putative RGL-1-mediated 
“Balanced Switch” may be key mechanisms that decrease developmental error 
(see above). An intriguing observation is that deletion of the RGL-1 “Balanced 
Switch” increases error rate as a result of stochasticity but not environmental 
perturbation. In contrast, while mutation perturbation of the balance of 1˚ vs. 2˚ 
signaling axes increases sensitivity to environmental perturbations, basal 
signaling error is not increased (Barkoulas et al., 2013; Braendle et al., 2010; 
Duveau and Felix, 2012; Milloz et al., 2008). We conclude that complex 
mechanisms exist to reduce noise in the signaling network that controls VPC 
patterning. Also, the consequences of perturbing the “Balanced Switch” is 
different than the consequences of perturbing the balance of 1˚ and 2˚ signals. 
Perhaps distinct mechanisms have evolved to minimize the consequences of 
these two different sources of “noise”. 
Conclusions 
A view is emerging of a sophisticated signaling network that controls the fate 
patterning of the C. elegans VPCs. In response to LIN-3/EGF, VPCs are precisely 
patterned by two main signaling cascades. The necessary and sufficient EGFR- 
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and Notch-mediated signals establish the skeleton pattern of initial fate 
specifications. A signaling gradient, orchestrated modulatory signaling cascades, 
and transcriptional reprogramming of mutual antagonism induction programs act 
together to further sculpt these fate decisions both spatially and temporally. 
Collectively, these and presumably additional, unknown mechanisms collaborate 
to generate a highly precise and robust pattern prior to terminal differentiation. 
Most of the signaling molecules described in the VPC patterning network are 
conserved in mammals as proto-oncogenes or tumor suppressor genes. Thus, 
study of the VPC patterning system provides insights into our understanding of 
signaling networks in both development and pathology. With the advent of 
additional insights into the mechanisms underpinning fidelity and robustness, the 




RAL SIGNALS THROUGH A MAP4 KINASE-P38 MAP KINASE CASCADE IN 
C. ELEGANS CELL FATE PATTERNING* 
Introduction 
Ras is the most mutated oncoprotein. Yet strategies to inhibit oncogenic Ras 
have failed, so Ras is considered to be mostly “undruggable” (Papke and Der, 
2017). Consequently, attention has shifted to oncogenic Ras effectors to identify 
therapeutic targets. Canonical oncogenic Ras effectors, the Raf-MEK-ERK and 
PI3K-PDK-Akt cascades, are among the best studied and most targeted signaling 
cascades (Ryan et al., 2015; Wong et al., 2010). Yet even potent small molecule 
inhibitors, like the BRAF inhibitor vemurafenib, are subject to multiple bypass 
mechanisms that permit initially responsive tumors to relapse (Sun et al., 2014). 
Thus, successful treatment will likely require multi-pronged regimens to 
simultaneously inhibit multiple Ras effectors. 
In addition to the canonical Raf and PI3K cascades, Ras uses RalGEF-Ral 
to promote tumorigenesis (Feig, 2003). Historically, canonical Ras-Raf and Ras- 
Reprinted with permission from. *MAP kinase cascade in C. elegans cell fate patterning.” 
by Hanna Shin#, Rebecca E.W. Kaplan#, Tam Duong, Razan Fakieh and David J. Reiner, 
Cell Reports Vol. 24, Issue 10, P2669-2681.e5, September 04, 2018. Doi: 
https://doi.org/10.1016/j.celrep.2018.08.011, Copyright [2018] by all authors. #These 
authors contributed equally to this work.  
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PI3K signaling was shown to cause cancer transformation of mouse primary 
fibroblasts (Khosravi-Far et al., 1996; Kyriakis et al., 1992; White et al., 1995). The 
emergence of immortalized human epithelial cell culture led to the key finding that 
Ras-RalGEF-Ral is also a critical player in human oncogenesis (Hamad et al., 
2002; Urano et al., 1996; White et al., 1996). RalGEF is an exchange factor that 
promotes GTP loading of the Ral (Ras like) small GTPase (Feig, 2003). Loss of 
RalGAP (Ral GTPase activating protein), a putative tumor suppressor, increases 
tumorigenesis without activated Ras (Oeckinghaus et al., 2014; Saito et al., 2013), 
further supporting the importance of Ral signaling in cancer. 
Three binding partners of Ral have been well validated: RalBP1 (Ral binding 
protein 1) and Sec5 and Exo84 subunits of the heterooctameric exocyst complex 
(reviewed in Gentry et al., 2014; Fig. 2. 1A). The exocyst represents an unusual 
roadblock to biochemical bootstrapping of signaling activities: the exocyst is 
broadly integral to essential cell biological processes (e.g. exocytosis, 
PAR/polarity complex; Wu and Guo, 2015) and potentially binds to hundreds of 
partners, thus mostly precluding identification of downstream signaling partners 
via binding studies. Consequently, beyond these immediate binding partners, we 
know little of downstream functions of Ral signaling through the exocyst in vivo. 
Studies in Drosophila provided key hints to the nature of Ral downstream 
signaling in development. In morphogenetic events, DRal was implicated in 
antagonizing the JNK MAP kinase (Sawamoto et al., 1999). In bristle apoptosis 
assays, DRal was found to have negative and positive relationships with JNK and 
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Figure 2. 1 A model of Ral effector use in VPC fate patterning and MAP4K 
families and sensitized backgrounds. A. Ras signals through RalGEF-Ral in 
cancer and C. elegans 2˚ fate induction. Mammalian Ral has three known 
oncogenic binding partners: Exo84, Sec5, and RalBP1. B-C. Unrooted 
dendrograms of GCK-2/GCK-I subfamily (C. elegans GCK-2, Drosophila 
Happyhour (Hppy), mammalian MAP4K1/HPK1, MAP4K2/GCK, MAP4K3/GLK, 
and MAP4K5/GCKR/KHS1) kinase (B) and CNH (C) domains. Between the GCK- 
2 and Drosophila Hppy orthologs, the kinase and CNH domains share 71% and 
31% identity, respectively. Reprinted with permission form Shin et. al, 2018
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Figure 2. 1 Continued. D-E. Unrooted dendrograms of MIG-15/GCK-IV subfamily 
(C. elegans MIG-15, Drosophila Misshapen (Msn), vertebrate MAP4K4/NIK/HGK, 
MAP4K6/MINK, MAP4K7/TNIK, and MAP4K8/NRK/NESK) kinase (D) and CNH 
(E) domains, calculated by CLUSTALW. Ce: C. elegans, Dm: D. melanogaster, 
and Hs: Homo sapiens. Between the GCK-2 and MIG-15 paralogs, the kinase 
domain and CNH domain share 45% and 29% sequence identity, respectively. 
Between the MIG-15 and Drosophila Msn orthologs, the kinase and CNH domains 
share 83% and 79% identity, respectively. Thus, sequence conservation is greater 
within a subfamily between species than across subfamilies within a species. F. 
Schematics of genetically sensitized backgrounds and responses to altered 
degree of modulatory 2˚ signaling (Zand et al., 2011). Wild-type animals have the 
3˚-3˚-2˚-1˚-2˚-3˚ pattern of vulval cell fates. In the let-60(n1046gf) background with 
ectopic 1˚ cells, levels of ectopic 1˚s go up when 2˚-promoting signal is blocked 
and go down when 2˚-promoting signal is activated. In the lin-12(n379d) 
background without an AC (and hence no LIN-3/EGF) and with occasional ectopic 
2˚ cells, levels of ectopic 2˚ cells are unaltered when 2˚-promoting signal is 
blocked and increased when 2˚-promoting signal is activated. Reprinted with 
permission form Shin et. al, 2018
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p38 MAP kinase cascades, respectively (Balakireva et al., 2006). Importantly, this 
study also established that exocyst component Sec5 binds to HGK/NIK/MAPK4, 
a CNH domain containing MAP4 kinase. The Drosophila ortholog, Msn 
(Misshapen) was found to function antagonistically to DRal (Balakireva et al., 
2006), and is known to function with JNK in Drosophila embryonic dorsal closure 
and other morphogenetic events (Su et al., 1998). Yet these studies relied on 
ectopic over-expression and dominant-negative reagents, which complicated 
interpretation. Furthermore, direct genetic epistasis could not be assayed 
because many of the proteins studied are essential for development in Drosophila. 
The Ste20 family of mitogen-activated protein kinase kinase kinase kinases 
(MAP4 Kinases or MAP4Ks) is conserved throughout eukaryotes (Dan et al., 2001; 
Delpire, 2009). Two paralogous subfamilies of this group, GCK-I and GCK-IV 
(Germinal Center Kinases), are defined by distinctive domain architecture: an N-
terminal S/T kinase domain, a C-terminal CNH domain (for Citron N-terminal 
Homology), and an unstructured poly-proline linker region (Fig. 2. 2A; Dan et al., 
2001). C. elegans GCK-2 (ZC404.9) is an 829-residue protein in the GCK-I 
subfamily (the “GCK-2 group”: Drosophila Hppy (Happyhour), mammalian 
MAP4K1/HPK1, MAP4K2/GCK, MAP4K3/GLK, and MAP4K5/GCKR/KHS1; Figs. 
2. 1B-C). C. elegans MIG-15 is in the GCK-IV subfamily (the “MIG-15 group”:
Drosophila Msn, mammalian MAP4K4/NIK/HGK, MAP4K6/MINK, MAP4K7/TNIK, 
and MAP4K8/NRK/NESK; Figs. 2. 1D-E). 
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Figure 2. 2 C. elegans CNH-domain organization MAP4Ks and VPC fate 
patterning.  A. Domain organization and conservation of paralogous C. elegans 
MAP4Ks GCK-2 and MIG-15. B. VPCs, P3.p through P8.p, are patterned to 
assume 3°-3°-2°-1°-2°-3° fate by coordinated graded action of EGF secreted from 
the anchor cell and Notch lateral signal. LET-60/Ras-LIN-45/Raf-MEK-2/MEK-
MPK-1/ERK and LET-60/Ras-RGL-1/RalGEF-RAL-1/Ral promote 1° fate and 2° 
induction, respectively. Reprinted with permission form Shin et. al, 2018
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Critically, Drosophila Hppy was as yet undiscovered at the time of Msn 
investigation relative to DRal (Balakireva et al., 2006). Hppy antagonizes 
canonical EGFR signaling through ERK MAPK in ethanol response; its 
relationship to DRal was not studied (Corl et al., 2009). Thus, we turned to C. 
elegans VPC fate patterning to investigate a signaling cascade downstream of 
Ral relative to these enigmatic MAP4 kinases. 
During the L3 stage, EGF produced by the gonadal Anchor Cell (AC) induces 
six initially equipotent Vulval Precursor Cells (VPCs), P3.p through P8.p, to 
assume the highly reproducible 3˚-3˚-2˚-1˚-2˚-3˚ pattern (Fig. 2. 2B). 1° and 2° 
cells undergo stereotyped divisions and morphogenesis to form the mature vulva, 
while uninduced 3˚ cells divide once and fuse with surrounding cells (Sternberg, 
2005). Historically, two competing models, the “Morphogen Gradient Model” and 
the “Sequential Induction Model”, were posited to describe VPC fate patterning. 
In the “Morphogen Gradient Model”, graded inductive signal controls fate 
patterning: the VPC closest to the AC (typically P6.p) receives the highest LIN-
3/EGF-LET-23/EGFR signal to induce 1˚ fate, while neighboring VPCs, P5.p and 
P7.p, receive lower LIN-3/EGF-LET-23/EGFR signal, and thus become 2˚ (Katz 
et al., 1995; Katz et al., 1996; Sternberg and Horvitz, 1986, 1989). Yet 
identification of key genes in VPC patterning led to the potentially contradictory 
“Sequential Induction Model”. LET-23/EGFR and LIN-12/Notch are necessary and 
sufficient for 1˚ and 2˚ induction, respectively (Aroian et al., 1990; Greenwald et 
al., 1983). Activation of LET-23/EGFR triggers a LIN-45/Raf-MEK-2/MEK-MPK-
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1/ERK canonical MAP kinase (MAPK) cascade to induce 1° fate (reviewed in 
Sundaram, 2013). These presumptive 1˚ cells in turn secrete DSL ligands to 
induce neighbors to become 2° via the LIN-12/Notch (Chen and Greenwald, 2004). 
LET-23/EGFR was found to function cell autonomously to induce 1˚ fate, further 
supporting the “Sequential Induction Model” (Koga and Ohshima, 1995; Simske 
and Kim, 1995). The two models long remained unreconciled, and no mechanism 
was known by which graded LIN-3/EGF-LET-23/EGFR activity promotes 2˚ fate 
(Kenyon, 1995). 
Overlaid on this system are “Mutual Antagonism” mechanisms by which, after 
initial induction, presumptive 1˚ and 2˚ cells enact programs to exclude potentially 
contradictory signals. For example, in presumptive 1° cells, LIN-12/Notch receptor 
is internalized and degraded to prohibit conflicting 2˚-promoting signaling (Shaye 
and Greenwald, 2002, 2005). Conversely, in presumptive 2˚ cells LIN-12/Notch-
dependent transcription of LIP-1/ERK phosphatase impedes conflicting 1˚-
promoting MPK-1/ERK signaling (Berset et al., 2001; Yoo et al., 2004). Such 
antagonistic signals are proposed to act collectively to transition from initial 
patterning specification to commitment (Sternberg, 2005), thereby avoiding 
inappropriate and/or ambiguous cell fates that can result from inappropriate 
signals. 
Given the importance of Ras-RalGEF-Ral signaling in cancer, we set out to 
define a role for this signaling module in VPC fate patterning. We found that LET-
60/Ras uses the non-canonical RGL-1/RalGEF-RAL-1/Ral effector to promote 2˚ 
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fate in support of LIN-12/Notch (Zand et al., 2011). Thus, both the Sequential 
Induction and Morphogen Gradient models are correct: LET-60/Ras switches 
effectors to interpret the EGF gradient. This mechanism reconciled the two 
competing models and established a platform for the in vivo study of RAL-1/Ral 
signaling in VPC fate patterning (Reiner, 2011; Zand et al., 2011; Fig. 2. 2B). Yet 
the downstream output of the LET-60/Ras-RGL-1/RalGEF-RAL-1/Ral 2˚-
promoting signal remained unknown. 
In this study, we determine that EXOC-8/Exo84, a well-validated Ral-binding 
protein in mammalian cells, is required to propagate the RAL-1 2˚-promoting 
signal. Significantly, we find that RAL-1 requires the CNH domain-containing 
GCK-2/MAP4K and PMK-1/p38 MAPK to promote 2˚ fate. Genetic perturbation of 
components of this cascade phenocopied perturbation of RAL-1, and these 
components are necessary for the 2˚-promoting activity of mutationally activated 
RAL-1. 2˚-promoting EGF signal requires GCK-2, putative mutationally activated 
endogenous GCK-2 is sufficient to increase ectopic 2˚ cell induction, and GCK-2 
functions cell autonomously in the VPCs. Using CRISPR/Cas9-dependent 
genome engineering to tag endogenous gene products with fluorescent protein 
(FP) and epitope, we observed expression and subcellular localization of 
endogenous RAL-1, GCK-2, and PMK-1 proteins in VPCs. Our in vivo analysis 
connects Ral to a novel effector cascade in C. elegans VPC fate patterning. 
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Results 
Criteria for a RAL-1-dependent 2˚-promoting signal. 
Since LIN-12/Notch, but not the LET-60/Ras-RGL-1/RalGEF-RAL-1/Ral 
signal, is necessary for 2˚ fate induction, we used a combination of parallelism 
and epistasis to test the genetic relationships among members of the VPC fate-
patterning network. Specifically, for this genetic analysis we used two sensitized 
genetic backgrounds (Fig. 2. 1F). The let-60(n1046gf) G13E activating mutation 
confers excess 1˚ induction, levels of which are sensitive to perturbation of both 
1˚- and 2˚-promoting signals. The weakly activating lin-12(n379d)/Notch mutation 
both causes ectopic 2˚ cells and abrogates development of the AC. Consequently, 
lin-12(n379d) provides a simplified signaling milieu in which EGF is not present 
(Greenwald et al., 1983). This background is sensitive to perturbation of 2˚- but 
not 1˚-promoting signals and responds to the EGF-dependent 2˚-promoting signal 
(Zand et al., 2011). 
Partly by using these tools, we developed a set of expectations for RAL-1 2˚-
promoting effectors. (1) Loss of effector function should phenocopy loss of ral-1 
function. (2) Constitutively activated effector should phenocopy constitutively 
activated RAL-1. (3) Loss of effector function should be epistatic to constitutively 
activated RAL-1. (4) The effector should function cell autonomously in the VPCs. 
(5) The effector should be expressed in the VPCs. Using these criteria, we 
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systematically evaluated a putative RAL-1 signaling cascade in 2˚ VPC fate 
induction. 
EXOC-8 functions in VPC fate patterning. 
We tested whether known Ral binding partners, Sec5 and Exo84 of the 
exocyst complex and RalBP1/RLIP76 (reviewed in Gentry et al., 2014; Fig. 2. 1A), 
met our first criterion for a RAL-1 effector: loss of effector function should 
phenocopy loss of ral-1 function. The heterooctameric exocyst complex generally 
consists of eight subunits used in different contexts: Sec3, Sec5, Sec6, Sec8, 
Sec10, Sec15, Exo70 and Exo84 (Wu and Guo, 2015), all of which have single 
conserved orthologs in C. elegans. 
Deletion of ral-1 leads to defects in cell polarity, apparently by disruption of 
the exocyst complex (Armenti et al., 2014), consistent with previous observations 
that mammalian Ral functions as a membrane-tethering member of the exocyst 
(Issaq et al., 2010; Moskalenko et al., 2002; Moskalenko et al., 2003). We 
previously found that ral-1(RNAi) alone did not confer significant vulval patterning 
defects, nor did a non-null intronic deletion allele of ral-1 that conferred sterility 
(Zand et al., 2011). We characterized the ral-1(gk628801rf) R139H mutation, 
which did not confer visible defects (Shin et al., in preparation). In the let-
60(n1046gf) background, gk628801rf caused increased 1° induction, consistent 
with as a loss-of-function (lf) but not null allele in ral-1. This result validated our 
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Figure 2. 3 EXOC-8 functions in VPC fate patterning. The Y-axis indicates 
number of ectopic 1˚ cells. A-B. The ral-1 (gk628801rf) R139H missense (A) and 
exoc-8(ok2523) deletion (B) mutations increased ectopic 1° induction in the let- 
60(n1046gf) background. C. The sec-5(pk2357) late nonsense allele (Frische et 
al., 2007) did not alter ectopic 1˚ induction in the let-60(n1046gf) background. D. 
The rlbp-1 out-of-frame deletion allele, tm3665, conferred no change in the let- 
60(n1046gf) background. N indicated in white on columns. P value calculated by 
t test. Error bars = S.E.M. Reprinted with permission form Shin et. al, 2018
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Figure 2. 4 EXOC-8 but not SEC-5 or RLBP-1 functions in VPC fate patterning. 
Y axes indicate number of ectopic 1˚ or 2˚ cells. A. ral-1(RNAi) increased ectopic 
1° induction in the let-60(n1046gf) background. gfp-directed RNAi was used for 
negative control (Zand et al., 2011). B. The exoc-7(ok2006) deletion did not alter 
ectopic 1˚ induction in the let-60(n1046gf) background. C. As predicted, the ral- 
1(gk628801) R139H missense mutation did not alter ectopic 2˚ induction in the 
lin-12(n379d) background. D. The exoc-8(ok2523) deletion conferred increased 
ectopic 2° induction lin-12(n379d). P values calculated by t test. Error bars = 
S.E.M. Reprinted with permission form Shin et. al, 2018
previous findings that reduced ral-1 signaling and hence reduced 2˚ signaling 
increased 1˚-promoting signals (Figs. 2. 3A, 2. 4A). 
In the same genetic background, we tested effects of the sec-5(pk2357) 
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strong hypomorph (Frische et al., 2007), exoc-8(ok2523), and rlbp-1(tm3665) 
deletion alleles (exoc-7(ok2006) was included as a negative exocyst control). 
Among these candidate RAL-1 effectors, only exoc-8(ok2523), a deletion allele, 
phenocopied ral-1(gk628801rf) (Figs. 2. 3B-D, 2. 4B). As expected, ral-
1(gk628801rf) caused no phenotypic changes in the lin-12(n379d) background 
(Fig. 2. 4C). These results are consistent with EXOC-8 mediating RAL-1 2˚-
promoting signal. 
We also tested exoc-8(ok2523) in the lin-12(n379d) background. We 
observed increased ectopic 2˚ induction (Fig. 2. 4D). This result is inconsistent 
with our expectation of a RAL-1 effector. Thus, EXOC-8 performs multiple 
functions in VPC fate patterning, one of which could include mediating a RAL-1 
2˚-promoting signal. 
Loss of GCK-2 but not MIG-15 confers the same phenotype as loss of RAL-1. 
To further explore our first criterion, we used C. elegans genetics to determine 
relationships among Ral and the paralogous “GCK-2 Group” and “MIG-15 Group” 
MAP4Ks. gck-2(ok2867) is an in-frame 549 bp deletion in exon 5, resulting in 
deletion of a part of the kinase domain. gck-2(tm2537) is an out-of-frame 565 bp 
deletion in exon 5, resulting in early stop codons (Khan et al., 2012). Most genetics 
were done using these alleles and gck-2-directed bacterially mediated RNAi 
(clone V-4P08; Fig. 2. 5A). mig-15(rh148) is a V168E missense mutation predicted 
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Figure 2. 5 Loss of GCK-2 but not MIG-15 confers the same phenotype as 
loss of RAL-1. A. gck-2 gene structure, domain location, and genetic tools. Light 
gray: the re113re222 (312 bp deletion) in-frame and re113re223 (312 bp deletion, 
35 bp insertion) out-of-frame mid-deletions remove the three PxxP sites. Black: 
tm2537 (565 bp out-of-frame deletion) and ok2867 (549 bp in-frame deletion). 
Dark gray: RNAi target sequence (Kamath et al., 2003). B-D. DIC images of late 
L4 vulvae and ectopic pseudovulvae. (B) N2 wild type (C) let-60(n1046gf), (D) let- 
60(n1046gf); gck-2(ok2867). Black arrow indicates normal vulva, white arrow 
indicates ectopic 1˚ pseudovulvae. Scale bar = 20 µm. E. gck-2(ok2867) 
enhances ectopic 1˚ induction in the let-60(n1046gf) background. F. gck-2(RNAi) 
(V-4P08) and mig-15(RNAi) (X-5G21) both increase 1˚ induction in the let- 
60(n1046gf) background. G. mig-15(rh80) and mig-15(rh148) do alter ectopic 2˚ 
induction in the lin-12(n379d) background. P values calculated by t test (E) or 
ANOVA (F, G). Error bars = S.E.M. Reprinted with permission form Shin et. al, 
2018
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to abolish kinase function. mig-15(rh80) is a W898* late nonsense mutation 
thought to confer strong loss of function (Chapman et al., 2008). We also used 
mig-15-directed bacterially mediated RNAi (clone X-5G21). 
gck-2(ok2867) conferred increased 1° induction in the let-60(n1046gf) 
background (Figs. 2. 5B-E), similar to ral-1(gk628801rf) or exoc-8(ok2523). gck-2 
(RNAi) conferred a phenotype similar to that of ral-1(RNAi) (Fig. 2. 5F vs. Fig. 2. 
4A). Also, mig-15(RNAi) conferred increased 1° induction in the let-60(n1046gf) 
background (Fig. 2. 5F). We also tested the mig-15(rh148) reduced function allele 
in the let-60(n1046gf) background. However, we observed severe vulval 
morphogenesis defects: 2˚ cells/lineages failed to migrate to join the 1˚ 
cell/lineage (Fig. 2. 6A). Thus, in double mutant animals we could not discriminate 
between ectopic 1˚s and 2˚s that had failed to join the 1˚ of the normal vulva, 
which precluded interpretation of VPC induction in these strains (Fig. 2. 6B). 
Taken together, these results are consistent with both GCK-2 and MIG-15 
functioning as either 2°-promoting or 1°-antagonizing signals. 
We assessed the roles of MIG-15 and GCK-2 in the lin-12(n379d) 
background (AC/EGF absent, mild ectopic 2˚ induction). Neither ral-1(gk628801rf) 
nor gck-2(ok2867 or tm2537) altered 2˚ induction in the lin-12(n379d) background 
(Figs. 2. 4C, 2. 6C, 2. 6D, respectively). In marked contrast, reduction of mig-15 
function robustly elevated 2˚ induction in the lin-12(n379d) background (Figs. 2. 
5G, 2. 6E; the strongest mig-15 allele, rh326, was not assayed due to poor 
viability). This assay was possible with mig-15 alleles because the isolated 2˚s in 
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Figure 2. 6 Loss of GCK-2 but not MIG-15 conferred defects consistent with 
a RAL-1 effector. A-B. Representative vulval morphogenetic defects in mig- 
15(rh148) (A) and let-60(n1046gf); mig-15(rh148) (B). Vulval morphogenetic 
defects of mig-15(rh148) animals precluded conventional scoring of 1˚ induction 
because 2˚ lineages fail to join the central 1˚ lineage (see Fig. 2. 5G). However, 
this mig-15 mutant morphogenetic defect does not confound scoring of isolated 
2˚s in the lin-12(n379d) background, because no migration occurs. Black arrows 
indicate normal vulvae, white arrows indicate ectopic pseudovulvae, the question 
mark is probably a 2˚, but separated from the main vulva due to morphogenetic 
defects. C-D. gck-2(ok2867) or gck-2(tm2537) does not alter 2˚ induction. E. mig- 
15(RNAi) shows increased ectopic 2˚ induction in the lin-12(n379d) background. 
F. gck-2(ok2867) partially suppresses the absent 1˚ induction phenotype of lin- 
3(n378rf). P value calculated by t test. Error bars = S.E.M. Reprinted with 
permission form Shin et. al, 2018
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the n379 background could be readily identified, unlike as in the n1046 
background, above. 
To test background specificity, we evaluated the impact of gck-2(ok2867) in 
the lin-3/EGF(n378rf) hypo-induced rather than the let-60(n1046gf) hyper-induced 
background. lin-3(n378rf) supports 20% vulval induction (Hill and Sternberg, 
1992). gck-2(ok2867) conferred increased vulval induction (Fig. 2. 6F), suggesting 
that the 2°-promoting signal of GCK-2 is not let-60(n1046gf) background 
dependent. 
Collectively, these genetic results are consistent with the hypothesis that 
GCK-2 functions as an effector of RAL-1 2˚-promoting activity. Meeting our first 
criterion, GCK-2 antagonizes 1˚ signal and is neutral in the absence of 2˚-
promoting EGF. This interpretation is supported below by further genetic analysis. 
Conversely, MIG-15 is not consistent with a simple criterion of a RAL-1 2˚-
promoting effector. Unlike RAL-1, MIG-15 antagonizes both 1˚ and 2˚ signals, 
even in the absence of EGF. We cannot exclude MIG-15 as a second RAL-1 
effector, perhaps in a negative regulatory relationship, which we will address in 
the Discussion. Yet we conclude that further analysis of MIG-15 function is outside 
the scope of this study. 
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Figure 2. 7 RAL-1 and GCK-2 are sufficient to drive 2° fate induction. A-B. 
Exogenous (reIs10[Plin-31::ral-1(gf)]) (A) and endogenous (ral-1(re160gf[mKate2^ 
3xFlag::ral-1(G26V)])) (B) activated RAL-1 increase 2° induction in the lin- 
12(n379d) background. Ectopic 2˚ induction is on the Y axis. C. Vulvaless (Vul) 
late L4 lin-12(n379d) animal. D. Ectopic 2˚ pseudovulvae (white arrows) in ral- 
1(re160gf) lin-12(n379d). Scale bar = 20 µ m. E. Western blot detection of GCK-2 
from lysates from endogenously tagged wild-type (re113), in-frame mid-deletion 
(re113re222), and out-of-frame mid-deletion (re113re223) animals, detected by 
anti-Flag antibody (1:2000). The mNG::3xFlag::GCK-2 fusion protein is predicted 
to be ~124 kDa, the mid deletion ~110 kDa. F. The in-frame mid-deletion gck- 
2(re113re222) but not the out-of-frame mid-deletion gck-2(re113re223) caused 
increased 2° induction in the lin-12(n379d) background. Ectopic 2˚ induction is on 
the Y axis. P value calculated by t test or ANOVA. Error bars = S.E.M. Reprinted 
with permission form Shin et. al, 2018
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GCK-2 is sufficient to induce 2° fate in support of LIN-12/Notch. 
Our second criterion is that activated effector should phenocopy constitutively 
activated RAL-1. RAL-1 is sufficient to promote 2° fate: transgenic VPC-
expressed ral-1(gf) significantly increased ectopic 2° induction in the lin-12(n379d) 
background (Zand et al., 2011). This same extrachromosomal array, when 
integrated as reIs10[ral-1(gf)] (Shin et al., in preparation), also increased ectopic 
2˚ s in the lin-12(n379d) background (Fig. 2. 7A). Using CRISPR/Cas9-mediated 
genome editing, we generated a gain-of-function mutation (G26V) in the 
endogenous ral-1 locus, also including an in-frame 5’-end mKate2^3xFlag tag. 
The resulting ral-1(re160gf[mKate2^3x Flag::ral-1(G26V)]) caused increased 2° 
fate induction in the lin-12(n379d) background (Figs. 2. 7B-D). 
To test whether GCK-2 is sufficient to induce 2˚ fate, we used CRISPR to 
generate a putative gck-2(gf). Deletion of the proline-rich linker is thought to 
constitutively activate Drosophila Msn ("MIG-15 group"; Su et al., 2000). We 
deleted the linker in GCK-2 by using the co-CRISPR strategy (Arribere et al., 
2014). The gck-2(re113re222) mid-Δ was generated in gck-
2(re113[mNG^3xFlag::gck-2]), which we had already engineered (see below and 
Figs. 2. 7E, 2. 8A). We also generated the gck-2(re113re223) out-of-frame mid-Δ, 
which served as a negative control. We assessed protein expression in these 
alleles by western blot: the out-of-frame re113re223 but not the in-frame 
re113re222 abolished detectable tagged GCK-2 (Fig. 2. 7E). The in-frame 
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re113re222 but not the out-of-frame re113re223 significantly increased ectopic 2° 
induction in the lin-12(n379d) background (Fig. 2. 7F). 
Figure 2. 8 Design and validation of endogenous GCK-2 mid-deletion and 
GCK-2 mid-deletion transgenics. A. The gck-2 mid-deletion removes the central 
proline-rich region from the gene and protein. The solid black line shows the in-
frame deletion while the line that becomes dotted represents the out-of-frame 
deletion. B. reEx143[Plin-31::gck-2(mid-deletion), Pmyo-2::gfp] extrachromosomal 
array in the lin-12(n379d); gck-2(+) background. C. reEx161[Plin-31::gck-2(mid-
deletion), Pmyo-2::gfp] extrachromosomal array in the lin-12(n379d); 
gck-2(tm2537) background. P value calculated by t test. Error bars = S.E.M. 
Reprinted with permission form Shin et. al, 2018
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We also tested GCK-2 cell autonomy by generating transgenes expressing 
VPC-specific putative activating gck-2(mid-Δ) into the lin-12(n379d) background, 
where we observed weakly increased ectopic 2˚ induction (p = 0.06; Fig. 2. 8B). 
The same transgene in the lin-12(n379d); gck-2(tm2537) background significantly 
increased ectopic 2˚ induction (p = 0.03; Fig. 2. 8C). Thus, GCK-2 is sufficient to 
induce increased 2˚ induction in support of LIN-12/Notch, consistent with GCK-2 
functioning as a 2˚-promoting effector of RAL-1. 
GCK-2 functions downstream of LIN-3/EGF and RAL-1. 
Our third criterion is that loss of effector function should be epistatic to 
constitutively activated RAL-1. reIs10[ral-1(gf)] enhanced ectopic 2° induction in 
the lin-12(n379d) background (Fig. 2. 7A) and was blocked by gck-2(ok2867) and 
gck-2(tm2537) (Fig. 2. 9A). Thus, GCK-2 meets our third criterion for a RAL-1 
effector. 
Critically, in light of complex results from exoc-8(ok2523) in different 
backgrounds (Fig. 2. 4D; see above), reIs10[ral-1(gf)]-dependent ectopic 2° 
induction was blocked by exoc-8(ok2523) (Fig. 2. 9B). That RAL-1 2˚-promoting 
activity depends on EXOC-8 is consistent with EXOC-8 functioning downstream 
of RAL-1 to transduce the 2˚-promoting signal. We therefore speculate that a RAL-
1-EXOC-8-GCK-2 cascade transduces a 2˚-promoting signal, while 
acknowledging that EXOC-8 may perform other functions (see Discussion). 
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Figure 2. 9 GCK-2 functions downstream of LIN-3/EGF and RAL-1 cell 
autonomously. A-B. gck-2(ok2867) and gck-2(tm2537) (A) blocked the 2˚-
promoting activity of reIs10[Plin-31::ral-1(gf)] in the lin-12(n379d) background, as 
does exoc-8(ok2523) (B). C-D. Strong enhancement of lin-12(n379d)-dependent 
2° induction by lin-15(n765ts) at 15˚ is reduced by ral-1(gk628801rf) (C), and gck- 
2(ok2867) (D). E-F. Vulva-specific expression of wild-type (reEx176) (E) but not 
K44E putative kinase dead (reEx181) GCK-2 (F) rescues the suppression of 
reIs10[ral-1(gf)] by gck-2(tm2537) in the lin-12(n379d) background. Each column 
pair compares array-bearing vs. non-array-bearing siblings. P value calculated by 
t test or ANOVA. Error bars = S.E.M. Reprinted with permission form Shin et. al, 
2018
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Multiple lines of evidence indicate that LIN-15 and many other genes in the 
“synMuv” group cooperate to redundantly restrict LIN-3/EGF expression to the AC 
(Cui et al., 2006; Fay and Yochem, 2007; Herman and Hedgecock, 1990; Huang 
et al., 1994; Myers and Greenwald, 2005). We previously exploited this feature of 
the vulval system to titrate LIN-3/EGF “dose” to induce ectopic 2˚ but not 1˚ VPCs 
in the lin-12(n379d) background (Zand et al., 2011), consistent with earlier 
manipulations of LIN-3/EGF and LET-23/EGFR signals to promote 2˚ fate, which 
supported the Morphogen Gradient Model (Katz et al., 1995; Katz et al., 1996). At 
15˚C, a temperature-sensitive mutation in lin-15, n765ts, supports normal vulva 
induction without inducing ectopic 1˚ cells. But in the lin-12(n379d) background at 
15˚C, n765ts strongly increased ectopic 2˚ induction. We showed that this 2˚-
promoting activity depends on LIN-3/EGF, LET-60/Ras, RGL-1/RalGEF, and 
RAL-1: RNAi depletion of let-60, rgl-1, and ral-1 blocked the increased ectopic 2˚s 
conferred by lin-12(n379d); lin-15(n765ts) at 15˚C. We further showed that excess 
expression of LIN-3/EGF and an activating mutation in LET-23/EGFR conferred 
similar promotion of 2˚ fate via activation of the LET-60-RGL-1-RAL-1 module 
(Zand et al., 2011). 
As expected, ral-1(gk628801rf) decreased ectopic 2° induction in the lin-
12(n379d); lin-15(n765ts) background at 15˚C (Fig. 2. 9C), validating our prior 
results using ral-1(RNAi) (Zand et al., 2011). Similarly, gck-2(RNAi) and gck-
2(ok2867) reduced ectopic 2° induction in the lin-12(n379d); lin-15(n765ts) 
background (Figs. 2. 9D; 2. 10A). Thus, we conclude that the 2˚-promoting signal 
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of EGF is, at least in part, GCK-2-dependent, consistent with RAL-1 signaling 
though GCK-2. 
Figure 2. 10 GCK-2 functions cell autonomously downstream of Ral. A. 
Strong enhancement of lin-12(n379d)-dependent 2° induction by lin-15(n765ts) at 
15˚ is inhibited by gck-2(RNAi), with gfp(RNAi) as a negative control. B-D. 
Additional transgenic arrays to repeat Figs. 2. 9E and 2. 9F (B: reEx167[Plin- 
31::gck-2(+), Pmyo-3::gfp], C: reEx177[Plin-31::gck-2(+), Pmyo-3::gfp], and D: 
reEx180[Plin-31::gck-2(K44E), Pmyo-3::gfp]).  Reprinted with permission form Shin 
et. al, 2018
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Figure 2. 10 Continued. E. Vulva-specific expression of GCK-2(+) does not alter 
ectopic 1˚ induction in the let-60(n1046gf) background (first two columns, let- 
60(n1046gf); reEx113[Plin-31::gck-2(+), Pmyo-2::gfp]), but does rescue the 
enhancement of ectopic 1˚ induction by the gck-2(ok2867) mutation (second two 
columns, let-60(n1046gf); gck-2(ok2867); reEx112[Plin-31::gck-2(+), Pmyo-2::gfp]). 
Each column pair compares array-bearing vs. non-array-bearing siblings. P value 
calculated by t test. Error bars = S.E.M. Reprinted with permission form Shin et. 
al, 2018
Kinase-dependent GCK-2 functions cell autonomously in VPCs. 
Our fourth criterion for a RAL-1 effector is that its 2˚-promoting activity 
function cell autonomously. We generated transgenic extrachromosomal arrays 
expressing VPC-specific GCK-2(+) and assessed rescue of mutant gck-2 
suppression of activated RAL-1. In the reIs10[ral-1(gf)]; lin-12(n379d); gck-
2(tm2537) and reIs10[ral-1(gf)]; lin-12(n379d); gck-2(ok2867) backgrounds, VPC-
specific expression of wild-type GCK-2 restored the increased 2˚ induction 
phenotype suppressed by gck-2 mutations (Figs. 2. 9E; 2. 10B-C). Conversely, in 
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the same backgrounds VPC-specific expression of putative kinase dead (KD) 
GCK-2 (for HPK1/MAP4K1, “GCK-2 group”; Kiefer et al., 1996) failed to rescue 
mutant gck-2 suppression of reIs10 (Figs. 2. 9F; 2. 10D). Remember that gck-
2(ok2867) enhanced ectopic 1˚ induction in the let-60(n1046gf) background (see 
Fig. 2. 5E, above). VPC-specific expression of GCK-2(+) had no effect in the let-
60(n1046gf) background, controlling for effects of VPC-specific GCK-2(+) 
overexpression (Fig. 2. 10E). VPC-specific expression of GCK-2(+) restored 
baseline levels of ectopic 1˚ induction in the let-60(n1046gf); gck-2(ok2867) 
background (Fig. 2. 10E). Taken together, these results suggest that GCK-2 
functions cell autonomously in VPCs, via its kinase activity. 
RAL-1 and GCK-2 are expressed in VPCs. 
Our fifth criterion is that a RAL-1 effector be expressed in the VPCs. When 
analyzing the sEx10525[Pgck-2::gfp+dpy-5(+)] transcriptional reporter transgene 
(Hunt-Newbury et al., 2007), we observed no GFP expression in VPCs. Therefore, 
we used CRISPR-Cas9 genome editing to insert mNG::3xFlag into the 5’ end of 
the endogenous gck-2 gene, generating gck-2(re113[mNG^3xFlag::gck-2]) (Fig. 
2. 12A). We confirmed alleles by western blot (Fig. 2. 12B). We observed cytosolic
tagged GCK-2 throughout vulval development (Figs. 2. 11A-B; 2. 12C-F). We 
observed the expression of GCK-2 in all tissues, including the germline and 
embryos in the adult hermaphrodite (Figs. 2. 12G-H). 
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Figure 2. 11 Endogenously tagged GCK-2 and RAL-1 are expressed in VPCs. 
A-B. Representative confocal and DIC micrographs of the presumptive 1˚ (P6.p) 
and 2˚ (P5,7.p) VPCs of gck-2(re113[mNeonGreen^3xFlag::gck-2]) animals. C-D. 
Confocal and DIC micrographs of the presumptive 1˚ (P6.p) and 2˚ (P5,7.p) VPCs 
of ral-1(re160gf[mKate2^3xFlag::ral-1(G26V)]) animals. E-F. Merged confocal 
and DIC micrographs of the presumptive 1˚ and 2˚ VPCs of the ral-1(re160gf); 
gck-2(re113) double mutant, from a separate animal than the single tags. “AC” 
label is placed directly above the Anchor Cell. Scale bar = 20 µm. Reprinted with 
permission form Shin et. al, 2018
We also inserted mKate2::3xFlag into the 5’ end of the endogenous ral-1 
gene, with and without the activating G26V mutation (Figs. 2. 12I-J, 2. 12Q-R). 
The observed subcellular localization of RAL-1 and RAL-1(G26V) was similar, 
suggesting that the activating mutation does not alter localization. We observed 
tagged RAL-1 and RAL-1(G26V) throughout vulval development (Figs. 2. 11C-D; 
2. 12K-N; 2. 12S-X). Tagged RAL-1 and RAL-1(G26V) expression in the animal
was ubiquitous, including vulva and germline, and localized primarily to plasma 
membrane and adherens junctions (Figs. 2. 12O-P, 2. 12Y-Z). To assess co-
localization of RAL-1 and GCK-2, we made the ral-1(re160gf[mKate2^3xFlag::ral-
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1(G26V)]); gck-2(re113[mNG^3xFlag::gck-2]) strain. We observed strong 
localization of RAL-1(G26V) to plasma membrane and junctions and GCK-2 to 
cytosol at Pn.p (1-cell) and Pn.px (2-cell) stages (Figs. 2. 11E-F; 2. 12AA-AB). 
Figure 2. 12 CRISPR knock-in strategies, western blot validations, and 
localization of endogenously tagged GCK-2, RAL-1(G26V), and RAL-1. A. 
The Self-Excising Cassette (SEC) has positive selection marker HygR 
(hygromycin resistance), negative selection marker sqt-1(d) (confers a dominant 
Rol phenotype), and heat-shock Cre to excise the cassette (Dickinson et al., 2015). 
Before heat shock, animals are selected by Rols that survive hygromycin 
treatment. After heat-shock, the region between the two LoxP sites is excised, 
and functional endogenously tagged gck-2 is generated. B. CRISPR knock-in 
results were confirmed by western blot. First lane: gck-
2(re112[mNG^SEC^3xFlag::gck-2]), second lane: gck-
2(re113[mNG^3xFlag::gck-2]). Endogenously tagged GCK-2 protein 
(mNG::3xFlag::GCK-2) is ~124 kDa, and was detected by anti-Flag antibody 
(1:2000) (Sigma-Aldrich F1804), with loading control Anti-α-Tubulin (1:2000) 
(Sigma-Aldrich T6199). “mNG” = mNeonGreen (Shaner et al., 2013).  Reprinted 
with permission form Shin et. al, 2018
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Figure 2. 12 Continued. C-F. Representative confocal and DIC micrographs of 
the 1˚ and 2˚ vulval lineages of gck-2(re113[mNG^3xFlag::gck-2]) animals at the 
Pn.px (2-cell) and Pn.pxx (4-cell) stages. Tagged GCK-2 is cytosolic in vulval 
lineages. The Anchor Cell (AC) exhibits strong cytosolic tagged GCK-2. “AC” label 
is placed directly above the Anchor Cell. G-H. Representative confocal and DIC 
micrographs of adult germlines of gck-2(re113[mNG^3xFlag::gck-2]) animals, 
exhibiting cytosolic expression. Brighter expression at the right side of the image 
is the spermatheca. Reprinted with permission form Shin et. al, 2018
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Figure 2. 12 Continued. I. SEC strategy for N-terminal tagging and G26V 
mutagenesis of endogenous RAL-1 was similar as for N-terminal tagging of GCK- 
2 (Fig. 2. 12A), except mKate2 was substituted for mNeonGreen and the 
downstream homology arm sequence contained a missense mutation predicted 
to confer a G26V change in tagged RAL-1 protein. J.  CRISPR knock-in results 
were confirmed by western blot: First lane: ral-1(re159[mKate2^SEC^3x Flag::ral- 
1(G26V)]), second lane: ral-1(re160gf[mKate2^3xFlag::ral-1(G26V)]). 
Endogenously tagged mKate2::3xFlag::RAL-1(G26V) was detected by anti-Flag 
antibody (1:2000) (Sigma-Aldrich F1804), showing a protein size of ~56 kDa for 
RAL-1A, with loading control Anti-α-Tubulin (1:2000) (Sigma-Aldrich T6199). 
“mK2” = mKate2 (Shcherbo et al., 2009). RNAseq data for ral-1 in Wormbase 
predict a potentially longer isoform predicted to run at 61 kD (RAL-1B), but with 
far less transcript (~13% of total). RAL-1B, if made, would encode an N-terminal 
extension not found in other species. Since we did not detect an additional band 
by western blotting, we hypothesize that RAL-1B is simply an extended 5’UTR 
that is not translated into an alternate isoform.  Reprinted with permission form 
Shin et. al, 2018
68 
Figure 2. 12 Continued. K-N. Representative confocal and DIC micrographs of 
the 1˚ and 2˚ vulval lineages of ral-1(re160gf[mKate2^3xFlag::ral-1(G26V)]) 
animals at the Pn.px (2-cell) and Pn.pxx (4-cell) stages show predominantly 
localization to plasma membrane and adherens junctions. O-P. Representative 
confocal and DIC micrographs of adult germlines of ral- 
1(re160gf[mKate2^3xFlag::ral-1(G26V)]) animals, showing plasma membrane 
localization. The lower left corner of (O) shows the double line of the intestinal 
lumen, where tagged RAL-1(G26V) is strongly localized to adherens junctions. 
Reprinted with permission form Shin et. al, 2018
69 
Figure 2. 12 Continued. Q. SEC strategy for N-terminal tagging of endogenous 
RAL-1(+). R. CRISPR knock-in results were confirmed by western blot: First lane: 
ral-1(re217[mKate2^SEC^3xFlag::ral-1(+)]), second lane: ral- 
1( [mKate2^3xFlag::ral-1(+)]). Endogenously tagged mKate2::3xFlag::RAL-1(+) 
was detected by anti-Flag antibody (1:2000) (Sigma-Aldrich F1804), with loading 
control Anti-α-Tubulin (1:2000) (Sigma-Aldrich T6199). S-X. Representative 
confocal and DIC micrographs of the 1˚ and 2˚ vulval lineages of ral- 
1(re218[mKate2^3xFlag::ral-1(+)]) animals at the Pn.p (1-cell), Pn.px (2-cell), and 
Pn.pxx (4-cell) stages show predominantly localization to plasma membrane and 
adherens junctions.  Reprinted with permission form Shin et. al, 2018
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Figure 2. 12 Continued. Y-Z. Representative confocal and DIC micrographs of 
adult germlines of ral-1(re160gf[mKate2^3xFlag::ral-1(G26V)]) animals, showing 
plasma membrane localization. AA-AB. Merged confocal and DIC micrographs of 
the presumptive 1˚ (P6.p) and 2˚ (P5,7.p) lineages of the ral- 
1(re160gf[mKate2^3xFlag::ral-1(G26V)]); gck-2(re113[mNG^3xFlag::gck-2]) 
double mutant at the Pn.px (2-cell) stage. Scale bar throughout = 20 µm. 
Reprinted with permission form Shin et. al, 2018 
Thus, expression of tagged endogenous RAL-1 (wild-type and G26V) and GCK-
2 are expressed in VPCs, one of our criteria for a RAL-1-GCK-2 signaling cascade. 
However, we did not observe evidence of 2˚-specific recruitment of GCK-2 to the 
plasma membrane by activated RAL-1. We will consider this incongruity further in 
the Discussion. 
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The PMK-1/p38 MAP kinase functions downstream of RAL-1 and is expressed in 
VPCs. 
The “GCK-2 group” is part of the Ste20 family of MAP4 kinases and is 
frequently associated with activation of JNK or p38 MAP kinase cascades (Dan et 
al., 2001; Delpire, 2009). Based on our model that RAL-1 signals through GCK-2, 
we investigated components of MAPK cascades as functioning downstream of 
RAL-1, identifying MLK-1/MAP3K and PMK-1/p38 as putative components of the 
RAL-1-GCK-2 2˚-promoting signaling cascade. 
C. elegans encodes orthologs of MAP3Ks and MAP2Ks (Sakaguchi et al., 
2004). The km19 deletion in MLK-1/MLK/MAP3K (Mizuno et al., 2004) enhanced 
let-60 (n1046gf) vs. n1046gf alone (p=0.009, N of 90 and 60, respectively), 
consistent with MLK-1/MAP3K acting in this cascade. In contrast, the ok1382 
deletion in MTK-1/MEKK4/ MAP3K failed to enhance let-60(n1046gf) vs. n1046gf 
alone (p=0.4, N of 50 and 91, respectively). The km4 deletion in SEK-
1/MKK3/6/MAP2K (Tanaka-Hino et al., 2002) and the ok1545 deletion in MKK-
4/MKK4/MAP2K failed to enhance let-60(n1046gf) vs. n1046gf alone (p=0.6 N of 
60, 60; and p=0.2 N of 90, 90, respectively). Several other MAP2Ks were not 
tested. 
C. elegans encodes three p38/MAPK paralogs in an operon, in order: PMK-2, 
PMK-3, and PMK-1. Of these, PMK-2 and PMK3 are expressed primarily in 
intestine, while PMK-1 is expressed more broadly. All three are thought to 
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Figure 2. 13 PMK-1/p38 functions downstream of RAL-1. A. Putative null, pmk- 
1(km25) confers increased ectopic 1°s in the let-60(n1046gf) background. B. pmk- 
1(km25) blocks the increased 2°s in the reIs10[Plin-31::ral-1(gf)]; lin-12(n379d) 
background. P values calculated by t test. Error bars = S.E.M. C-D. 
Representative confocal and DIC micrographs of pmk-1(re170[pmk- 
1::mNG^3xFlag]). Endogenously tagged PMK-1 is expressed in VPCs. Solid 
arrow: VPC nuclei. Open arrow: Gut nuclei. Scale bar = 20 µ m. E. A signaling 
transduction model. A LET-60/Ras-RGL-1/RalGEF-RAL-1/Ral-EXOC-8/Exo84-
GCK-2/MAP4K-MLK-1/MAP3K-PMK-1/MAPK cascade promotes 2˚ fate in C. 
elegans VPC fate patterning.  Reprinted with permission form Shin et. al, 2018
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contribute to innate immunity and stress response (Mertenskotter et al., 2013). 
Fitting some of our criteria for a RAL-1 effector, putative null pmk-1(km25) (Mizuno 
et al., 2004) conferred increased ectopic 1° induction with let-60(n1046gf) and 
blocked increased ectopic 2° induction with ral-1(gf); lin-12(n379d) (Figs. 2. 13A-
B). 
Figure 2. 14 PMK-1 expression and localization. A. We used a similar CRISPR 
knock-in strategy for C-terminal tagging of PMK-1 as for N-terminal tagging of 
GCK-2 and RAL-1 (Figs. 2. 12A, 2. 12I, 2. 12Q). B. CRISPR knock-in results were 
confirmed by western blot: First lane: pmk-1(re169[pmk-1::mNG^SEC^3xFlag]), 
second lane: pmk-1(re170[pmk-1::mNG^3xFlag]). Endogenously tagged PMK- 
1::mNG^3xFlag was detected at ~74 kDa by anti-Flag antibody (1:2000) (Sigma-
Aldrich F1804), with loading control Anti-α-Tubulin (1:2000) (Sigma-Aldrich 
T6199).  Reprinted with permission form Shin et. al, 2018
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Figure 2. 14 Continued. C-F. Representative confocal and DIC micrographs of 
the 1˚ and 2˚ vulval lineages of pmk-1(re170[pmk-1::mNG^3xFlag]) animals at the 
Pn.px (2-cell) and Pn.pxx (4-cell) stages show the expression both in nucleus and 
in cytoplasm of VPCs. G-J. confocal and DIC micrographs of Ppmk-1::pmk-1(+)::gfp, 
rol-6 (su1006) animals showing expression in intestine, but not in VPCs at L3 
stage and vulva at L4 stage.  Reprinted with permission form Shin et. al, 2018
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Figure 2. 14 Continued. K-N. Confocal and DIC micrographs of low copy number 
of reSi6[Plin-31::mKate2::linker::pmk-1::unc-54 3’UTR] at the Pn.p (1-cell) and 
Pn.px (2-cell) stages also shows the expression both in nucleus and in 
cytoplasm of VPCs. Reprinted with permission form Shin et. al, 2018
We tagged the endogenous pmk-1 gene with mNG::3xFlag at the 3’ end (Figs. 
2. 14A-B). We observed PMK-1::mNG expression in vulval lineages and
throughout the rest of the animal, with the exception of the germline; germline 
expression appeared to be silenced, an established phenomenon with certain 
foreign DNA insertions (Figs. 2. 13C-D; 2. 14C-F; Dickinson et al., 2015). Thus, 
expression of PMK-1 meets the criteria of an effector that functions downstream 
of RAL-1. Using a transgenic pmk-1 promoter translational GFP fusion (Ppmk-
1::pmk-1::gfp; Mertenskotter et al., 2013), we observed no vulval signal (Figs. 
2.14G-J). However, since pmk-1 is the last gene in an operon, key regulatory 
elements may be absent from the construct. 
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We had hoped to observe activity-dependent cytosol-to-nucleus translocation 
(Ben-Levy et al., 1998) of PMK-1 as a biomarker for upstream RAL-1 signaling 
activation. Instead, we observed nuclear and cytosolic localization in all cells, 
including vulval lineages (Figs. 2. 13C-D; 2. 14C-F). We considered our C-terminal 
CRISPR tagging scheme may have altered PMK-1 localization, even though we 
did not observe phenotypic changes conferred in the sensitized background by 
PMK-1::mNG. Therefore, we N-terminally tagged PMK-1 expressed from lin-31 
promoter in VPCs, using the miniMos system (de la Cova et al., 2017), and with 
mKate2 rather than mNG. We observed localization to both nuclei and cytosol of 
VPCs (Figs. 2. 14K-N). Consequently, we propose that our tagging strategies do 
not disrupt PMK-1 function, but rather that part of the endogenous PMK-1 
population is constitutively targeted to the nucleus. We speculate that over-
expression from the extrachromosomal array shows mostly cytosolic localization 
because only a small subset of the total PMK-1 molecules occupy the nucleus, 
and that the proportion of nuclear PMK-1 to total protein is much higher when 
looking at endogenous rather than over-expressed protein. 
Discussion 
We found that EXOC-8/Exo84 contributes to the LET-60/Ras-RGL-
1/RalGEF-RAL-1/Ral 2˚-promoting signal during patterning of C. elegans VPC 
fate. By our genetic criteria GCK-2, a CNH domain-containing MAP4K 
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orthologous to Drosophila Hppy and mammalian MAP4K1, 2, 3 and 5, is a 
downstream effector of RAL-1, as are MLK-1/MAP3K and PMK-1/p38 MAPK (Fig. 
2. 13E). The LET-60-RGL-1-RAL-1-EXOC-8-GCK-2-MLK-1-PMK-1 cascade is a
non-essential 2˚-promoting signal in C. elegans VPC fate patterning that supports 
the essential 2˚-promoting signal via LIN-12/Notch. We showed that GCK-2 and 
PMK-1 function downstream of RAL-1 cell autonomously, and that GCK-2 is 
sufficient to promote 2˚ fate in support of LIN-12/Notch. We did not observe 
evidence of ectopic 2˚ induction by reIs10[ral-1(gf)] or ral-1(re160gf). Thus, given 
the modest modulatory role of the RAL-1 2˚-promoting cascade, there is no reason 
to propose that RAL-1 is sufficient to induce 2˚ fate, though the actual experiment 
in the absence of lin-12 is as yet prohibitively difficult (abrogation of LIN-12 
function duplicates the anchor cell, and thus results in complex VPC induction; 
(Greenwald et al., 1983). 
Sec5 and Exo84 are subunits of the exocyst complex and known Ral binding 
partners in mammals (reviewed in (Gentry et al., 2014; Kashatus, 2013). Ral-
Exo84 and Ral-Sec5 regulate exocytosis, cancer cell proliferation, and immunity 
(Chien et al., 2006; Fukai et al., 2003; Issaq et al., 2010; Jin et al., 2005; 
Moskalenko et al., 2002; Moskalenko et al., 2003; Sugihara et al., 2002). Yet we 
do not understand how Ral signaling is propagated through the Sec5 and Exo84 
exocyst partners. Exo84 and Sec5 also confound biochemical identification of 
downstream signaling partners, since the exocyst is involved in central cell 
biological processes and potentially interacts with myriad partners (Tanaka et al., 
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2017; Wu and Guo, 2015). There are some exceptions: RalB-Sec5 directly 
recruits and activates the atypical IκB kinase family member TBK1 to contribute 
to human cancer cell survival (Chien et al., 2006), RalB-Exo84 promotes 
autophagosome assembly under starvation conditions in human epithelial cells 
(Bodemann et al., 2011), while under replete conditions RalB-Sec5 stimulates 
mTORC1 activation in pancreatic tumor cells to promote cell invasion and inhibit 
autophagy (Martin et al., 2014). Yet we lack biomarkers for activated Ral and have 
limited knowledge of effectors downstream of Sec5 and Exo84. Using 
developmental patterning of the C. elegans VPCs as a simple model system, we 
defined a potentially new signaling cascade downstream of RAL-1 in development. 
Additional signaling cascades may function downstream of Ral in different tissues. 
The GCK-2 paralog, MIG-15, also contributes to VPC patterning: depletion of 
mig-15 derepressed both 2˚- and 1˚-inducing backgrounds, respectively lin-
12(n379d) and let-60(n1046gf). A 3˚-promoting gene might be predicted to 
similarly antagonize both 1˚- and 2˚-promoting signals. However, the connection 
of MIG-15 to 1˚-promoting signals and 2˚-promoting signals is unclear, and is 
complicated by the role of MIG-15 in vulval morphogenesis. In contrast, we clearly 
delineated GCK-2 genetically as a component of a positive regulatory cascade 
downstream of RAL-1-EXOC-8. 
While mutation of neither RLBP-1/RalBP1 nor SEC-5/Sec5 altered vulval 
patterning in sensitized backgrounds, mutation of EXOC-8/Exo84 conferred 
phenotypes consistent with functioning as a signaling intermediary in a RAL-1 2˚-
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promoting cascade. However, mutation of EXOC-8 also conferred defects 
consistent with other activities in VPC fate patterning: unlike reduced RAL-1 or 
GCK-2 function, reduced EXOC-8 function conferred increased 2˚ induction in the 
lin-12(n379d) 2˚-inducing background. We speculate that EXOC-8 performs at 
least two functions: (1) an intermediary in RAL-1-GCK-2 2˚-promoting signaling, 
and (2) in an anti-2˚ capacity, perhaps with MIG-15. Thus, the roles of EXOC-8 
and MIG-15 in VPC fate patterning are enigmatic, and will be the subject of future 
genetic and biochemical studies, particularly as we develop better experimental 
tools via use of CRISPR. 
Activation of the p38 and JNK families of MAPKs have variously been 
associated with activation of the GCK-I (GCK-2) and GCK-IV (MIG-15) 
subfamilies of CNH domain MAP4Ks (Delpire, 2009). Neither subfamily has been 
studied systematically. Our ongoing observation of the literature is consistent with 
the GCK-2 and MIG-15 subfamilies generally being associated with p38 and JNK, 
activation, respectively. Yet so many of these studies depend on protein over-
expression that we hesitate to draw general conclusions. Here we connect GCK-
2 with PMK-1/p38 function, while in Drosophila dorsal closure of the embryo Msn 
(MIG-15 subfamily) is associated with JNK function (Su et al., 2000; Su et al., 
1998). 
Activation of MAP kinases is often associated with cytosol-to-nuclear 
translocation, initially shown with the canonical ERK MAPK (Gonzalez et al., 1993; 
Lenormand et al., 1993) but also shown for p38 MAPK (Ben-Levy et al., 1998). 
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Extrachromosomal transgenic C. elegans PMK-1::GFP similarly translocated from 
cytosol to the nucleus upon stress (Mertenskotter et al., 2013). Yet we found that 
this PMK-1::GFP fusion was not expressed in the VPCs, perhaps because pmk-
1 is expressed as part of a multi-gene operon, and so the transgene is missing 
key regulatory sequences. Further, the transgenic PMK-1::GFP is likely to be 
over-expressed, as is typical for C. elegans transgenic arrays, and thus may 
obscure more nuanced regulatory inputs. Consequently, we generated 
endogenous PMK-1::mNG via CRISPR and also introduced VPC-specific single-
to-low copy mK2::PMK-1 (Fig. 2. 13, Fig. 2. 14). While we observed that 
endogenous PMK-1::mNG was expressed in VPCs, to our surprise we observed 
consistent nuclear PMK-1::mNG throughout the animal, including VPCs 
throughout their fate patterning, and nuclear mK2::PMK-1 in VPCs throughout 
their patterning. One could speculate that we perturbed PMK-1 function both 
through C- and N-terminal tagging, yet we showed that PMK-1::mNG function 
appeared normal in the let-23(sa62gf) background. These observations leave us 
at an impasse. Is the prevailing model for MAP kinase activation flawed? Is PMK-
1/p38, a known stress kinase, tonically activated as a consequence of 
endogenous stressors or culture conditions? Or is translocation a modest part of 
the activation process that was previously masked by assay conditions? Our 
observation may lead to important mechanistic considerations of p38 activation 
and activation of MAP kinases in general, and is worth further investigation. 
81 
Many small GTPases, including mammalian RalA and RalB, are membrane-
targeted through prenylation. Based on its C-terminal CAAX sequence, RAL-1 is 
inferred to be geranylgeranylated (Reiner and Lundquist, 2016), and our CRISPR 
tag of endogenous RAL-1 showed strong localization to the plasma membrane in 
all cells. The canonical mechanism for effector activation, originally defined for 
Ras-Raf (Block et al., 1996; Chiu et al., 2002), is recruitment of cytosolic effector 
to the plasma membrane by activated small GTPase. While our genetic analysis 
indicates that GCK-2 functions downstream of the 2˚-promoting RAL-1 in VPCs, 
we did not observe co-localization of tagged endogenous RAL-1 and GCK-2, or 
activity-dependent enrichment of plasma membrane GCK-2, in presumptive 2˚ 
cells. This observation could be explained by activated, membrane-tethered RAL-
1 recruiting only a small portion of cytosolic GCK-2. Alternatively, perhaps RAL-1 
effector activation proceeds through an atypical mechanism, consistent with the 
non-canonical nature of the exocyst as an effector. The exocyst presents an 
interesting conundrum in signaling: it is clearly required for much Ral signaling 
(reviewed in Gentry et al., 2014), yet thwarts conventional biochemical 
bootstrapping through signaling cascades. Thus, the lack of co-localization of 
RAL-1 and GCK-2 could also be explained by certain populations of RAL-1 and 
GCK-2 being constitutively associated, perhaps at the exocyst complex. Though 
not the same subfamily (GCK-2 vs. MIG-15), this model is consistent with co-
immunoprecipitation of mammalian Sec5 and HGK/MAP4K4 (Balakireva et al., 
2006). We speculate that the complex of RAL-1/EXOC-8/GCK-2 recruits a co-
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activator when RAL-1 is activated. Such a mechanism was implicated in studies 
of mammalian MAP4K3 (in the GCK-2 subfamily), in which a putative activating 
phosphorylation event was detected (Yan et al., 2010). While shown to be 
inhibited by PP2AT61ε, the kinase(s) mediating this phosphorylation event 
remains unknown. Alternatively, perhaps RAL-1 and GCK-2 never physically 
interact, and thus genetic analysis was required to reveal this cascade. 
The advent of CRISPR-based tools permits analysis of endogenous proteins, 
and hence potentially improved cell biological and biochemical analysis. For 
example, all known Ral binding partners were discovered by yeast two-hybrid 
analysis, an approach with a strong record but also ample false negatives, say, in 
conditions of activity-dependent interactions or metazoan-specific subcellular 
localization. Thus, we may be able to use biochemical approaches to with tagged 
endogenous RAL-1 to identify novel interactors. Yet we also recognize the 
balance of strengths and weaknesses in the model invertebrate system, so 
mammalian cell-based studies may complement our genetic analysis to elucidate 
details of molecular mechanisms. 
It is as yet unclear whether our findings of a genetic requirement for PMK-1 
downstream of the RAL-1 2˚-promoting activity herald a similar use of p38 
downstream of mammalian Ral isoforms during development or cancer. An 
alternative possibility is that Ral in various metazoa signals through an array of 
effectors, only of some of which are relevant to cancer. Genetic and tissue 
heterogeneity of tumors, coupled with the historic difficulty of assessing Ral 
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activation levels in tumors, make this question non-trivial to address rigorously. 
This question is further complicated by the diverging functions of RalA and RalB 
in cancer, and their mostly poorly defined roles in non-pathogenic development 
and physiology. Yet this study could lead to surveys of phospho-p38 levels in Ras-
positive tumors as a function of RalA or RalB, thus potentially satisfying the great 
demand for cancer biomarkers of Ral activation. Alternatively, establishment of a 
viable in vivo invertebrate model for RAL-1 function, added to the development of 
elegant genetic tools, should lead to extensive investigation of RAL-1 in diverse 
areas of biology, potentially leading us to clinically important biomarkers and 
“druggable targets” other than p38. 
In conclusion, we have demonstrated that the LET-60/Ras-RGL-1/RalGEF-
RAL-1/Ral 2˚-promoting signal acts through exocyst component EXOC-8/Exo84 
to trigger a GCK-2/MAP4K-PMK-1/p38 cascade. From a developmental biology 
standpoint, the mechanism by which the EGF morphogen gradient promotes 2˚ 
VPC fate in support of LIN-12/Notch is of long-standing interest (Kenyon, 1995). 
From a cancer biology standpoint, this study may also contribute to development 
of diagnostic biomarkers and small molecule inhibitors for Ras- and Ral-
dependent cancers. 
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Materials and Methods 
C. elegans handling and genetics. 
All strains were derived from the N2 wild type. Nomenclature was as 
described (Horvitz et al., 1979). Animals were cultured using standard conditions 
on OP50 bacteria on NGM agar places at 20˚C (Brenner, 1974) except where 
noted. Strains used are shown in Table 2. 1. 
PCR primers are listed in Table 2. 2. Single animal genotyping PCR reactions 
used Taq PCR Master Mix (QIAGEN). Deletions in gck-2 were detected by triplex 
primers REW88/89/90 (Tm: 58˚C, 32 cycles), resulting in 298 bp (wild-type), 478 
bp (ok2867), and 462 bp (tm2537) amplicons. PCR products were sequenced to 
confirm reported allele perturbations (Khan et al. 2012). The exoc-8(ok2523) 
deletion was detected by triplex primers REW109/110/111 (Tm: 58˚C, 32 cycles), 
resulting in 411 bp (wild-type) and 270 bp (ok2523) amplicons. The pmk-1(km25) 
was detected by PCR using triplex primers, REW85/86/87 (Tm: 55.5˚C, 32 cycles), 
resulting in 345 bp and 591 bp (wild-type) and 216 bp (km25). ral-1(gk628801) 
was detected by primers DJR778/779 (Tm: 57˚C, 32 cycles) to generate a 250 bp 
amplicon, followed by overnight digestion with HpyCH4IV (NEB) to yield wild-type 
(121 bp, 51 bp, 48 bp and 30 bp) and gk628801 (151 bp, 51 bp and 48 bp) bands. 
85 
The sec-5(pk2357)/+ mutation was maintained as a stable heterozygote by 
GFP-tagged balancer mIn1mIs14, and homozygotes were obtained by scoring 
non-green progeny. 
Vulval induction scoring assay. 
To score vulval induction, late L4 animals were mounted on slides with a 3% 
agar pad in M9 buffer with 5 mM sodium azide. Invaginations of ectopic 
pseudovulvae were scored under DIC/Nomarski optics (Nikon eclipse Ni). Images 
were captured using NIS-Elements AR 4.20.00 software. The vulval induction 
index for ectopic 1˚ and 2˚ induction was scored as described elsewhere. Briefly, 
we counted vulval invaginations, comprising cell lineages of single VPCs 
undergoing morphogenesis, which were distinct from the composite 2˚-1˚-2˚ 
normal vulva lineages (the “Christmas tree”, which we argue more closely 
resembles the Stanley Cup). As expected, in the let-60(n1046gf) background the 
normal vulva was oriented on the AC in the center of the gonad. The morphology 
of ectopic 1˚ lineages generally conformed with the symmetrical “cap” 
characteristic of isolated 1˚ lineages (Katz et al., 1995). In the lin-12(n379d) 
background, the AC and normal vulva were mostly absent, as described 
(Greenwald et al., 1983). The morphology of ectopic 2˚ lineages generally 
conformed with the asymmetric “beret” characteristic of isolated 2˚ lineages 
(Green et al., 2008; Katz et al., 1995). When the AC and normal vulva were 
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present in a lin-12(n379d) animal, data from that animal were flagged and 
excluded from the final count of ectopic 2˚ cells. 
As previously described (Zand et al., 2011), the let-60(n1046gf) strain is liable 
to drift, resulting in increased induction of 1˚ cells. We established many frozen 
strains of n1046 single mutants, and n1046 outcrossed to N2, and established 
that the typical baseline is 1.2 to 1.5 ectopic 1˚ cells. We have also consistently 
observed that the n1046 baseline is increased by ~0.2 when grown on bacterially 
mediated RNAi, including gfp or luciferase control strains (Zand et al., 2011; this 
study). Consequently, for all strains harboring an n1046 mutation, we use a 
stringent protocol to minimize drift: strains are scored and a parafilmed plate 
established immediately after construction or thawing, strains are refreshed (if 
necessary) by chunking, and animals are never grown for several generations in 
culture. Assays in which n1046 control strains deviate from the expected baseline 
are discarded. When using this rigorous protocol, we rarely observe significant 
deviations from expected baselines. Each figure panel with VPC counts is from 
animals grown together at the same time. 
Plasmids, generation of transgenic lines and integrated lines. 
Details of plasmid construction are available upon request. Plasmids are 
listed in Table 2. 3. Transgenic lines were generated by microinjection of pB255-
derived plasmids (50 ng/µl) with co-injection marker (20 ng/µl; either pPD118.33 
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[Pmyo-2::gfp] or pPD93.97 [Pmyo-3::gfp]) into the relevant strain and maintained by 
selecting for fluorescent animals. reIs10[Plin-31::ral-1(Q75L)+ Pmyo-2::gfp] was 
generated and mapped to position I+5.1 (Shin, et al., in preparation). 
Fluorescent microscopy. 
L3 animals were mounted in 5 mM sodium azide/M9 buffer on slides with 3% 
agar pad. pmk-1(re170[pmk-1::mNG^3xFlag]) animals were grown on 
Comamonas sp. (DA1877) (Avery and Shtonda, 2003) and mounted in 2 mg/mL 
tetramisole in M9 buffer on slides with 3% agar pad. We hypothesized that stress 
caused constitutive translocation to the nucleus. However, growth on 
Comamonas sp. bacteria, which are thought to be non-inflammatory (Avery and 
Shtonda, 2003), did not alter the degree of nuclear translocation. Similarly, 
mounting animals on tetramisole rather than sodium azide did not abolish nuclear 
translocation. All images were captured by A1si Confocal Laser Microscope 
(Nikon) using NIS Elements Advanced Research, Version 4.40 software (Nikon). 
CRISPR/Cas9-dependent genome editing. 
Repair templates were generated by PCR amplification from genomic DNA 
of ~500 bp homology by Q5 polymerase (NEB), digesting of the target SEC vector, 
and Gibson Assembly (NEB) directed by homologous ends. The sgRNA targeting 
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sequences were inserted into pJW1236, the Cas9+sgRNA (F+E) plasmid (Ward, 
2015), by Q5 site-Directed Mutagenesis (NEB). Plasmids, sgRNA sequences 
including PAM, and repair ssODNs used were listed in Tables 2. 3-2. 5. 
mNG^3xFlag::GCK-2 was generated by microinjection of repair template (20 
ng/µl), sgRNA-Cas9 #1 (25 ng/µl), sgRNA-Cas9 #2 (25 ng/µl), and injection 
marker Pmyo-2::mCherry (2.5 ng/µl) into wild-type (N2) animals. sgRNA targeting 
sequences are listed (Table 2. 4). mKate2^3xFlag::RAL-1(+) and 
mKate2^3xFlag::RAL-1(G26V) were generated by microinjection of repair 
template (20 ng/µl), sgRNA-Cas9 #1 (25 ng/µl), sgRNA-Cas9 #2 (25 ng/µl), and 
injection marker Pmyo-2::gfp (10 ng/µl) into N2. The ral-1(G26V) mutation was 
generated by Q5 site-Directed Mutagenesis (NEB) into the homology arm of the 
repair template used for CRISPR. PMK-1::mNG^3xFlag was generated by 
microinjection of repair template (10 ng/µl), sgRNA-Cas9 #1 (50 ng/µl), sgRNA-
Cas9 #2 (50 ng/µl), and injection marker Pmyo-2::mCherry (2.5 ng/µl) into N2. To 
minimize steric hindrance, the linker sequence N-SAGGSAGGSAGG-C (Komatsu 
et al., 2011; 5’ -TCAGCCGGAGGTAGCGCCGGCGGAAGTGCTGGTGGA - 3’) 
was inserted between pmk-1 and mNG coding sequences, while RAL-1 and GCK-
2 tagging had shorter linker N-SAGG-C (5’ -GGAGCCGGATCT- 3’) between 
FP::epitope and the N-terminus. Animals were handled and treated with 5 mg/ml 
hygromycin as described (Dickinson et al., 2015). The CRISPR knock-in results 
were confirmed by genotyping PCR using Taq PCR Master Mix (QIAGEN) and 
sequencing (Genewiz). Using the previously tagged DV3228 gck-
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2(re113[mNG^3xFlag::gck-2]) as a starting point, the gck-2(mid-Δ) was generated 
by Co-CRISPR using dpy-10(cn64gf) as a Co-CRISPR marker (Arribere et al., 
2014). sgRNA-Cas9 constructs were prepared by Q5 site-Directed Mutagenesis 
(NEB) of pJW1236. The repair ssODN, providing 35 bases of flaking homology 
arms on each side of the repaired break, was synthesized by IDT. We 
microinjected DV3228 with the two sgRNA-Cas9 constructs (each 25 ng/µl), repair 
oligo (10 µM), sgRNA for dpy-10(cn64gf) (pJA58) (25 ng/µl), ssODN repair donor 
for dpy-10(cn64gf) (600 nM), and injection maker Pmyo-2::mCherry (2.5 ng/µl). 
Animals were handled and isolated as described (Arribere et al. 2014) by picking 
Rols and Dpys for PCR genotyping to detect the deletion, followed by sequence 
analysis of the repaired region and outcrossing to N2. 
We assessed CRISPR tagged alleles for possible impacts on function by 
crossing tagged alleles into the let-60(n1046gf) and the let-23(sa62gf) sensitized 
backgrounds and comparing ectopic 1˚ induction of n1046 or sa62 alone vs. 
n1046 or sa62+tagged allele strains. We observed induction indices of 1.4 vs. 1.4 
for n1046 vs. n1046; gck-2(re113), respectively (P = 0.9), 1.4 vs. 1.2 for n1046 vs. 
n1046; ral-1(re218), respectively (P = 0.3), and 1.3 vs. 1.3 for sa62 vs. sa62; pmk-
1(re170), respectively (P = 0.8). The functional impact of CRISPR putative gain-
of-function mutations are shown in Fig. 2. 7B (for the ral-1(re160gf) G26V allele) 
and Fig. 2. 7F (for the gck-2(re113re222) mid-Δ allele). By visual inspection, none 
of the CRISPR tags or mutations altered the wild-type development. 
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Western blotting. 
Animals were lysed in 4% SDS loading buffer by boiling at 90˚C for 2 minutes. 
Protein samples were run on 4-15% SDS gel (BIO-RAD). Monoclonal anti-Flag 
antibody (Sigma-Aldrich F1804) and monoclonal anti-α-tubulin antibody (Sigma-
Aldrich T6199) were diluted 1:2000 in blocking solution. Secondary antibody, goat 
anti-mouse (MilliporeSigma 12-349), diluted in 1:5000 in blocking solution. ECL 
reaction (Thermo Fisher Scientific) has done for signal generation. Immunoactive 
proteins were detected by film processor, SRX-101A (Konica Minolta) on X-ray 
film (Phenix). 
Bacterially mediated RNA interference. 
RNAi plasmids used were: III-7M13 (ral-1), V-4P08 (gck-2), X-5G21 (mig-15), 
gfp (Zand et al., 2011), and luciferase. For an RNAi negative control, a luciferase 
fragment not having sequence overlap with the C. elegans genome was amplified 
from SRE-luciferase plasmid and cloned into the HindIII- and XhoI-cut sites of 
L4440/pPD129.36. The host of bacterially-mediated RNAi clones was HT115 
(Timmons and Fire, 1998). RNAi experiments were performed at 23˚C on NGM 
agar plates supplemented with 1 mM IPTG and 50 µg/ml carbenicillin. Plates were 
seeded with 80 µl dsRNA-producing bacteria, grown overnight at room 
temperature, then populated with late L4 animals. Parents were transferred to 
91 
another RNAi plate after 1 day, and ectopic pseudovulvae were scored by DIC at 
the late L4 stage, 2 days later. 
MiniMos. 
reSi6 [Plin-31::mKate2::linker::pmk-1::unc-54 3’UTR] was generated by 
miniMos (de la Cova et al., 2017; Frokjaer-Jensen et al., 2014). 
mKate2::linker(SAGG) was tagged to the N-terminal of pmk-1 with lin-31 promoter 
and unc-54 3’UTR. MiniMos-based plasmid pSH41 was generated by subcloning 
of mKate2::linker::pmk-1 into pCC249 (Plin-31::unc-54 3’UTR) using Gibson 
Assembly (NEB). We microinjected N2 wildtype with the Pmyo-2::gfp (20 ng/µl), 
pGH8 (Prab-3:mCherry:unc-54 3’UTR) (10 ng/µl), pCFJ601 (Peft-3:mos1 
transposase::tbb-2 3’UTR) (65 ng/µl), pMA122 (Phsp16.41::peel-1::tbb-2 3’UTR) (10 
ng/µl), and pHS41 (Plin-31::mKate2::linker::pmk-1::unc-54 3’UTR) (10 ng/µl). The 
insertion site is unknown. MiniMos results were tracked by observing mKate2 
signal in VPCs. 
Quantification and statistical analysis. 
In every bar graph panel, animals were scored concurrently to avoid v
ariability, using scoring standards described in the Methods. Values represe
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nt either ectopic induction (0-3; 1˚ or 2˚), or, in the case of under-induction,
total number of VPCs induced (0-3; both 1˚ and 2˚). Each bar represents 
mean induction of the cell type indicated, with error bars representing S.E.
M. N equals the animals scored, and is indicated as a white number on e
ach bar. To avoid bias, N was determined randomly, with all prepared ani
mals scored and statistical tests only performed post hoc. General statistica
l methods are described in each figure legend. Briefly, pairwise tests were 
performed by t-test, multiple tests by ANOVA. P value is shown in each p
anel, n.s. = not significant. Significance was defined as >0.05, but inmost c
ases each relationship was tested via multiple assays. For statistical analys
es we used GraphPad Prism 5. 
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Table 2. 1 Strains for GCK-2 study 
Strain Genotype Used in Figures 
MT2124 let-60(n1046gf) IV 
2. 3A, 2. 3B, 2. 3C, 2.
3D, 2. 4A, 2. 4B, 2. 5C, 
2. 5E, 2. 5F, 2. 10E, 2.
13A 
DV2799 ral-1(gk628801) III; let-60(n1046gf) IV 2. 3A
DV2672 exoc-8(ok2523) I; let-60(n1046gf) IV 2. 3B
DV2698 
sec-5(pk2357) / mIn1[mIs14 dpy-
10(e128)] II; let-60(n1046gf) IV 
2. 3C
DV2711 exoc-7(ok2006) I; let-60(n1046gf) IV 2. 4B
DV2682 rlbp-1(tm3665) I; let-60(n1046gf) IV 2. 3D
DV2443 lin-12(n379d) III; him-8(e1489) IV 
2. 4C, 2. 4D, 2. 5G, 2.
6C, 2. 6D, 2. 6E, 2. 7A, 
2. 7B, 2. 7C, 2. 7F, 2.
8B 
DV3460 




exoc-8(ok2523) I; lin-12(n379d) III; him-
8(e1489) IV 
2. 4D
DV2657 let-60(n1046gf) IV; gck-2(ok2867) V 2. 5D, 2. 5E, 2. 10E
DV2710 
lin-12(n379d) III; him-8(e1489) IV; gck-
2(ok2867) V 
2. 6C
DV2727 lin-12(n379d) III; gck-2(tm2537) V 2. 6D, 2. 8C
DV2965 lin-12(n379d) III; mig-15(rh80) X 2. 5G
DV2964 lin-12(n379d) III; mig-15(rh148) X 2. 5G
NJ490 mig-15(rh148) X 2. 6A
DV3498 let-60(n1046gf) IV; mig-15(rh148) X 2. 6B
MT378 lin-3(n378rf) IV 2. 6F
DV2833 lin-3(n378rf) IV; gck-2(ok2867) V 2. 6F
DV3326 
ral-1(re160gf[mKate2^3xFlag::ral-
1(G26V)]) lin-12 (n379d) III; him-
8(e1489) IV 
2. 7B, 2. 7D
DV2712 
reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 
lin-12 (n379d) III; him-8(e1489) IV 
2. 7A, 2. 9A, 2. 9B, 2.
13B 
DV3440 





Table 2. 1 Continued 
Strain Genotype Used in Figures 
DV3441 
lin-12(n379d) III; gck-2(re113re223 
[mNG^3xFlag::gck-2(mid-Δ)]) V 
2. 7F
DV3228 gck-2(re113[mNG^3xFlag::gck-2]) V 
2. 7E, 2. 11A, 2. 11B, 2.
12B, 2. 12C, 2. 12D, 2. 



















reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 
lin-12(n379d) III; gck-2(ok2867) V 
2. 9A, 2. 10B
DV2726 
reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 
lin-12(n379d) III; gck-2(tm2537) V 
2. 9A, 2. 9E, 2. 9F, 2.
10C, 2. 10D 
DV2734 
reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] 
exoc-8(ok2523) I; lin-12(n379d) III; him-
8(e1489) IV 
2. 9B
DV2449 lin-12(n379d) III; lin-15(n765ts) X 2. 9C, 2. 9D, 2. 10A
DV3499 
ral-1(gk628801) lin-12(n379d) III; him-
8(e1489) IV; lin-15(n765ts) X 
2. 9C
DV3403 
lin-12(n379d) III; him-8(e1489) IV; gck-
2(ok2867) V; lin-15(n765ts) X 
2. 9D
DV3194 
reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 




reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 




reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 
lin-12(n379d) III; him-8(e1489) IV; gck-




reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 




Table 2. 1 Continued 
Strain Genotype Used in Figures 
DV3243 
reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 














2. 11C, 2. 11D, 2. 12J,
2. 12K, 2. 12L, 2. 12M,
2. 12N, 2. 12O, 2. 12P
DV3402 ral-1(re218[mKate2^3xFlag::ral-1]) III 
2. 12R, 2. 12S, 2. 12T,
2. 12U, 2. 12V, 2. 12W,



















DV2706 pmk-1(km25) let-60(n1046gf) IV 2. 13A
DV2769 
reIs10[Plin-31::ral-1(Q75L), Pmyo-2::gfp] I; 
lin-12(n379d) III; pmk-1(km25) IV 
2. 13B
DV3268 pmk-1(re170[pmk-1::mNG^3xFlag]) IV 
2. 13C, 2. 13D, 2. 14B,
2. 14C, 2. 14D, 2. 14E,
2. 14F
AU0328 Ppmk-1::pmk-1(+)::gfp, rol-6 (su1006) 









2. 14K, 2. 14L, 2. 14M,
2. 14N
Reprinted with permission form Shin et. al, 2018
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Table 2. 2 Primers for GCK-2 study 


















































REW86 5’ -CTTGACTCCAATTGGTACCGGAG- 3’ 
pmk-1(km25) 
genotyping 
REW87 5’ -GTGGTCATCGTTGAGTCGCTG- 3’ 
pmk-1(km25) 
genotyping 





















Table 2. 2 Continued 
Name Sequence Use 
REW111 5’ -CATCGTCGCTGAGCAGTTGGAC- 3’ 
exoc-8(ok2523) 
genotyping 
TD185 5’ -GCCGGAAGAGTGATGAACCC- 3’ 
ral-1(re160), ral-1 
(re218) genotyping 
TD186 5’ -TAATGAGCTCGGAGACCATGGC- 3’ 
ral-1(re160), ral-1 
(re218) genotyping 
TD187 5’ -CGCACCTCATCATACATGAACTGC- 3’ 
ral-1(re160), ral-1 
(re218) genotyping 









HS138 5’ -CGTGAGGCACTGACGAAC- 3’ 
gck-2(re113) 
genotyping 




















DJR769 5’ -CACCTCCTATTGCGAGATGTCTTG- 3’ 
Universal 
Mutagenesis PCR 






primer for mNG:: 
3xFlag::GCK-2 
CRISPR sgRNA #1 
plasmid 
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Table 2. 2 Continued 





primer for mNG::  
3xFlag::GCK-2 






primer for mKate2:: 
3xFlag::RAL-1(+ or 
G26V) CRISPR 





primer for mKate2:: 
3xFlag::RAL-1(+ or 
G26V) CRISPR 





primer for PMK-1:: 
mNG::3xFlag 






primer for PMK-1:: 
mNG::3xFlag 






primer for generating 






primer for generating 






Primer for amplifying 
upstream homology 





Table 2. 2 Continued 





Primer for amplifying 
upstream homology 








Primer for amplifying 
downstream 









Primer for amplifying 
downstream 









Primer for amplifying 
upstream homology 
arm to generate 
repair template 
(mKate2::3xFlag::RA






Primer for amplifying 
upstream homology 
arm to generate 
repair template 
(mKate2::3xFlag::RA
L-1(+ or G26V) 
CRISPR) 
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Table 2. 2 Continued 






Primer for amplifying 
downstream 










Primer for amplifying 
downstream 










Primer for amplifying 
upstream homology 









Primer for amplifying 
upstream homology 








Primer for amplifying 
downstream 








Primer for amplifying 
downstream 
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primer for GCK-2 
mid-Δ CRISPR 





primer for GCK-2 
mid-Δ CRISPR 





Primer for amplifying 









Primer for amplifying 









Primer for amplifying 









Primer for amplifying 





Reprinted with permission form Shin et. al, 2018
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Table 2. 3 Plasmids for GCK-2 study 
Name Description Used for 
pREW2 
RNAi of luciferase was 
subcloned into L4440 
Negative control for RNAi 
experiments 
pREW18 Plin-31::gck-2(+)::let-858 3’UTR 
Rescue experiment in let-
60(n1046gf); gck-2(ok2867) 
pREW24 Plin-31::gck-2(+)::unc-54 3’UTR 






2° induction experiment in lin-





Kinase dead negative control 




Homology arms (534 bp 
upstream and 875 bp 
downstream) was subcloned 
into pDD268 
mNG^3xFlag::GCK-2 CRISPR 
knock-in (repair template) 
pHS13 
Mutagenized pJW1236 using 
primers, DJR769 and HS130 
mNG^3xFlag::GCK-2 CRISPR 
knock-in (sgRNA-Cas9 plasmid) 
(sgRNA #1) 
pHS14 
Mutagenized pJW1236 using 
primers, DJR769 and HS131 
mNG^3xFlag::GCK-2 CRISPR 
knock-in (sgRNA-Cas9 plasmid) 
(sgRNA #2) 
pTD36 
Homology arms (869 bp 
upstream and 754 bp 




knock-in (repair template) 
pTD40 
Homology arms (869 bp 
upstream and 754 bp 
downstream) was subcloned 
into pDD285 
mKate2^3xFlag::RAL-1(G26V) 
CRISPR knock-in (repair 
template) 
pTD38 
Mutagenized pJW1236 using 
primers, DJR769 and TD143 
mKate2^3xFlag::RAL-1(+) and 
mKate2^3xFlag::RAL-1(G26V) 
CRSIPR knock-in (sgRNA-Cas9 
plasmid) (sgRNA #1) 
pHS23 
Mutagenized pJW1236 using 
primers, DJR769 and HS166 
mKate2^3xFlag::RAL-1(+) and 
mKate2^3xFlag::RAL-1(G26V) 
CRISPR knock-in (sgRNA-Cas9 
plasmid) (sgRNA #2) 
103 
Table 2. 3 Continued 
Name Description Used for 
pHS40 
Homology arms (785 bp 
upstream and 875 bp 
downstream) was subcloned 
into pDD268 
PMK-1::mNG^3xFlag CRISPR 
knock-in (repair template) 
pHS26 
Mutagenized pJW1236 using 
primers, DJR769 and HS177 
PMK-1::mNG^3xFlag CRISPR 
knock-in (sgRNA-Cas9 plasmid) 
(sgRNA #1) 
pHS25 
Mutagenized pJW1236 using 
primers, DJR769 and HS178 
PMK-1::mNG^3xFlag CRISPR 
knock-in (sgRNA-Cas9 plasmid) 
(sgRNA #2) 
pHS38 
Mutagenized pJW1236 using 
primers, DJR769 and HS264 
GCK-2 mid-deletion CRISPR 
knock-in (sgRNA-Cas9 plasmid) 
(sgRNA #1) 
pHS39 
Mutagenized pJW1236 using 
primers, DJR769 and HS265 
GCK-2 mid-deletion CRISPR 





subcloned into pCC249 (Plin-
31::unc-54 3’UTR) 




Reprinted with permission form Shin et. al, 2018
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Table 2. 4 sgRNA sequences and PAMs 
sgRNA sequence and PAM Used for 
5’ -ACTGATGAGTGGGTGGTCGGAGG- 3’ 
mNG^3xFlag::GCK-2 CRISPR 
knock-in sgRNA #1. Inserted 
in pHS13.  
5’ -ATTGTTATGGAGTACTGCGGCGG- 3’ 
mNG^3xFlag::GCK-2 CRISPR 
knock-in sgRNA #2. Inserted 
in pHS14. 
5’ -TTCAGAATGGAGGGTTACGGTGG- 3’ 
mKate2^3xFlag::RAL-1(+) and 
mKate2^3xFlag::RAL-1(G26V) 
CRSIPR knock-in sgRNA #1. 
Inserted in pTD38. 
5’ -GCTTCATAAAAAACAAGGGGCGG- 3’ 
mKate2^3xFlag::RAL-1(+) and 
mKate2^3xFlag::RAL-1(G26V) 
CRSIPR knock-in sgRNA #2. 
Inserted in pHS23. 
5’ -TAAGGATGATTCAGTGCGGGGG- 3’ 
PMK-1::mNG^3xFlag CRISPR 
knock-in sgRNA #1. Inserted 
in pHS26. 
5’ -GCTTCATAAAAAACAAGGGGCGG- 3’ 
PMK-1::mNG^3xFlag CRISPR 
knock-in sgRNA #2. Inserted 
in pHS25. 
5’ -CTTCGTCAGAATCAGATCGGAGG- 3’ 
GCK-2 mid-deletion CRISPR 
knock-in sgRNA #1. Inserted 
in pHS38. 
5’ -ATTGATTCCAAAGGTTCCGATGG- 3’ 
GCK-2 mid-deletion CRISPR 
knock-in sgRNA #2. Inserted 
in pHS39. 
Table 2. 5 Repair ssODN 










Repair ssODN for 
dpy-10 (cn64gf) 
(101 bp) 
Reprinted with permission form Shin et. al, 2018
Reprinted with permission form Shin et. al, 2018
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CHAPTER III 
DEVELOPMENTAL FIDELITY IS IMPOSED BY GENETICALLY SEPARABLE 
RALGEF ACTIVITIES THAT MEDIATE OPPOSING SIGNALS 
Introduction 
Developmental patterning of the C. elegans vulva precursor cell (VPC) fates 
is a textbook system for analysis of cell-cell signaling. The vulva develops from 
six roughly equipotent VPCs – P3.p through P8.p – that are induced to assume a 
3˚-3˚-2˚-1˚-2˚-3˚ pattern of cells fates. The anchor cell (AC) in the somatic gonad 
produces the LIN-3/EGF inductive signal (Fig. 3. 1A). Historically, two models for 
VPC fate patterning have been advanced. The Morphogen Gradient Model posits 
that it is the distance of each VPC from the AC, and hence EGF-EGFR dose, that 
dictates its fate. (Katz et al., 1995; Katz et al., 1996; Sternberg and Horvitz, 1986, 
1989). 
In contrast, identification and molecular genetic analysis of genes that are 
necessary and sufficient for the 1˚- and 2˚-promoting VPC fate patterning signals 
led to the Sequential Induction Model. LIN-3 signals via the LET-23/EGFR-LET-
60/Ras-LIN-45/Raf-MEK-2/MEK-MPK-1/ERK canonical MAP kinase cascade to 
induce 1˚fate (Fig. 3. 1B; Sundaram, 2013). In turn, redundant DSL ligands 
produced by presumptive 1˚ cells induce neighboring VPCs via LIN-12/Notch to 
become 2˚ (Chen and Greenwald, 2004; Zhang and Greenwald, 2011); LIN-12 is 
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necessary and sufficient for 2˚ fate (Greenwald et al., 1983) and controls 2˚-
specific transcriptional targets (Fig. 3. 1B; Berset et al., 2001; Yoo et al., 2004; 
Yoo and Greenwald, 2005). LET-23 is necessary for 1˚ but not 2˚ fate (Koga and 
Ohshima, 1995; Simske and Kim, 1995), but these mosaic analyses did not 
address whether LET-23/EGFR might transduce a lower dose contribution to 2˚ 




Figure 3. 1 Schematics of VPC fate patterning and its signaling network. A. 
Initially equipotent VPCs are induced by the Anchor Cell (AC) to assume the 3˚-
3˚-2˚-1˚-2˚-3˚ pattern of fates (anterior-to-posterior), based on their position 
relative to the AC. Over time, induced VPCs progress from naïve to initially 
specified to terminally committed to their fates, represented by equipotent and 
uninduced (gray) progressing through initially specified (hybrid colors with one 
color dominant) to terminally committed to 1˚ (blue), 2˚ (rose) or 3˚ (yellow) fates. 
Yet the precise time course, molecular steps and network re-wiring events 






Figure 3. 1 Continued. B. The synthesis of the Sequential Induction, Morphogen 
Gradient, and Mutual Antagonism models of the VPC patterning signal 
transduction network, with the hypothesized RGL-1/RalGEF Balanced Switching 
mechanism superimposed. Necessary and sufficient cascades are in dark colors 
(dark blue for 1˚-promoting LET-23/EGFR-LET-60/Ras-LIN-45/Raf-MEK-2/MEK-
MPK-1/ERK; dark rose for LIN-12/Notch and the CSL transcriptional complex, 
CSL not pictured). Modulatory cascades are shown in lighter colors (light blue for 
1˚-promoting AGE-1/PI3K-PDK-1/PDK-AKT-1/Akt, with light rose for inhibitory 
DAF-18/PTEN lipid phosphatase; light rose for 2˚-promoting RGL-1/RalGEF-RAL-
1/Ral). Green represents proteins capable of promoting 1˚ or 2˚ fate, like LIN-
3/EGF, LET-23/EGFR and LET-60/Ras, depending on signal dose and as yet 
unknown factors. Mutual antagonism operates by excluding potentially 
contradictory signals from initially specified VPCs: in presumptive 1˚ cells, LIN-
12/Notch is internalized and degraded (gray), while in presumptive 2˚ cells MPK-
1/ERK activation is repressed by transcriptional activation of LIP-
1/MKP/DUSP/Erk phosphatase. The putative RGL-1/RALGEF Balanced Switch 
is circled in green both in presumptive 1˚ and presumptive 2˚ cells, and connected 




Figure 3. 1 Continued. C. A wiring diagram of the naive 1˚/2˚ VPC patterning 
signaling network, illustrating parallel and anti-parallel signals, with essential 
signals in dark blue and rose, and modulatory signals in light blue and rose. Data 
support RGL-1/RalGEF functioning in antagonistic 1˚-promoting (non-canonical) 
and 2˚-promoting (canonical) cascades. Deletion of rgl-1 would perturb both 
modulatory cascades but not alter the balance of 1˚- and 2˚-promoting signals, 
even in sensitized backgrounds. 
 
 
Vulval induction is a stepwise progression: VPC fates are initially specified 
and later become committed (Fig. 3. 1A; Sternberg, 2005). Initial specification is 
accompanied by alterations of expression of certain signaling genes. Some of 
these transcriptional changes contribute to Mutual Antagonism, whereby 
contradictory signals are excluded from cells committing to cell fate. For example, 
the LIP-1/ERK phosphatase, a LIN-12 transcriptional client gene, is expressed in 
initially specified 2˚ cells to restrict inappropriate ERK activation (Berset et al., 
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2001; Yoo et al., 2004). Conversely, LIN-12, via mechanisms not entirely 
understood, is targeted for internalization and degradation in initially specified 1˚ 
cells to restrict inappropriate 2˚-promoting signal (Deng and Greenwald, 2016b; 
Shaye and Greenwald, 2002, 2005).  
We reconciled these potentially contradictory models by identifying the 
mechanism by which the 2˚-promoting activity of the EGF gradient was 
transduced. Initial sequential induction establishes the specification of the VPC 
pattern, and overlaid on this pattern is a spatial EGF gradient that reinforces the 
initial pattern. To interpret different doses of EGF signal, LET-60/Ras dynamically 
switches effectors during VPC fate patterning, from LIN-45/Raf signaling through 
the canonical MEK-2/MEK-MPK-1/ERK MAP kinase cascade to promote 1˚ fate, 
to RGL-1/RalGEF-RAL-1/Ral signaling to promote 2˚ fate (Reiner, 2011; Zand et 
al., 2011). Additionally, VPCs may undergo Notch autocrine signaling that 
reinforces graded EGF signaling (Hoyos et al., 2011).  
We have further found that RAL-1 promotes 2˚ fate through EXOC-8/Exo84, 
a subunit of the heterooctameric exocyst complex, a known downstream 
oncogenic Ral signaling intermediary in mammalian cells. The GCK-2 MAP4 
kinase and a downstream PMK-1/p38 MAP kinase cascade is necessary and 
sufficient for Ral-dependent induction of 2˚ cells, in support of the necessary and 
sufficient LIN-12 (Shin et al., 2018). 
More recently, VPC fate patterning has been used to compare mechanisms 
of induction across nematode species both closely and distantly related to C. 
 
110 
elegans (Felix and Barkoulas, 2012; Grimbert and Braendle, 2014; Mahalak et al., 
2017; Sommer and Bumbarger, 2012). Additionally, the vulva has been used to 
assess heterogeneity in polymorphic wild C. elegans isolates (Grimbert and 
Braendle, 2014; Sterken et al., 2017), and also developmental robustness in the 
face of environmental insult: the VPCs are pattered with 99.8% accuracy 
(Braendle and Felix, 2008). But this accuracy is modulated by weak mutations or 
natural genetic variation affecting the delicate balance of 1˚ and 2˚ inductive 
signals (Barkoulas et al., 2013; Braendle et al., 2010; Duveau and Felix, 2012; 
Milloz et al., 2008). One conclusion from these studies is that there are heretofore 
unidentified properties of signaling networks that increase fidelity and/or 
robustness. 
Ras is the most mutated mammalian oncoprotein: more than a quarter of all 
tumors harbor activating mutations in Ras (Hobbs et al., 2016). Three main 
oncogenic Ras effector cascades have been identified (Fig. 3. 2). Two of these, 
the Raf-MEK-ERK MAP kinase and the PI3-Kinase-PDK-Akt cascades, have 
been extensively studied and pharmacologically targeted (Fruman et al., 2017; 
Papke and Der, 2017; Wong et al., 2010). The RalGEF-Ral effector signal is 
poorly characterized, though it may be as important for oncogenesis as the Raf 
and PI3K cascades (Feig, 2003; Hamad et al., 2002; Lim et al., 2005; Lim et al., 
2006; Urano et al., 1996; White et al., 1996). Ras binds and activates RalGEF, an 
exchange factor that stimulates GTP loading on the Ral small GTPase. Ral is a 




Figure 3. 2 Signaling network comparisons between humans and C. elegans. 
A-B. Signaling relationships in (A) Mammalian carcinomas and (B) C. elegans 
VPC fate patterning. Historically, mammalian interactions have been shown 
directly, while C. elegans interactions were deduced from a combination of 
phenotypes, genetic epistasis, and inferences from biochemical relationships 
among mammalian orthologs. Color coding is the same as in other figures: blue = 
1˚-promoting, rose = 2˚-promoter, dark = necessary and sufficient signal, light = 
modulatory signal. Green = both 1˚- and 2˚-promoting (rather than green, RGL-1 
is shown in two places, with a green two-headed arrow denoting possible dual 
function in both non-canonical 1˚-promoting and canonical 2˚-promoting roles). 
Activation of C. elegans AGE-1/PI3K by a receptor other than DAF-2, or by LET-
60/Ras, has not been suggested in the literature. The interactions between RGL-
1, PDK-1 and AKT-1 are inferred from genetic relationships in this study, and have 
not been shown directly. JIP-1, a potential intermediary between Akt and 
RalGDS/RalGEFs inferred from mammalian biochemical analyses in the Feig lab, 
is not shown. 
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is conserved throughout Metazoa (Reiner and Lundquist, 2016). For most Ras 
family members, including Ral, this GDP/GTP cycle is controlled by activating 
GEFs and inactivating GAPs. Despite their structural and primary sequence 
similarities, Ral interacts with a very different set of effectors than does Ras 
(Gentry et al., 2014). 
Mammals encode three Ras proteins (K-, N-, H-Ras), four GEFs with RA 
domains (RalGDS, RGL, RGL1, RGL2), two Rals (A, B), three Rafs (A-, B-, C-Raf) 
and three PI3Ks (, , ). C. elegans and Drosophila each harbor single Ras-
encoding genes, as well as single RalGEF-, Ral-, Raf-, and PI3K-encoding genes 
(Fig. 3. 2B). All three oncogenic Ras effectors are involved as essential or 
modulatory cascades promoting 1˚ or 2˚ VPC fate. The essential LET-60/Ras-LIN-
45-MEK-ERK MAP kinase cascade promotes 1˚ fate with support of the 
modulatory AGE-1-PDK-1-AKT-1 cascade, while the essential LIN-12/Notch 
cascade promotes 2˚ fate with support of the modulatory LET-60/Ras-RGL-1-
RAL-1 cascade. 
Here we pursue the unexpected findings that RGL-1/RalGEF is functionally 
non-equivalent to RAL-1 in two distinct ways. First, while RAL-1 is essential for 
viability and fertility (Armenti et al., 2014; Zand et al., 2011), RGL-1 is inessential. 
Second, RGL-1 and RAL-1 are non-equivalent in VPC fate patterning. While RAL-
1 functions as a simple intermediary to propagate the 2˚-promoting LET-60-RGL-
1-RAL-1 signal, RGL-1 additionally performs an opposing, putative 1˚-promoting 
function that offsets its canonical 2˚-promoting function. As a consequence, 
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deletion of RGL-1 has no net effect on the delicate balance of 1˚- and 2˚-promoting 
signals in sensitized mutant backgrounds. Using GEF-specific mutations and 
genetic bypass experiments, we show that the opposing functions of RGL-1 in 
VPC fate patterning are genetically separable, and that both RGL-1 activities 
function cell autonomously in VPCs. In the context of mammalian studies that 
argue that RalGEF physically interacts with PDK and Akt as a scaffold (Hao et al., 
2008; Tian et al., 2002), our genetic epistasis results are consistent with RGL-1 
functioning as a scaffold for PDK-1 and AKT-1 in the modulatory 1˚-promoting 
AGE-1/PI3K cascade. Our analysis raises the question of how activity in two 
apparently opposing cascades contribute to VPC fate patterning. Comparing VPC 
fate patterning in different environments, we found that the error rate in patterning 
was 15-fold higher in the rgl-1 deletion mutants than in the wild type. We 
hypothesize that the two opposing activities of RGL-1, which tie together the two 
opposing 1˚ and 2˚-promoting modulatory cascades, are orchestrated to reduce 
the level of noise in the signaling network, and hence reduce the rate of 
ambiguous fates or mis-patterning events. We propose that these properties of 
RGL-1 identify a novel “balanced switch” to coordinate modulatory signaling 
activities in the reinforcement stage of VPC fate patterning that leads to fate 








The C. elegans RalGEF ortholog, RGL-1, is non-essential.  
 
We previously described that ral-1(tm2760) mutant animals are sterile but 
otherwise wild type. Efforts to feed or inject dsRNA in the RNAi hypersensitive rrf-
3 background failed to phenocopy this sterility. Yet consistent with our depletion 
by bacterially mediated RNAi and injected dsRNA, tm2760 abrogated the 2˚-
promoting activity of RAL-1 (Zand et al., 2011). 
Subsequent analysis of the ral-1(tm5205) deletion allele led to the conclusion 
that RAL-1 function is maternally rescued and necessary for various facets of 
embryonic, post-embryonic, and germline development that require function of the 
PAR complex in cell polarity (Armenti et al., 2014). This function is ascribed to a 
central role of RAL-1 in the exocyst complex, as described for mammals (Brymora 
et al., 2001; Chien et al., 2006; Issaq et al., 2010; Jin et al., 2005; Moskalenko et 
al., 2002; Moskalenko et al., 2003; Sugihara et al., 2002). We observed that ral-
1(tm5205) mutants become sickly in the fourth larval stage and become sterile 
adults, but VPCs are patterned normally (N = 52). 
Mammalian studies suggest that Ral associates with the exocyst in an 
activity-dependent manner to promote complex assembly (Brymora et al., 2001; 
Chien et al., 2006; Issaq et al., 2010; Jin et al., 2005; Moskalenko et al., 2002; 
Moskalenko et al., 2003; Sugihara et al., 2002). Thus, abrogation of GTP-loading, 
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either through blockade of total RalGEF activity or Ral GTP-loading activity, 
should phenocopy loss of Ral and result in defective exocyst function. C. elegans, 
which encodes only a single RalGEF ortholog (Zand et al., 2011), provides a 
system to test this relationship between RalGEF and Ral in vivo. 
rgl-1(RNAi) revealed a role in promoting 2˚ fate (Zand et al., 2011). We 
reproduced RNAi depletion of rgl-1 with bacterially mediated and injected dsRNA 
in wild-type and rrf-3 mutant backgrounds and observed no overall impact on 
development or fertility. Strikingly, four different deletion mutants of RGL-1 are 
superficially wild type, develop normally, are fertile, and can be grown indefinitely 
in culture (Table 3. 1). One of these mutations, fax-1(gm27), deletes several 
neighboring genes on the X chromosome, including rgl-1 (Much et al., 2000). 
Using robust primer sets (see Materials and Methods), we failed to amplify rgl-1 
sequences from the gm27 mutant animal. No role for LET-60/Ras has been found 
in exocyst and PAR complex function (Yochem et al., 1997). 
We also previously published that nonsense mutants for the alpha or beta 
subunits of the heterodimeric RalGAP, HGAP-1 and HGAP-2, respectively, are 
also viable and fecund (Martin et al., 2014). The G26V putative activating mutation 
in RAL-1 also fails to confer developmental defects in an otherwise wild-type 
background (Shin et al., 2018). The observation that deletion of RGL-1/RalGEF 
or HGAP-1/2/RalGAP does not result in the same phenotype as deletion of RAL-
1 raises the interesting possibility that Ral and RalGEF are functionally non-
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equivalent, contrary to the model derived from biochemical experiments in 
mammalian cell culture. 
 
Sensitized genetic backgrounds reveal nuances in signaling.  
 
Four signaling cascades – two central and two modulatory – control 1˚ and 
2˚ fate induction. We present a schematic of the signaling cascades discussed in 
this study (Figs. 3. 1B-C; Fig. 3. 2). Core 1˚- and 2˚-promoting signals are 
detectable by direct mutation: since they are necessary and sufficient to induce 
their respective fates, mutational perturbation of them causes loss or gain of vulval 
cell types. In contrast, the role of the two modulatory cascades is not revealed 
through single mutant analysis, but rather requires sensitized genetic 
backgrounds. 
To detect such signals, we use let-60(n1046gf), a moderately activating 
G13E mutation analogous to mutations found in a subset of mammalian cancers 
(Golden, 2017). In this background, gain and loss of the RAL-1 2˚-promoting 
signal resulted in decrease and increase of ectopic 1˚ cells, respectively. We have 
similarly used the let-23(sa62gf) activating mutation in the LET-23/EGFR. For an 
under-induced background, we used lin-45(n2506) (Zand et al., 2011). Through 
combined use of genetic principles of parallelism and epistasis, we are able to 
dissect the modulatory signals. We present these principles as a network circuitry 
diagram (Fig. 3. 1C). We have exploited such techniques to delineate a 2˚- 
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promoting signaling cascade downstream of RAL-1 (Shin et al., 2018). Here we 
use these techniques to similarly dissect the two roles of RGL-1/RalGEF in 2˚- 




Figure 3. 3 RGL-1 and RAL-1 are functionally non-equivalent in VPC 
patterning. A-D. 1000x photomicrographs of late L4 (A) wild-type, (B) let-
60(n1046gf); gfp(RNAi) compared to 600x photomicrographs of (C) let-
60(n1046gf); rgl-1(RNAi), and (D) let-60(n1046gf); rgl-1(tm2255) animals. White 
lines = normal 2˚-1˚-2˚ L4 vulvae, white arrows = L4 ectopic 1˚ pseudovulvae. 




Figure 3. 3 Continued. E. RNAi depletion of rgl-1 and ral-1 enhance 1˚ induction 
relative to gfp(RNAi) control. Data are the mean ± standard error of the mean 
(SEM). For statistical reasons single, non-pooled assays are shown, and white 
numbers represent animals scored therein. Significance was calculated by 
Kruskal-Wallis, Dunn test. Data shown were scored concurrently and are 
representative of 4 independent assays (this study) and 6 prior independent 
assays (Zand et al., 2011). The let-60(n1046gf) 1˚ induction baseline is 
consistently higher when grown on HT115 bacterially-mediated RNAi food 
compared to the standard OP50 (Shin et al., 2018; Zand et al., 2011). F. Deletion 
of ral-1 but not rgl-1 enhances ectopic 1˚ induction by let-60(n1046gf). Data shown 






Figure 3. 3 Continued. G. Re-constructed strains show the same result: ok1921, 
tm2255 and gm27 deletions fail to significantly enhance ectopic 1˚ induction by 
let-60(n1046gf). Left: Three n1046-containing isolates, with and without rgl-1 
mutations and scored concurrently. The concurrently scored MT2124 1˚ induction 
baseline was not significantly different from outcrossed lines DV2214 and DV2215 
(see Table 3. 1), N = 30 for each, and from assays that showed the most deviation 
of double mutants from the single mutant, but are still not significantly different. 
Right: DV2251 let-60(n1046gf); lon-2(e678) vs. DV2252 let-60(n1046gf); lon-
2(e678) gm27 animals scored concurrently but separate from the left group, 
representative of two assays. H. A general model for opposing RGL-1 GEF/RAL-
1-dependent and -independent functions (green = bifunctional, blue = 1˚-
promoting, rose = 2˚-promoting; see Fig. 3. 1).  
 
 
RGL-1 performs a function in VPC cell fate patterning that opposes its canonical 
2˚-promoting function.  
 
We previously showed that depletion of rgl-1 by RNAi revealed a role of RGL-
1 in promoting 2˚ fate consistent with the established Ras-RalGEF-Ral signal in 
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mammals (Zand et al., 2011). We reproduce these RNAi-based experiments here 
(Figs. 3. 3A-C, 3. 3E). We also found that ral-1(tm5205) confers enhancement of 
1˚ induction in the let-60(n1046gf) background (Fig. 3. 3F), validating our previous 
results with RAL-1. 
To our surprise, analysis of various strong loss or putative null rgl-1 mutations 
in the let-60(n1046gf) background caused no net effect compared to the let-
60(n1046gf) single mutant (Figs. 3. 3D, F, G; see Table 3. 1 and Fig. 3. 7A for rgl-




Figure 3. 4 RGL-1 controls cell fate decision. A. Percent Pn.px-staged let-60(gf) 
L3 larvae with CFP-positive lineages neighboring the P6.p lineage (P5.p or P7.p 
derived) with luc(RNAi) vs. rgl-1(RNAi). Shown are average percentages of 
animals with adjacent 1° cell fate. B. Percent Pn.px-staged let-60(gf) L3 larvae 
with CFP-positive lineages neighboring the P6.p lineage (P5.p or P7.p derived) 
with rgl-1(+) or rgl-1(tm2255Δ). Y axis is percent adjacent 1˚s, white numbers in 




Figure 3. 4 Continued. C-E. Expression of the 1˚ fate reporter arIs92 Pegl-17∷cfp-
lacZ in VPC daughters. Overlaid DIC and CFP fluorescence images of (C) let-
60(n1046gf); luc(RNAi), (D) let-60(n1046gf); rgl-1(RNAi) and (E) let-60(The black 
bar indicates P6.px and white bar indicates P7.px cells. n1046gf); rgl-1(tm2255Δ) 
at the Pn.px stage. F. Hypo-induced lin-45(n2506) background with and without 
tm2255. Y axis is total induced VPCs (0 = vulvaless, 3 = normal wild-type vulva.) 
White numbers are number of animals assayed. G. let-23(sa62gf) with and without 
tm2255. Y axis is mean ectopic 1˚ induction. Error bars show S.E.M. P value 
calculated via Mann-Whitney test. 
 
 
background (Yoo et al., 2004; Zand et al., 2011), we found that rgl-1(RNAi) but 
not rgl-1(tm2255) significantly increases the occurrence of adjacent 1˚s (Figs. 3. 
4A-E). To test that these results are not specific to the let-60(n1046gf) sensitized 
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background or a 1˚ over-inducing background, we also assessed the role of 
deleted rgl-1 in under-induced background lin-45(n2506) and over- induced 
background let-23(sa62gf) (Katz et al., 1996; Zand et al., 2011), finding no effect 
of rgl-1(tm2255) (Figs. 3. 4F-G). 
Our results are consistent with the working model that RGL-1 performs an 
additional, Ral-independent function that antagonizes its canonical function, 
perhaps by promoting 1˚ fate. The discrepancy between RNAi- and mutational-
based analyses is consistent with RGL-1 having different functional thresholds in 
level of gene product for the two opposing activities, which we have been unable 
to further investigate.   
 
The rgl-1 transcriptional fusion is expressed in both 1˚ and 2˚ lineages.  
 
We previously described a transgenic ral-1 transcriptional fusion that 
expressed GFP dynamically over the time course of VPC fate induction (Zand et 
al., 2011). To summarize published results, early in the 3rd larval stage (L3), GFP 
was expressed consistently in all six VPCs. Later in L3, after induction, GFP 
expression was excluded from presumptive 1˚ cells while persisting in 
presumptive 2˚ cells. These observations provided a potentially critical 
mechanistic insight: by reducing inferred RAL-1 expression in presumptive 1˚ cells 
while retaining expression in presumptive 2˚ cells, the signaling network 




Figure 3. 5 VPC expression pattern of the rgl-1 transcriptional GFP fusion 
over time. We used a combination of DIC analysis of VPCs and migration of the 
gonadal distal cells for staging to characterize the dynamic pattern of GFP 
expression from sEx14985 (McKay et al., 2003) over time. Initial expression in 
naïve VPCs is uniform. Around the time of induction, expression is restricted to 
presumptive vulval lineages. Later expression, after the first cell division, remains 
higher in 1˚ than 2˚ linages. Later stages show low levels of expression in 







preventing potentially contradictory LET-60 signaling through RGL-1-RAL-1 in 
presumptive 1˚ cells. 
We similarly tested the expression pattern of a transgene harboring the rgl-1 
promoter transcriptional fusion to GFP, sEx14985 (McKay et al., 2003). As with 
the ral-1 promoter transcriptional fusion, the transgenic rgl-1 reporter was 
expressed in all VPCs early in L3 (Fig. 3. 5). But, unlike the ral-1 transcriptional 
fusion, GFP from the rgl-1 transcriptional fusion persisted in presumptive 1˚ cells 
throughout vulval patterning, proliferation and morphogenesis. After the first VPC 
cell division GFP expression was consistently higher in 1˚ relative to 2˚ cells. The 
significance of this change is unclear, since many transcriptional fusions of vulval 
signaling genes change expression patterns around this time (Berset et al., 2001; 
Berset et al., 2005; Yoo et al., 2004; Yoo and Greenwald, 2005; Zand et al., 2011; 
Rasmussen et al., re-submitted). Yet one interpretation is that increased 
expression of RGL-1 in presumptive 1˚ cells accounts for resistance to rgl-1(RNAi) 
of this putative 1˚-promoting activity of RGL-1. 
 
Tagged endogenous RGL-1 is expressed uniformly throughout VPC development.  
 
To validate the RGL-1 transcriptional fusion, we used the self-excising 
cassette (SEC) approach (Dickinson et al., 2015) to tag the endogenous 5’ end of 
the endogenous rgl-1 locus with sequences encoding mNeonGreen fluorescent 
protein (mNG, FP) and a 3xFlag epitope tag (Fig. 3. 6). We observed mNG 
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throughout vulval lineages, consistent with that observed with the rgl-1 




Figure 3. 6 N-terminal CRISPR tagging of endogenously expressed RGL-1 
protein. A. Strategy for N-terminal tagging of the endogenous RGL-1 protein, 
using the SEC approach (Dickinson et al., 2015). See Methods. B.  Western blot 
validation of RGL-1 N-terminal tag prior to (lane 1) and after SEC excision (lane 
2). Below: alpha-tubulin loading control. C. Tagged endogenous mNG::RGL-1 is 






RGL-1 performs opposing GEF-dependent and GEF-independent functions in 
VPC fate patterning.  
 
A list of rgl-1 mutations and other genetic tools is shown (Figs. 3. 7A-B; Table 
3. 1). The Million Mutation Project (MMP) described random sequence 
identification of a large collection of mutagenized C. elegans lines, demanding 
only that mutant animals be viable and fertile over many generations (Thompson 
et al., 2013). We analyzed the sole non-synonymous mutation in ral-1, gk628801, 
which caused an R139H mutation. Arg-139 is conserved in all Ras family 
members in metazoans. Outcrossed ral-1(gk628801) single mutant vulvae were 
superficially wild type (N = 83). In the let-60(n1046gf) background, ral-1(gk628801) 
increased 1˚ induction (Fig. 3. 7C), consistent with our previously published 
analysis using ral-1(RNAi) and deletion mutations (Fig. 3. 3; Zand et al., 2011). 
Thus, ral-1(gk628801) perturbs RAL-1 2˚-promoting signaling but does not disrupt 
RAL-1 sufficiently to confer PAR- and exocyst-associated phenotypes. 
Of 30 total non-synonymous mutations in rgl-1, two are likely to perturb 
function. rgl-1(gk275304) causes an R361Q change. Arg-361 is conserved in all 
CDC25/RasGEF domains. rgl-1(gk275304) conferred significant increase in 
ectopic 1˚ induction in the n1046gf background (Fig. 3. 7D), consistent with 
disrupting GEF domain function and hence abrogating activation of RAL-1. rgl-
1(gk275305) causes a W163* change, which did not alter ectopic 1˚ induction in 
the let-60(n1046gf) background. Both outcrossed single mutant strains were 
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superficially wild type (N = 48 and 61, respectively). We therefore hypothesized 
that rgl-1 encodes GEF-dependent and GEF-independent activities.  
Using the VPC-specific lin-31 promoter (Tan et al., 1998) in the let-
60(n1046gf); rgl-1(tm2255) double mutant background we generated transgenic 
extrachromosomal arrays expressing VPC-specific RGL-1(+) or RGL-1(R324E), 
a mutation deficient in GEF catalytic activity in mammalian RalGDS (RalGEF; 
Wolthuis et al., 1997). Animals bearing the R324E transgenes showed significant 




Figure 3. 7 RGL-1 encodes genetically separable functions. A. A schematic 
of the rgl-1 gene and genetic reagents for this analysis. Green triangle = 
mNeonGreen::3xFlag tag by CRISPR (Fig. 3. 6). Light green exon 2: by RNAseq 
this is a rare mRNA species, and the 20 residues coded for by Exon 2 are not 
conserved among Drosophila and mammalian RalGEFs. Purple, pink and bright 
green lines: REM, GEF and RA (Ras Association) domains (The REM domain is 
a structural component of some but not all Ras family GEFs). Red gk alleles: 
W163* and R361Q mutations from the million mutation project. Orange: canonical 
R324E GEF-deficient mutation in transgenes reEx94 and reEx95. Light blue: 
coverage of bacterially mediated RNAi clone (library location; Kamath et al., 2001). 
Red lines: sequences deleted by ok921, tm2255 and gm27 deletions (dotted line 




Figure 3. 7 Continued. B. An alignment of a portion of the RalGEF domain 
containing the canonical GEF-deficient R324E and gk275304 R361Q mutations 
(top to bottom: Human RGL2, in which the GEF-deficient mutation was validated, 
fly RalGEF, C. elegans RGL-1). C. The ral-1(gk628801) R139H missense 
mutation enhances 1˚ induction in the let-60(n1046gf) background. D. rgl-1 
mutation gk275304 (R361Q) but not gk275305 (W163*) enhances 1˚ induction in 
the let-60(n1046gf) background. E. Transgenic rescue of rgl-1(tm2255) in the let-
60(n1046gf) background. Transgenic array-bearing animals harboring Plin-31::rgl-
1 cDNA with Pmyo-2::gfp co-injection marker and their non-array-bearing siblings 
were scored. The reEx94 (shown) and reEx95 (not shown) R324E mutant 
transgenes enhanced 1˚ induction relative to their non-transgenic siblings, as 
scored in separate concurrent assays for each array, suggesting that a GEF-
independent 1˚-promoting activity of RGL-1 functions cell autonomously in the 
VPCs. The reEx109 (shown) and reEx110 (not shown) wild-type transgenes failed 
to alter 1˚ induction relative to their non-array-bearing siblings, as scored in 
separate concurrent assays for each array, suggesting that the GEF-dependent 




Figure 3. 7 Continued. F. reIs10[Plin-31::ral-1A(Q75L), Pmyo-2::gfp] (“ral-1(act)”) 
suppressed ectopic 1˚ induction in the let-60(n1046gf) background; in a single 
concurrent assay, 1˚ induction was further suppressed by rgl-1(tm2255), revealing 
an opposing RGL-1 signal that may be 1˚-promoting. Data are the mean ± 
standard error of the mean (SEM). For statistical reasons single, non-pooled 
assays are shown, and white numbers represent animals scored therein. 
Significance was calculated by Kruskal-Wallis, Dunn test. G. A schematic of the 
bypass experiment in (F). Left: canonical and non-canonical RGL-1 activities are 
opposed and roughly equivalent (in the backgrounds assayed). Right: constitutive, 
VPC-specific activation of RAL-1 bypasses the GEF activity while also revealing 
a GEF-independent function of RGL-1, resulting in increased 2˚-promoting signal 




bearing the wild-type transgenes were not different than their non-array-bearing 
siblings (Fig. 3. 7E). Consequently, we propose that RGL-1 performs GEF-
dependent and GEF-independent functions that are genetically separable by 
mutating the GEF domain. We also conclude that the GEF-independent RGL-1 




Figure 3. 8 Genetically separable functions of RGL-1. A. let-60(n1046gf); rgl-
1(tm2255) animals rescued by VPC-specific expression of GEF dead (R326E) 
RGL-1 fail to respond to ral-1-directed vs. control GFP RNAi. B. let-60(n1046gf); 
rgl-1(tm2255) animals rescued by VPC-specific expression of wild-type RGL-1 
rescue responsiveness to ral-1-directed but not control GFP RNAi. C.  lin-
31(n301) bypassed the putative 1˚-promoting but not the putative 2˚-promoting 
activity of rgl-1, revealed by the tm2255 mutation enhancing ectopic 1˚ induction. 
D. reIs10[Plin-31::ral-1(Q75L) + Pmyo-2::gfp] suppressed the level of ectopic 1˚ 
induction in let-60(n1046gf), as previously described for reEx24 (Zand et al., 
2011). Y axis represents mean ectopic 1˚ cells, white labels number of animals 




Transgenic animals expressing VPC-specific RGL-1(+) but not RGL-
1(R324E) should restore responsiveness to ral-1(RNAi). We evaluated 
responsiveness of the let-60(n1046gf); rgl-1(tm2255) background harboring each 
transgene. reEx94/95 transgenic RGL-1(R324E) animals failed to respond to ral-
1(RNAi) compared to control gfp(RNAi) (Fig. 3. 8A; the 1˚ induction baseline is 
elevated due to rescue of the putative GEF- independent function shown in Fig. 
3. 7E). In contrast, reEx109/110 transgenic RGL-1(+) animals restored 
responsiveness to ral-1(RNAi), resulting in increased 1˚ induction, consistent with 
VPC-specific rescue of GEF activity and thus cell autonomy of the GEF-
dependent function of RGL-1 (Fig. 3. 8B). 
 
Genetic bypass further reveals a GEF-independent activity of RGL-1.  
 
We previously showed that the ectopic vulva induction caused by mutation of 
lin-31, which confers ectopic 1˚ induction, was insensitive to perturbation of LET-
60-LIN-45-MEK-2-MPK-1 1˚-promoting signaling but sensitive to perturbation of 
LET-60-RGL-1- RAL-1 2˚-promoting signaling. These results were consistent with 
the model of LIN-31 functioning downstream of ERK/MAPK-1 but in parallel to 
LET-60-RGL-1-RAL-1. In that assay, rgl-1 function was assessed by RNAi, which 
resulted in increased 1˚ induction, as did depletion of let-60 and ral-1 (and lin-12 
positive control; Zand et al., 2011). Here, rgl-1(tm2255) similarly increased ectopic 
1˚ induction of lin-31(n301) animals (Fig. 3. 8C). This result is consistent with 
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genetically separable functions of RGL-1, with the LIN-31/FoxB transcription 
factor functioning downstream of the putative non-canonical, GEF-independent 
signal, but in parallel to the canonical LET-60-RGL-1-RAL-1 signal (Zand et al., 
2011).  
We bypassed the requirement for RGL-1 GEF activity by generating the 
reIs10[Plin-31::ral-1A(Q75L), Pmyo-2::gfp] integrated transgene expressing 
mutationally activated RAL-1 specifically in the VPCs (Zand et al., 2011). reIs10 
decreased ectopic 1˚ induction in the let-60(n1046gf) background (Fig. 3. 8D). Into 
this background we crossed the rgl-1(tm2255) out-of-frame deletion mutation and 
scored the three strains concurrently. rgl-1(tm2255) mutation significantly 
decreased ectopic 1˚ induction below the level observed with reIs10 alone, nearly 
to wild-type levels (Fig. 3. 7F). This result is consistent with further deletion of a 
1˚-promoting activity when RGL-1 GEF activity is bypassed by activated RAL-1. 
Taken together, these experiments suggest that rgl-1 encodes two antagonistic 
signals, the GEF- and Ral-dependent 2˚-promoting signal, and an unknown 
antagonistic signal, schematized in Fig. 3. 7G. 
 
RGL-1 may function in the 1˚-promoting PI3K-PDK-Akt cascade.  
 
Mammalian RalGDS binds to PDK and Akt1 in cultured cells, possibly 
functioning as a scaffold for PDK and Akt (Hao et al., 2008; Tian et al., 2002). The 
AGE-1/PI3K-PDK-1 signal has been described as promoting 1˚ fate in VPC fate 
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patterning (Nakdimon et al., 2012), but AKT-1 was not implicated downstream of 
this process, potentially because of redundancy of AKT-1 and AKT-2 in C. elegans 
(Paradis et al., 1999; Paradis and Ruvkun, 1998). Previously, a gain-of-function 




Figure 3. 9 RGL-1 may function in the 1˚-promoting PI3K-PDK-Akt cascade. 
A. The constitutively activating akt-1(mg144gf) mutation increased promotion of 
1˚ fate in the let-60(n1046gf) background, and this effect was partially blocked by 
rgl-1(tm2255), though the triple mutant was not suppressed to the double mutant 
baseline level. Animals were scored concurrently. These results were replicated 
with a re-built strain (Fig. 3. 10A) and the strain with rgl-1(ok1921) (Fig. 3. 10B). 
Data are the mean ± standard error of the mean (SEM). For statistical reasons 
single, non-pooled assays are shown, and white numbers represent animals 
scored therein. Significance was calculated by Kruskal-Wallis, Dunn test. B. The 
constitutively activating pdk-1(mg142gf) mutation increased promotion of 1˚ fate 
in the let-60(n1046gf) background, and was completely suppressed to baseline 
level by rgl-1(tm2255). Animals were scored concurrently and are representative 




Figure 3. 9 Continued. C-D. Mutation of the negative regulatory PTEN ortholog 
by daf-18(ok480) similarly increased 1˚ induction, and was completely suppressed 
to baseline level by rgl-1(tm2255) (C) and rgl-1(ok1921) (D). Animals for each 
were scored concurrently and scoring was repeated once, with the same general 
results. rgl-1(gk275305) (nonsense; Fig. 3. 10C) but not rgl-1(gk265304) (GEF; 
Fig. 3. 10D) suppressed this ok480 enhancement, suggesting that the pertinent 
RGL-1 activity is GEF-independent/non-canonical. 
 
 
no effect was found, leading to the model that AKT-1 did not contribute to vulval 
induction (Nakdimon et al., 2012). We re-evaluated the akt-1(mg144gf) mutation 
in the let-60(n1046gf) background and observed significant increase in ectopic 1˚ 
induction (Fig. 3. 9A). To corroborate previously published results, we assessed 
the impact of both activated AKT-1 and PDK-1 in the hypo-induced lin-45(n2506rf) 
background: akt-1(mg144gf) did not alter the hypo-induced lin-45(n2506rf) 
phenotype, but pdk-1(mg142gf) did suppress the 1˚-induction defect (Figs. 3. 
10C-D). This result, coupled with earlier analysis (Nakdimon et al., 2012), 
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suggests that the canonical AGE-1/PI3K-PDK-1/PDK-AKT-1/Akt cascade 
functions to promote 1˚ vulval fate. 
Including the rgl-1(tm2255) mutation in the let-60(n1046gf); akt-1(mg144gf) 
background significantly suppressed ectopic 1˚ induction, but not to the baseline 
of the n1046gf single mutant (Fig. 3. 9A). Since we observed intermediate 
suppression, we constructed this strain twice and observed a similar result (Fig. 
3. 10A). We also reproduced this result with rgl-1(ok1921) and observed similar 
intermediate strength suppression that remained significantly above the baseline 




Figure 3. 10 RGL-1 interacts genetically with the 1˚-promoting AGE-1/PI3K-
PDK-1-AKT-1 cascade. A-B. akt-1(mg144gf) enhances1˚ induction in let-
60(n1046gf) animals, and this enhancement is blocked by (A) rgl-1(tm2255) and 




Figure 3. 10 Continued. C-D. The lin-45(n2506) under-induced mutant is partially 
suppressed by (C) pdk-1(mg142gf) not (D) akt-1(mg144gf). E-F. Unlike other 
assays, data shown are total induced VPCs, not ectopic 1˚s. daf-18(ok480) 
enhances 1˚ induction in let-60(n1046gf) animals, and this enhancement is 
blocked by the (E) rgl-1(gk275305) nonsense mutation but not the (F) rgl-
1(gk275304) R361Q putative GEF dead mutation. G. jip-1-directed RNAi 
suppressed the increase in ectopic 1˚ induction in the let-60(n1046gf) background 
conferred by daf-18(ok480), compared to gfp(RNAi). H. pdk-1- and rgl-1-directed 




Figure 3. 10 Continued. I. The jip-1 deletion mutation, jip-1(tm6137), enhances 
let-60(n1046gf) alone but suppresses daf-18(ok480) let-60(n1046gf), consistent 
with JIP-1 performing two functions. J. The observed genetic interactions are 
consistent with RGL-1 and JIP-1 functioning in the AGE-1-PDK-1-AKT-1 1˚ 
promoting cascade, as described for mammalian orthologs (Hao et al., 2008; Tian 
et al., 2002). Except for lin-45(rf), Y axis represents mean ectopic 1˚ cells, white 
labels number of animals counted, error bars show S.E.M. P value calculated via 
Mann-Whitney test or ANOVA. 
 
 
We further tested the relationship of RGL-1 with the rest of the PI3K cascade. 
Mutational activation of PDK-1 via the pdk-1(mg142gf) mutation also increased 
ectopic 1˚ induction in the let-60(n1046gf) background. This effect was completely 
suppressed by rgl-1(tm2255) (Fig. 3. 9B), suggesting a quantitatively detectable 
difference between the epistatic relationships of PDK-1 and AKT-1 with RGL-1. 
Genetic disruption of DAF-18/PTEN, a negative regulator of this cascade in C. 
elegans in general (Gil et al., 1999; Ogg and Ruvkun, 1998) and VPC fate 
patterning in particular (Nakdimon et al., 2012), increases ectopic 1˚ induction in 
the n1046gf background. We found that rgl-1(tm2255) completely blocked this 
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effect (Fig. 3. 9B). The nonsense rgl-1(gk275305) but not the putative GEF-
deficient rgl-1(gk275305) mutation similarly suppressed (Figs. 3. 10E-F), 
suggesting that the putative RGL-1 1˚-promoting is GEF-independent. 
While mammalian RalGDS bound directly to PDK, RalGDS bound indirectly 
to Akt through the intermediary scaffold, JIP (JNK Interacting Protein; Hao et al., 
2008; Tian et al., 2002). Deletion the sole C. elegans JIP ortholog, JIP-1 (Fig. 3. 
10I) or RNAi depletion of JIP-1 (Fig. 3. 10G) suppressed the ectopic 1˚ phenotype 
of the daf-18(ok480) let-60(n1046gf) double mutant, consistent with JIP-1 
collaborating with RGL-1 to scaffold PDK-1 and AKT-1 1˚-promoting signaling. 
RNAi depletion of both pdk-1 and rgl-1 similarly suppressed the enhanced 1˚ 
induction of daf-18(ok480) let-60(n1046gf) (Fig. 3. 10H). However, the jip-1 
deletion allele enhanced n1046gf alone while suppressing daf-18(ok480) let-
60(n1046gf) (Fig. 3. 10I). We speculate that JIP-1 functions in the PI3K cascade, 
but may also function elsewhere in VPC fate patterning, perhaps in its canonical 
role as a scaffold for JKK and JNK MAP kinases. Further investigation of the role 
of JIP-1 is beyond the scope of this study. 
A common target of the C. elegans PI3K-Akt cascade is inhibition of the DAF-
16/FoxO transcription factor (Lin et al., 1997; Ogg et al., 1997). We tested the role 
of daf-16 alleles mu26, mu86 and mgDf47 in different backgrounds, with 
inconclusive results. Consequently, we were unable to determine the role, if any, 
of DAF-16/FoxO in VPC fate patterning. 
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Taken together, these genetic epistasis experiments, using an assay of 
parallelism with let-60(n1046gf), suggest that RGL-1 contributes to the AGE-
1/PI3K-PDK-1/PDK-AKT-1/Akt cascade, including the negative regulator lipid 
phosphatase, DAF-18/PTEN, in VPC fate patterning. Alone among the genetic 
tools used, the gain-of-function mutation in the downstream AKT-1 was only 
partially suppressed by rgl-1(tm2255), while the effect of other Akt cascade 
activators was completely suppressed by rgl-1(tm2255). We propose that RGL-1 
is essential for the PDK-1 1˚-promoting signal (and AGE-/PI3K, through inference 
from our DAF-18/PTEN deletion experiments), but only partially required for the 
AKT-1 1˚ promoting signal. We note that mammalian Akt is activated via parallel 
mechanisms: phosphorylation by upstream PDK and binding of PIP3, resulting in 
recruitment to the plasma membrane and activation (Vanhaesebroeck and Alessi, 
2000). If RGL-1 functions as a scaffold for PDK-1 and AKT-1, its deletion would 
be expected to result in reduction of the PDK-1 phosphorylation of AKT-1 but not 
PIP3-dependent recruitment of AKT-1 to the plasma membrane. Thus, a 
parsimonious interpretation of our data is that RGL-1 functions as a scaffold for 
PDK-1-AKT-1 signaling in 1˚ fate induction, and that this activity is independent of 
the GEF-dependent role of RGL-1 in promoting 2˚ fate through RAL-1 activation. 
However, we cannot rule out the possibility of parallelism between a GEF-
independent RGL-1 activity and the AKT-1 cascade, or RGL-1 functioning in a 
bifurcated cascade downstream of AKT-1 that is not revealed by the mechanism 
of constitutively activated PDK-1 or DAF-18/PTEN upstream. 
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Deletion of RGL-1 decreases fidelity of VPC patterning.  
 
Based on a relatively small sample size, RGL-1 deletions cause no gross 
VPC patterning defects, consistent with both cascades being modulatory, not 
central. We hypothesized that RGL-1 orchestrates activation of these two 
potentially opposing cascades – Akt output to presumptive 1˚ cells and Ral output 
to presumptive 2˚ cells – to improve robustness of the VPC developmental system 
in response to environmental stressors. A previous study investigated the impact 
on VPC fate patterning of environmental stressors: the N2 baseline error rate 
under laboratory conditions was 0.2% (Braendle and Felix, 2008). We similarly 
investigated the impact of environmental stressors of starvation, heat, and 
osmotic stress, compared to non-stressful conditions, on wild-type, rgl-1(ok1921), 
and rgl-1(tm2255) animals.  
We evaluated 300 animals per genotype under each condition, totaling 1,200 
animals per genotype and 3,600 animals overall (Fig. 3. 11A). Similar to previous 
results (Braendle and Felix, 2008), wild type animals exhibited very low error rates 
(0.0 – 0.3%), not only in control but also in stressful conditions. In contrast, the 
error rate in VPC patterning of both rgl-1 mutants was substantially increased 
across all experimental environments (1.0 – 3.7%), including control environments, 
in which patterning error rates were increased more than 15-fold relative to the 
wild type. These results suggest an environmentally-insensitive increase in error 




Figure 3. 11 Deletion of RGL-1 increases patterning errors but not 
susceptibility to environmental stress. A. rgl-1 deletions ok1921 and tm2255, 
introgressed to the wild type for eight generations (DV2696, DV2697), caused 15-
fold increased patterning defects compared to the wild type. (N = 1,200 per 
genotype, pooled from 300 for each condition.) B. A model for the role of Balanced 
Switches in VPC fate patterning, in the context of “developmental topology” (e.g. 
“canalization”; Waddington, 1957). We hypothesize that through decreasing error 
rate, the RGL-1 signaling circuit effectively increases the “barrier” between 1˚ and 
2˚ fates, thus decreasing error rate. 
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impacts robustness selectively, and not in response to environmental stressors. 
Rather, we hypothesize that RGL-1 mitigates stochasticity within the complex 
signaling network that regulates VPC fate patterning. This observation represents 





The impetus for this analysis was two enigmatic genetic observations. First, 
deletion of RAL-1 but not RGL-1 confers developmental defects. Second, deletion 
of RAL-1 but not RGL-1 confers a net effect on 1˚ vs. 2˚ induction. Thus, despite 
the linear Ras-RalGEF-Ral signaling module defined in mammals and validated 
in C. elegans VPC fate patterning, in two different ways RGL-1 is non-equivalent 
to RAL-1. By pursuing these two genetic observations, we arrived at important 
models regarding the multiple roles of RalGEF and Ral in signal transduction and 
development. 
 
RAL-1 but not RGL-1 is essential for development.  
 
RAL-1 was previously implicated in essential developmental events. Yet 
despite the ostensible linearity of Ras-RalGEF-Ral signaling, we unexpectedly 
found that RGL-1 is not essential. Given that deletion of neither the GEF nor the 
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GAP disrupts exocyst-dependent developmental events but deletion of RAL-1 
does so, we hypothesize that the RAL-1 role as a membrane tether for the exocyst 
is independent of nucleotide-bound state. This hypothesis does not imply that 
there is no activation-dependent alteration of exocyst function by RAL-1, merely 
that such is not essential for the described developmental events. 
An alternative hypothesis is that other GEFs or GAPs function redundantly 
with RGL-1 and HGAP-1/2 to regulate the GDP/GTP cycle of RAL-1 (and by 
extension, with LET-60/Ras). We find that RGL-1 and RAL-1 are required for the 
2˚-promoting signal. But this other GEF would need to be specific for RAL-1 
association with the exocyst and their functions in development, but not signaling 
to promote 2˚ fate. While we cannot exclude this possibility, no GEFs fitting that 
role have been described in any system: RalGPS, a mammalian Ral-selective 
GEF that contains SH3 and PH domains, is not encoded in the C. elegans genome; 
(Zand et al., 2011), nor is TD-60/RCC2, similar to the Ran GEF RCC1 that controls 
nuclear import/export, which has been proposed to be an atypical GEF for RalA 
(Papini et al., 2015). 
 
RGL-1 performs genetically separable and opposing functions in VPC fate 
patterning.  
 
To our surprise, we found that deletion alleles of rgl-1 caused no net alteration 
of the balance of 1˚ and 2˚ VPCs in the let-60(gf) background. By genetic analysis, 
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RGL-1 performs its canonical role in promoting 2˚ fate as a signaling intermediary 
between LET-60/Ras and RAL-1 (Zand et al., 2011; this study), a role that mirrors 
extensive biochemical and cell biological evidence from mammalian cell culture 
(reviewed in Feig, 2003; Gentry et al., 2014; Kashatus, 2013). Here, further 
genetic analysis reveals an additional, unexpected role for RGL-1, that of a non-
canonical signaling participant opposing the canonical role as an activator of RAL-
1. This non-canonical role apparently counteracts or “cancels out” the canonical 
role. In sensitized backgrounds, putative null mutations have no net effect on the 
sensitive balance between 1˚ and 2˚ VPC fates. We do not intend to imply that 
opposing functions are “equal”, only that in our assays they appear to counter-
balance each other with approximate equivalency. The observation that deletion 
of RGL-1 increased the basal error rate of patterning 15-fold supports the idea 
that RGL-1 serves an important function, that of fidelity. 
In mammalian cell culture RalGEF-Ral and PDK-Akt cascades worked in 
concert (Hao et al., 2008). Yet mammalian RalGEF-Ral signaling has also been 
found to oppose canonical Ras effectors in cell culture (Goi et al., 1999). We 
speculate that the relationship between these cascades may depend on cell 
context, and in the case of vertebrates, which paralog of RalGEF is expressed. 
RGL-1 is not the first protein in the VPC fate patterning network found to be 
bifunctional and promote both 1˚ and 2˚ fates. Depending on signaling dose and 
via mechanisms we do not understand, LIN-3/EGF-LET-23/EGFR signaling was 
found to promote both 1˚ and 2˚ fates, resulting in the original Morphogen Gradient 
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Model (Katz et al., 1995; Katz et al., 1996; Sternberg and Horvitz, 1989). We found 
that LET-60/Ras can promote 1˚ or 2˚ fate depending on its use of effector, LIN-
45/Raf or RGL-1/RalGEF (Reiner, 2011; Zand et al., 2011). Yet the situations are 
not equivalent. LIN-3, LET-23, and LET-60 are essential for vulval induction: 
strong loss results in complete absence of 1˚ fate induction and hence a vulvaless 
phenotype (Aroian et al., 1990; Beitel et al., 1990; Han and Sternberg, 1990; Hill 
and Sternberg, 1992), and thus their roles in 2˚ fate induction were teased out 
only in sensitized backgrounds or special assays (Katz et al., 1995; Katz et al., 
1996; Zand et al., 2011). In contrast, RGL-1 is dispensable for 1˚ and 2˚ fate 
induction, permitting dissection of its balanced and opposing functions. 
Furthermore, deletion of RGL-1 does not alter any other known developmental 
events.  
These observations positioned us to discover an unexpected aspect of RGL-
1 function: it contributes to two modulatory cascades, neither of which is essential 
for VPC induction. And since the two cascades promote opposing outcomes, loss 
of both together has no net effect on the delicate balance between 1˚ and 2˚ fates. 
Consequently, this unusual feature of RGL-1 function in vulval signaling, in the 
anatomically simple nematode that mostly lacks paralog redundancy, provided the 
opportunity to discover what may be a heretofore unknown property of signaling 
networks. We speculate that we have identified a signaling switch that is 
dispensable for development, and that precise regulation of this switch increases 
the fidelity of signaling networks and hence development. Specifically, in this case 
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RGL-1 may orchestrate the opposing outputs of AKT-1, which promotes 1˚ fate 
through unknown downstream targets (this study), and RAL-1, which promotes 2˚ 
fate through EXOC-8/Exo84 of the exocyst, the GCK-2/MAP4 kinase, MLK-
1/MAP3K, and PMK-1/p38 MAP kinase (Shin et al., 2018). 
 
Linking opposed signaling cascades and mitigating development noise.  
 
To occur with high fidelity, the VPC fate patterning system must strictly define 
developmental fields in response to an initial point source of LIN-3/EGF ligand. In 
other words, it must generate the precise 3˚-3˚-2˚-1˚-2˚-3˚ pattern with 99.8% 
accuracy without mis-specified or ambiguous fates that might block mating and 
egg laying, which would negatively impact reproductive fitness. A critical question, 
then, is how the programming of signal transduction networks decreases the 
potential for errors (developmental stochasticity or “noise”). Previously, the fidelity 
of VPC fate patterning was thought to be a property that emerges from the 
combination of three mechanisms: 1) Sequential Induction sets up the basic 
pattern, 2) the Morphogen Gradient collaborates with Sequential Induction to 
more precisely sculpt the initial pattern, and 3) Mutual Antagonism serves to 
exclude potentially conflicting signals from cells that are initially specified, thus 
preventing assumption of wrong or ambiguous fates. We speculate that the roles 
we describe here for RGL-1 define a fourth method that is woven into the other 
three: orchestration of two modulatory cascades to more sharply demarcate fates 
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as a function of the VPC’s spatial relationship to the AC and other VPCs. We 
name this property “Balanced Switches”.  
Yet is the participation of RGL-1 in two opposing cascades necessarily a 
novel mechanism that promotes fidelity? Perhaps not. Perhaps RGL-1 as a point 
of intersection between two conserved but opposing cascades is coincidental. In 
this alternative model, the loss of fidelity observed in deletion mutants of rgl-1 may 
be merely the consequence of losing two independent modulatory cascades, with 
AKT-1 and RAL-1 outputs, that each reinforces their respective fates. In this model, 
the loss of fidelity observed in rgl-1 deletion mutants is happenstance, a side effect 
of losing roughly equal and opposite modulatory cascades. 
Yet the wiring of these two cascades together in opposition could be of 
mechanistic significance. How such a mechanism would function is unclear. One 
possibility is that the RGL-1 “Balanced Switch” functions as an “Insulated Switch”. 
The simplest way to envision this model is through mechanisms of subcellular 
recruitment and sequestration: RGL-1 engagement in one signal could physically 
exclude its engagement in the opposing signal, perhaps because the RGL-1 
protein has been re-localized to a portion of the cell insufficient to participate in 
both signals, or is concomitantly modified to prevent interaction in its 
complementary function. For example, binding of Ras to the RA domain 
presumably recruits RGL-1 to the plasma membrane, consistent with Ras 
interactions with other effectors in mammalian cells. This recruitment could 
sequester RGL-1 away from the subcellular compartment in which PDK-1 and 
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AKT-1 signal. Conversely, RGL-1 bound as a scaffold to PDK-1 and AKT-1 could 
be sequestered away from the subcellular compartment in which Ras interacts 
with RGL-1, preventing participation in the canonical LET-60-RGL-1-RAL-1 2˚-
promoting cascade. A metaphor for such a switch is the two-headed Pushmi-
Pullyu from Dr. Doolittle: when one head pulls forward, the other is by necessity 
pulled back, and vice-versa. An inessential signaling protein with this property – 
like RGL-1 – could function to reinforce two different cell fates to improve 
developmental fidelity. And the mutually exclusive bi-directionality of such a switch 
would ensure that inappropriate signaling is minimized. 
The mechanism by which RGL-1 contributes to different fates remains to be 
determined. We do not yet have fluorescent biomarkers for RAL-1 or AKT-1 output 
in the VPCs. And because of the brief developmental window of VPC patterning 
and the tiny volume of VPC lineages relative to the entire animal, biochemical 
approaches are inadequate. The concept of the “Balanced Switch” being woven 
into signaling networks is a fascinating one, and one difficult to test with the typical 
manifold gene redundancy present in mammalian systems, or the essential nature 
of many signaling genes in the developmentally more complex Drosophila. 
Perhaps developmental patterning of the C. elegans vulva is the right place to test 
this idea, but more tools are needed to do so. Yet, in the dawn of the CRISPR era, 
we remain confident about our ability to do so in the future, including the possibility 
of generating two rgl-1 genes, each of which governs one but not the other 
function, i.e. uncoupling the two halves of the “switch”. 
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Robustness to stochastic variation vs. environmental variation.  
 
Increasing noise could result from three sources: stochasticity, environmental 
insult, or genetic variability. Developmental fidelity depends on mitigating noise 
from all three sources. In the mostly isogenic lines containing two different 
introgressed rgl-1 mutations, genetic variability is unlikely. Thus, we tested 
whether rgl-1 mutants were more susceptible to environmental variability. To our 
surprise, deletion of RGL-1 increased robustness in response to stochastic 
variation but not environmental perturbation. Conversely, small changes in 
function, from weak mutation of certain cascades or introgression into different 
genetic backgrounds that might harbor mutations, caused increased sensitivity to 
environmental insult (Braendle and Felix, 2008; Milloz et al., 2008). A four-fold 
change in EGF dose did not appreciably alter VPC patterning (Barkoulas et al., 
2013). We speculate that balanced change caused by deletion of RGL-1 does not 
decrease robustness. In other words, perhaps it is disruption of the delicate 
balance of 1˚- and 2˚-promoting signals that sensitizes the system to 




We define a putative regulatory system, which we term “Balanced Switching”, 
that potentially mitigates potential signaling noise and hence developmental error. 
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This system would likely not be discovered in experimental platforms with 
extensive paralog redundancy, or where the genes in question are essential for 
viability or the process being studied. Whether Balanced Switches are 
generalizable to other systems, and the molecular details by which they function, 
await further analysis. 
In addition to divergent functions of RGL-1 in signaling, we also delineate 
mechanistic details of RAL-1 vs. RGL-1 function in essential functions performed 
by the exocyst and PAR complexes. Our results suggest that the role of RAL-1 in 
central machinery of cell biology is independent of GDP/GTP state, though we 
cannot rule out some switchable modulation of exocyst and PAR complex 
regulation by RAL-1.  
 
Materials and Methods  
 
C. elegans handling and genetics.  
 
Nomenclature is as described (Dickinson et al., 2013; Horvitz et al., 1979). 
All strains were derived from the N2 wild type. Except where noted, animals were 
cultured on NGM agar plates with OP50 bacteria on at 20˚C (Brenner, 1974). 
Strains used are shown in Table 3. 2. Data were analyzed with GraphPad Prism 




Figure 3. 12 PCR detection of rgl-1(ok1921). A. A scale schematic of the rgl-1 
gene, the ok1921 lesion, and detection primers. B. Agarose gel of +/+, ok1921/+ 
and ok1921/ok1921 single animal PCR reactions. 
 
 
PCR primers are listed in Table 3. 3. For single animal genotyping PCR (Taq 
PCR Master Mix, Qiagen) reactions were run concurrently with +/+, m/+ and m/m 
controls. Each PCR genotype was double-checked after completion of the strain 
construction. For newly analyzed mutations, PCR products were sequenced to 
confirm break points. rgl-1(ok1921) was detected by triplex PCR using primers 
DJR614/615/616 (Tm: 59˚C, 35 cycles), resulting in 366 bp (wild type) and 233 bp 
(ok1921) bands (Fig. 3. 12). Point mutations in rgl-1 were tracked in trans to 
ok1921. Early constructions detected rgl-1(tm2255) by triplex PCR using primers 




Figure 3. 13 PCR detection of rgl-1(tm2255). A. A scale schematic of the rgl-1 
gene, the tm2255 lesion, and detection primers. B. Agarose gel of +/+, tm2255/+ 
and tm2255/tm2255 single animal PCR reactions. 
 
 
595 bp (tm2255) bands (Fig. 3. 13). Later constructions detected rgl-1(tm2255) 
by triplex PCR using primers FSM7/8/9 (Tm: 58˚C, 35 cycles), resulting in 509 bp 
(wild-type) and 254 bp (tm2255) bands. pdk-1(mg142gf) was amplified by primers 
DRC1/2 (Tm: 60˚C, 35 cycles) to generate a 426 bp band, then digested with Hpa 
II (NEB; 5 units added to total reaction a 426 bp band, then digested with Hpa II 
(NEB; 5 units added to total reaction volume doubled with water with NEB buffer 
#1 to 0.5x total, digested overnight at 37˚C). The band from the wild-type allele 
was digested to yield 126 and 300 bp bands, while the mg142 lesion abolishes 
the Hpa II site. daf-18(ok480) was detected by triplex PCR using primers 
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FSM4/5/6 (Tm: 54˚C, 35 cycles), resulting in 388 bp (wild-type) and 216 bp (ok480) 
bands. For this study, dpy-9(e14) was used as a balancer for daf-18(ok480), and 
the ok480 genotype confirmed after construction. akt-1(mg144gf) was balanced 
during strain constructions by dpy-11(e224) unc-76 (e905). ral-1(gk628801) was 
detected by amplification with primers DJR778/779 (Tm = 59.9˚C, 35 cycles) to 
generate a 250 bp band and digested with HpyCH4 IV (NEB; 5 units added to 
total reaction volume doubled with water with NEB buffer #1 to 0.5x total, digested 
overnight at 37˚C). The band from the wild-type allele was digested to yield 122 
and 128 bp bands, while the gk628801 lesion abolishes the HypCH4 IV site. 
Transgenic extrachromosomal array reEx24[Plin-31::ral-1(Q75L), Pmyo-2::gfp)] 
(Zand et al., 2011) was integrated by irradiation of late L4 animals using a 
Stratalinker (Stratagene) at dose of 12 mJ/cm2. 451 F2 progeny were screened 
for integration to obtain reIs10 [Plin-31::ral-1(Q75L), Pmyo-2::gfp)]. reIs10 was 
mapped to the region of Chromosome I +5. 
 
VPC induction assays.  
 
VPC induction was analyzed by DIC/Nomarski optics (Nikon eclipse Ni with 
images captured using NIS-Elements AR 4.20.00 software) in late L4 animals on 
an agar pad (molten 3% NG agar with 5 mM sodium azide) in a 5 µl drop of M9 
buffer. Ectopic pseudovulvae were scored as invaginations at 600x or 1000x. 
Ectopic 1˚ vulval induction index, from 0 to 3 ectopic 1˚s, is described elsewhere 
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(Shin et al., 2018; Zand et al., 2011). Under-induced backgrounds were scored as 
total VPCs induced, typically 0-3 (in under-induced backgrounds the entire vulva 
is frequently uninduced). To summarize, we scored the wild-type vulval induction 
based on the stereotypical 2˚-1˚-2˚ lineages centered on the AC at the A-P 
midpoint of the gonadal primordium (forming the “Christmas Tree” or “Stanley Cup” 
shape). In the let-60(n1046gf) and let-23(sa62gf) backgrounds, the morphology 
of ectopic 1˚ cells generally conformed with the described “cap” structure where 
the entire 1˚ lineage has pulled away from the cuticle (Katz et al., 1996). We did 
not observe ectopic pseudovulvae with the characteristic asymmetrical “beret” 
lineage of 2˚ lineages, where one side remains attached to the cuticle. 
As described previously (Shin et al., 2018; Zand et al., 2011), we occasionally 
observed drift of the severity of the let-60(n1046gf) but not let-23(sa62gf) Muv 
phenotype. Consequently, we employed a stringent protocol for all VPC induction 
scoring experiments. We analyzed parental MT2124 and outcrossed strains 
harboring the n1046gf single mutant, and established that the baseline of 
undrifted strains averaged 1.2-1.5 ectopic 1˚s. (When grown on bacterially 
mediated RNAi food source HT115, induction was consistently higher: 1.5-1.8; 
(Shin et al., 2018; Zand et al., 2011). We additionally always worked with freshly 
thawed or chunked strains; our animals were always freshly derived from a cross 
or thaw. For all strains harboring the n1046gf mutation we always employed 
stringent scoring criteria: the n1046gf single mutant was scored first, and 
experiments deviating from the aforementioned expected range of induction were 
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discarded. Additionally, we only compared genotypes that were scored 
concurrently, thus minimizing variation from assay to assay. 
 
DIC, epifluorescence and confocal microscopy.  
 
For epifluorescent imaging, animals were mounted in 2 mg/ml tetramisole/M9 
buffer and visualized using a Nikon Eclipse TE2000U microscope equipped with 
a DVC-1412 CCD camera (Digital Video Camera Company), with Hamamatsu 
SimplePCI acquisition software. Confocal images were captured by A1si Confocal 
Laser Microscope (Nikon) using NIS Elements Advanced Research, Version 4.40 
software (Nikon). 
 
Bacterially mediated RNA interference.  
 
RNAi was performed as described previously (Shin et al., 2018; Zand et al., 
2011) with HT115 bacterial host (Timmons and Fire, 1998). RNAi plasmids used 
were: pREW2 (luciferase/luc; Shin et al., 2018), X-2K11 (rgl-1), III-7M13 (ral-1), I-
1K04 (pop-1), and gfp (Zand et al., 2011). Each RNAi clone was sequence verified. 
Bacteria were grown on NGM plates supplemented with 50 µg/ml carbenicillin and 
1 mM IPTG. Bacteria were grown (but not overgrown) overnight, without antibiotic 
selection. 80 µl of fresh culture was seeded on plates on day 1, grown overnight, 
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L4 animals were added on day 2, transferred to a fresh plate on day 3, and scored 
on day 5. 
 
Plasmid subcloning and transgene generation.  
 
Using primers RGL-1F and RGL-1R, the rgl-1a cDNA was amplified from 
clone yk643d11, and digested with Bgl II and Not I. This isoform lacks exon 2, 
which by RNAseq data is rare (Wormbase WS263), yet still rescues, arguing that 
exon-2 is not required for vulval signaling. Plasmid vector pB255, which contains 
the lin-31 promoter and additional regulatory sequences and drives expression in 
VPCs (Tan et al., 1998), was digested with Bgl II and Not I to receive the rgl-1 
insert. The putative R324E GEF-deficient mutation was introduced by PCR with 
Pfu Turbo using primers KM1 and KM2. The resulting plasmids, Plin-31::rgl-1(+) 
and Plin-31::rgl-1(R324E), were injected at 5 ng/µl along with co-injection marker 
pPD118.33(Pmyo-2::gfp) at 5 ng/µl into strain DV2190 let-60(n1046gf); rgl-
1(tm2255) to generate arrays reEx109 and reEx110 (rgl-1(+)) and reEx94 and 
reEx95 (rgl-1(R324E)), which express wild-type and GEF-deficient RGL-1, 







CRISPR/Cas9-dependent genome editing.  
 
rgl-1(re179[mNeonGreen::3xFlag::rgl-1]) was generated using the positive-
negative selection self-excising cassette method (Dickinson et al., 2015). The 
repair template for rgl-1 5’ tagging was generated by Gibson Assembly (NEB) with 
digested target SEC vector pDD268, and ~500 bp of homology arms amplified 
from genomic DNA by Q5 polymerase (NEB). We used two sgRNA sequences: 
(#1) 5’-ACACCTTCGTATCCTTGTGGCGG-3’ and (#2) 5’-
GGTCTGAGTTCTTCTGACGATGG-3’ (PAMs underlined), and hence generated 
two targeting vectors and one repair template. Repair template (20 ng/µl), sgRNA-
Cas9 #1 (25 ng/µl), sgRNA-Cas9 #2 (25 ng/µl) and injection marker Pmyo-
2::mCherry (2.5 ng/µl) were microinjected into wild-type animals. Genotyping and 
sequencing of rgl-1 5’ CRISPR tagging was performed with HS125/126/127 (Tm: 
54˚C). Validation was performed by western blotting using monoclonal anti-Flag 
antibody (Sigma-Aldrich F1804; 1:2000), monoclonal anti-α-tubulin antibody 
(Sigma-Aldrich T6199; 1:2000) and goat anti-mouse secondary antibody 
(MilliporeSigma 12-349; 1:5000).  
For reasons unknown, all seven rgl-1 CRISPR alleles generated harbored 
mutations. Repair templates were re-checked by sequencing to confirm that 
sequences were wild type. DV3225 rgl-1(re179[mNeonGreen::3xFlag::rgl-1]) 
harbored only promoter mutations (C insertion at -614, C deleted at -375, C to T 
at -395) and so was selected for further analysis. Analysis of the ModEncode 
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database showed no peaks of promoter occupancy at these sites. rgl-
1(re179[mNeonGreen::3xFlag::rgl-1]) had no effect on 1˚ induction in the let-
60(n1046gf) background (P = 0.57 between strains with and without the re179 
insertion, N = 86 and 78, respectively). 
 
Assessment of patterning error rate with environmental insults.  
 
The vulval cell lineages and Pn.p fates (and errors) were described in early 
to mid L4 individuals as previously described (Braendle and Felix, 2008; 
Sternberg and Horvitz, 1986). Nematode populations of N2 wild type and the two 
rgl-1 mutations were kept in identical environmental conditions for at least three 
generations prior to experiments. Animals were age-synchronized by hypochlorite 
treatment and liquid arrest for ~24 hours, then randomly allocated to the four 
experimental environments: control (20˚C), heat stress (29˚C), osmotic stress 
(250 mM NaCl NGM plates, 20˚C; Lamitina et al., 2004), and starvation (20˚C; 
Grimbert et al., 2018). In starvation conditions, L1 larvae were cultivated on 
standard NGM plates until they reached the mid L2 stage, at which point they 
were transferred to unseeded NGM plates containing 1mg/ml of ampicillin to 
prevent bacterial growth. After 48 hours, starved animals were transferred to 
regular NGM plates seeded with E. coli OP50 and the vulval phenotype was 











In-frame deletion, GEF 
domain 
Wild type none 
rgl-1(tm2255) 
Out-of-frame deletion, GEF 
domain 
Wild type none 
fax-1(gm27)b 
rgl-1 and 8 other genes 
deleted  
Uncc none 
rgl-1(gk275305) nonsense Wild type none 
rgl-1(gk275304) 
Missense, R361Q, GEF 
domain 
Wild type Decreased 2˚ 
ral-1(tm2760) Intron 3 deletion Steriled Decreased 2˚d 




ral-1(gk628801) Missense, R139H Wild type Decreased 2˚ 
ral-1(re179) mNeonGreen::3xFlag::rgl-1 Wild type nonef 
 
a Alteration in network signaling determined from phenotype in let-60(n1046gf). 
b Documented in (Much et al., 2000). 
c Deletion of fax-1 causes an Uncoordinated phenotype (Much et al., 2000). 
d Intron 2 deletion breaks in the middle of the splice donor site, conferring sterility, 
reduced 2˚ induction, and disruption of polarity (Zand et al., 2011). 
e Exons 2 and 3 deletion removes GTPase domain sequences, confers sterility, 
delayed growth and reduced 2˚ induction (Armenti et al., 2014), this study. 




Table 3. 2 Strains for RGL-1 study 
Strain Genotype Application 
DV3311 
ral-1(tm2760) / qC1 [dpy-19(e1259ts) glp-




ral-1(tm5205) / qC1 [dpy-19(e1259ts) glp-
1(q339) nIs189[Pmyo-2::gfp] III 
Inspecting 
mutant VPCs 
MT2124 let-60(n1046gf) IV 
Fig. 3. 3B, 3. 3C, 
3. 3E, baselines 
throughout 
DV2214 let-60(n1046gf) IV (2x outcrossed) Results 
DV2215 let-60(n1046gf) IV (2x outcrossed) Results 
RB1576 rgl-1(ok1921) X Starting reagent 
DV2194 rgl-1(ok1921) X (4x outcrossed) throughout 
FX2255 rgl-1(tm2255) X Starting reagent 
DV2175 rgl-1(tm2255) X (4x outcrossed) throughout 
DV2937 
ral-1(tm5205) / qC1 [dpy-19(e1259ts) glp-
1(q339) nIs189[Pmyo-2::gfp] III; let-60(n1046gf) 
IV 
Fig. 3. 3F 
DV2190 let-60(n1046gf) IV; rgl-1(tm2255) X 
Fig. 3. 3D, 3. 3F, 
3. 3G 
DV2248 let-60(n1046gf) IV; rgl-1(ok1921) X Fig. 3. 3F, 3. 3G 
DV2251 let-60(n1046gf) IV; lon-2(e678) X Fig. 3. 3G 
DV2252 let-60(n1046gf) IV; fax-1(gm27) lon-2(e678) X Fig. 3. 3G 
DV2191 
let-60(n1046gf) IV; arIs92[Pegl-17::NLS-
cfp::LacZ + Pttx-3::gfp] V 




cfp::LacZ + Pttx-3::gfp] V; rgl-1(tm2255) X 
Fig. 3. 4B, 3. 4E 
WU49 lin-45(n2506rf) unc-24(e138) IV 
Fig. 3. 4F, 3. 10E, 
3. 10F 
DV2783 
lin-45(n2506rf) unc-24(e138) IV; rgl-1(tm2255) 
X 
Fig. 3. 4F 
PS1524 unc-4(e120) let-23(sa62gf) II Fig. 3. 4G 
DV2958 unc-4(e120) let-23(sa62gf) II; rgl-1(tm2255) X Fig. 3. 4G 
BC14985 
dpy-5(e907) I; sEx14985[rCesF28B4.2::gfp + 
pCeh361(dpy-5(+))] 
Fig. 3. 5 
DV3312 rgl-1(re179[mNeonGreen^3xFlag::rgl-1]) X Fig. 3. 6 




Table 3. 2 Continued 
Strain Genotype Application 
DV2942 ral-1(gk628801rf) III (6x outcrossed) Results 
DV2799 ral-1(gk628801rf) III; let-60(n1046gf) IV Fig. 3. 7C 
VC20011 rgl-1(gk275304) X (unoutcrossed) Results 
DV2883 rgl-1(gk275304) X (4x outcrossed) Results 
VC40052 rgl-1(gk275305) X (unoutcrossed) Results 
DV2884 rgl-1(gk275305) X (4x outcrossed) Results 
DV2764 let-60(n1046gf) IV; rgl-1(gk275304) X Fig. 3. 7D 
DV2765 let-60(n1046gf) IV; rgl-1(gk275305) X Fig. 3. 7D 
DV2537 
let-60(n1046gf) IV; rgl-1(tm2255) X; 
reEx94[Plin-31::rgl-1(R324E) + Pmyo-2::gfp] 
Fig. 3. 7E, 3. 8A 
DV2538 
let-60(n1046gf) IV; rgl-1(tm2255) X; 
reEx95[Plin-31::rgl-1(R324E) + Pmyo-2::gfp] 
Fig. 3. 7E, 3. 8A 
DV2736 
let-60(n1046gf) IV; rgl-1(tm2255) X; 
reEx109[Plin-31::rgl-1(+) + Pmyo-2::gfp] 
Fig. 3. 7E, 3. 8B 
DV2737 
let-60(n1046gf) IV; rgl-1(tm2255) X; 
reEx110[Plin-31::rgl-1(+) + Pmyo-2::gfp] 
Fig. 3. 7E, 3. 8B 
MT301 lin-31(n301) II Fig. 3. 8C 
DV2763 lin-31(n301) II; rgl-1(tm2255) X Fig. 3. 8C 
DV2140 
let-60(n1046gf) IV; reEx24[Plin-31::ral-1(Q75L), 
Pmyo-2::gfp] 
Zand et al., 2011 
derived reIs10 
DV2335 reIs10[Plin-31::ral-1(Q75L) + Pmyo-2::gfp] I Results 
DV2699 
reIs10[Plin-31::ral-1(Q75L) + Pmyo-2::gfp] I; let-
60(n1046gf) IV 
Fig. 3. 7F, 3. 8D 
DV2700 
reIs10[Plin-31::ral-1(Q75L) + Pmyo-2::gfp] I; let-
60(n1046gf) IV; rgl-1(tm2255) X 
Fig. 3. 7F 
CB2065 dpy-11(e224) unc-76(e905) V akt-1 balancer 
GR1310 akt-1(mg144gf) V Fig. 3. 9 
DV2746 let-60(n1046gf) IV; akt-1(mg144gf) V Fig. 3. 9A, 3. 10A 
DV2747 
let-60(n1046gf) IV; akt-1(mg144gf) V; rgl-
1(tm2255) X 
Fig. 3. 9A, 3. 10A 
GR1318 pdk-1(mg142gf) X Fig. 3. 9 
DV2773 let-60(n1046gf) IV; pdk-1(mg142gf) X Fig. 3. 9B, 3. 10B 
DV2782 let-60(n1046gf) IV; pdk-1(mg142gf) X Fig. 3. 9B 
DV2844 let-60(n1046gf) IV; pdk-1(mg142gf) X Fig. 3. 9B 
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Table 3. 2 Continued 
Strain Genotype Application 
SP934 unc-1(e538) dpy-3(e27) X Fig. 3. 9B 
DV2774 unc-1(e538) dpy-3(e27) rgl-1(tm2255) X Fig. 3. 9B 
DV2819 pdk-1(mg142gf) rgl-1(tm2255) X Fig. 3. 9B 
DV2822 
let-60(n1046gf) IV; pdk-1(mg142gf) rgl-
1(tm2255) X 
Fig. 3. 9B 
DV2791 
lin-45(n2506rf) unc-24(e138) IV; akt-
1(mg144gf) V 
Fig. 3. 10F 
DV2795 
lin-45(n2506rf) unc-24(e138) IV; pdk-
1(mg142gf) X 
Fig. 3. 10E 
RB712 daf-18(ok480) IV Starting reagent 
DV2855 daf-18(ok480) IV (2x outcrossed) Fig. 3. 9 
DV2510 daf-18(ok480) let-60(n1046gf) IV 
Fig. 3. 9C, 3. 9D, 
3. 10C, 3. 10D, 3. 
10G, 3. 10H 
DV2535 
daf-18(ok480) let-60(n1046gf) IV; rgl-1(tm2255) 
X 
Fig. 3. 9C 
DV2509 
daf-18(ok480) let-60(n1046gf) IV; rgl-1(tm2255) 
X 
Fig. 3. 9D 
DV2679 jip-1(km18) II Fig. 3. 10I 
DV3013 jip-1(km18) II; let-60(n1046gf) IV Fig. 3. 10I 
DV3358 jip-1(tm6137) II (4x outcrossed) Fig. 3. 10I 
DV3505 jip-1(tm6137) II; let-60(n1046gf) IV Fig. 3. 10I 
DV3506 
jip-1(tm6137) II; daf-18(ok480) let-60(n1046gf) 
IV 
Fig. 3. 10I 
DV2696 rgl-1(ok1921) X (8x outcrossed) Fig. 3. 11 








Table 3. 3 Primers for RGL-1 study 







































































Table 3. 3 Continued 


































































Ras is the most mutated oncoprotein across all cancers (Bos, 1989) and is 
the founding member of the Ras superfamily of small GTPases (Wennerberg et 
al., 2005). Ras paralogs are encoded by three distinct genes, and each Ras 
protein binds to GDP/GTP with picomolar affinity, thus preventing direct 
pharmacological inhibition. Ras uses many effectors, with three main effectors 
associated with cancer: Raf S/T kinase, PI3K lipid kinase, and RalGEF exchange 
factor for the Ras-like small GTPase, Ral. Like most small GTPases, Ras is lipid-
modified at its C-terminus to regulate membrane-targeting. Yet blockade of Ras 
lipid modification fails due to alternative lipid modification (Cox et al., 2014). 
Therefore, Ras is thought to be mostly undruggable, with certain exceptions 
(Downward, 2014; Papke and Der, 2017). Historically, canonical Ras-Raf and 
Ras-PI3K have been shown to cause cancer transformation of mouse primary 
fibroblasts (Khosravi-Far et al., 1996; Kyriakis et al., 1992; Shields et al., 2000; 
White et al., 1995). Subsequent studies supported the idea that Ras-RalGEF-Ral 
mediates the transformation of immortalized human epithelial cells (Hamad et al., 
2002); most malignant human cancers are derived from epithelial cells (Hanahan 
and Weinberg, 2011). Furthermore, loss of the heterodimeric RalGAP, a putative 
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tumor suppressor, promotes tumorigenesis independently of Ras (Oeckinghaus 
et al., 2014; Saito et al., 2013). Therefore, Ras-RalGEF-Ral is an oncogenic signal 
perhaps as canonical Ras effectors Raf and PI3K. 
RalGEF was identified as a Ras effector by yeast two hybrid screens in early 
1990s (Albright et al., 1993; Hofer et al., 1994; Spaargaren and Bischoff, 1994; 
Wolthuis et al., 1996). RalGEF is a guanine nucleotide exchange factor for small 
GTPase Ral. The RalGEF has a REM (Ras Exchanger Motif) domain, a CDC25 
homology domain (RasGEF), and a RA (Ras Association) domain (Ferro and 
Trabalzini, 2010). Humans have four RalGEFs: RalGDS (Ral Guanine nucleotide 
Dissociation Stimulator), Rgl1, 2, and 3 (Isomura et al., 1996; Kikuchi et al., 1994; 
Shao and Andres, 2000; Wolthuis et al., 1996). C. elegans encodes a single 
RalGEF, RGL-1, while Drosophila encodes two RalGEF proteins from a single 
gene (RGL and RGL2; Gentry et al., 2014).  
Ras uses different effectors, or combinations of effectors, in different cancers 
(Martin et al., 2011). This phenomenon raises the question of combinatorial 
effector inhibitors as a strategy to treat Ras-dependent tumors. It also raises the 
interesting question of how Ras decides between effectors: currently we have no 
idea how this switching is regulated. RalGEF has been shown to enhance Ras-
mediated-transformation and -tumorigenic growth in human cells (Lim et al., 2005). 
The activated RalGEF, Rgl2, promotes anchorage-independent growth and 
invasion in human pancreatic adenocarcinoma cell lines and immortalized rodent 
melanocytic cells (Mishra et al., 2010; Vigil et al., 2010). 
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In the response of LIN-3/EGF, LET-23/EGFR signals through LET-60/Ras-
LIN-45/Raf-MEK-2/MEK-MPK-1/ERK to promote 1˚ fate in C. elegans vulva 
precursor cell (VPC) fate patterning. The LET-23-mediated 1˚-promoting signal in 
turn induces DSL Notch ligands expression in the presumptive 1˚ cell, P6.p. DSL 
Notch ligands are secreted from the P6.p to signal laterally to the adjacent P5.p 
and P7.p. The spatially graded LIN-3 promotes LET-23/EGFR-LET-60/Ras-RGL-
1/RalGEF-RAL-1/Ral to induce P5.p and P7.p become 2˚ cells in support of LIN-
12/Notch activation (Zand et al., 2011). 
There are additional complications of LET-60 signaling and outcomes in C. 
elegans. Different LET-60 gain-of-function mutants showed different phenotypes. 
For examples, let-60(n1046gf) has the canonical G13E mutation and shows 
Multivulva (Muv) phenotype with mild fertility defect (Beitel et al., 1990; Han and 
Sternberg, 1991), but no obvious effect on fluid homeostasis. Another LET-60 gf 
mutant, ay75ts, has G60R mutation, which promotes mammalian Ras 
transforming activity (Lowy et al., 1991). The let-60(ay75ts) shows strong fluid 
homeostasis defect (Schutzman et al., 2001). On the other hand, let-60(ga89ts), 
which has a L19F mutation, confers strong sterility (Eisenmann and Kim, 1997). 
The LET-60 signals through LIN-45/Raf to function in all three tissues, so these 
differences are difficult to explain. One possibility is that LET-60 orchestrates 
multiple effectors in each tissue. The functions of LET-60-RGL-1 have not been 
investigated except its role as a 2˚-promoting signal in VPC fate patterning. The 
different effectors, LIN-45 and RGL-1, may shape different LET-60 activity to be 
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able to regulate multiple functions in different tissues, or even other effectors could 
be involved. However, we do not know how LET-60 switches its effectors or 
whether LET-60 uses multiple or one effector for the specific functions. We will 
investigate LET-60 effector switching mechanism using C. elegans.  
Patterning of C. elegans VPC fates is an ideal system to study this question, 
since this developmental decision is dispensable for viability. Additionally, C. 
elegans lacks the paralog redundancy of mammals (e.g. three Ras-, three Raf- 
and four RalGEF-encoding genes). The developmental simplicity of C. elegans is 
also an advantage: mutation of many of the relevant genes in C. elegans are lethal 
or at least yield some live animals, while most are essential in Drosophila. The 
relative ease of CRISPR manipulation (Dickinson et al., 2015; Dickinson et al., 
2013) and the optical clarity of the third larval stage animal positions us to observe 
effector recruitment in real time. 
Plasma membrane-locailzed Ras in its GTP-bound state recruits Raf to the 
plasma membrane by binding to the Ras binding domain (RBD) of Raf (Leevers 
et al., 1994; Pritchard and McMahon, 1997; Stokoe et al., 1994; Tamada et al., 
1997). The activation of Raf also requires phosphorylation/dephosphorylation 
(Dhillon et al., 2002; Fabian et al., 1993). In C. elegans, SOC-2/SUR-8 has been 
shown to function as a scaffold protein between LET-60 and LIN-45 genetically 
(Selfors et al., 1998; Sieburth et al., 1998) and was later shown to bind to both (Li 
et al., 2000; Matsunaga-Udagawa et al., 2010). 
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Our preliminary data showed that upon VPC induction, LIN-45/Raf and RGL-
1/RalGEF are differently recruited to the basolateral plasma membrane of the 
presumptive 1˚ cell and the apical plasma membrane in presumptive 2˚ cells, 
respectively. We conclude we are witnessing two distinct regulatory axes. First, 
we observed clear segregation of signals along the apical-basolateral axis, with 
no evidence of either effector being mislocalized. Second, we observed clear 
segregation between presumptive 1˚ and 2˚ VPCs, though in this case low level 
and sporadic recruitment of RGL-1 to the apical plasma membrane of presumptive 
1˚ cells was also observed. Thus, we will follow multiple avenues of investigation 
to determine mechanisms for both of these segregations. We plan to thus 
determine the mechanism of Ras effector switching. 
Going forward we will test multiple hypotheses. First, we hypothesize the 
different localization of LET-60 effectors in different cells is controlled by restriction 
of specific scaffold proteins to either apical membrane or basolateral membrane 
in VPCs. The LIN-45 recruitment to the basolateral membrane in 1˚ cell could be 
restricted by SOC-2, a well-known scaffold protein between LET-60 and LIN-45. 
Alternatively, SOC-2 could function as an insulator, excluding RGL-1 from the 
basolateral cell compartment. Or a similar scaffold could function to spatially 
regulate the LET-60-RGL-1 interaction.  
Another hypothesis is that the PAR system, which generally sets of polarity 
in polarized epithelial cells across metazoans (Thompson et al., 2013) sets up 
apical-basal polarity of LET-60 effector usage. Ample PAR tools are available in 
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C. elegans, the animal in which the PAR system was discovered (Kemphues, 
2000). 
A hypothesis addressing 1˚ vs. 2˚ segregation of RGL-1 is that 
phosphorylation of RGL-1 regulates the interaction between it and LET-60. The 
RGL-1 has a potential phosphorylation site neighboring the RA domain 
(Bodenmiller and Aebersold, 2011). This putative phosphosite is similar to 
consensus sequence for phosphorylation by MAP kinases or CDKs, Cyclin-
Dependent Kinases. The LET-60/Ras-LIN-45/Raf-MEK-2/MEK-MPK-1/ERK 
signaling cascade promotes 1˚ fate. We hypothesize that phosphorylation of this 
putative phosphosite by MPK-1/ERK in the presumptive 1˚ cell could abolish LET-
60/Ras binding to RGL-1. Conversely, since MPK-1/ERK activity is quenched by 
2˚-specific expression of the LIP-1/ERK phosphatase, RGL-1 may remain 
unphosphorylated and permit binding to LET-60. 
We will additionally prepare tools for pairwise immunoprecipitation and mass 
spectrometry to discover shared LET-60-RGL-1 and LET-60-LIN-45 binding 
partners. This unbiased approach will complement our mechanistically specific 
approaches. I expect this extension of my thesis work to uncover important 





LIN-45/Raf was recruited to the basolateral membrane in presumptive 1˚cell, but 
not in presumptive 2˚ cells. 
 
The Ras effector, Raf, showed recruitment to the plasma membrane in 
mammalian cell culture system (Block et al., 1996; Chiu et al., 2002). The LET-
60/Ras-LIN-45/Raf is a well-known 1˚-promoting signal in C. elegans VPC fate 
patterning. Since LET-60 and LIN-45 are necessary and sufficient for 1˚ fate 
induction, we hypothesized that LIN-45 should be recruited to the plasma 
membrane of presumptive 1˚ VPCs during induction. Therefore, using 
CRISPR/Cas9-mediated genome editing (Dickinson et al., 2013) we tagged 
endogenous LIN-45 with mNeonGreen (mNG; Shaner et al., 2013) fluorescent 
protein (FP) and the 3xFlag epitope tag (generously provided by N. Rasmussen).  
mNG::LIN-45 appears to be ubiquitously expressed in the animal. Specifically, 
mNG::LIN-45 is localized in the cytoplasm of VPCs at early Pn.p stage, 1-cell 
stage (Figs. 4. 1A-B). During VPC induction LIN-45::mNG is recruited to the 
basolateral plasma membrane in presumptive 1˚ but not 2˚ cells (Figs. 4. 1A-B). 
The basolateral surface of presumptive 1˚ cell, P6.p, is juxtaposed with the ventral 
surface of the AC, and so is close to the source of LIN-3/EGF. P6.p, the 
presumptive 1˚ cell, is at least twice the width of the AC (Sherwood and Sternberg, 




Figure 4. 1 Subcellular localization of LIN-45::mNG in VPCs at different 
stages. A. LIN-45::mNG is localized to the cytoplasm of VPCs and the AC at early 
Pn.p, 1-cell, stage. LIN-45::mNG is recruited to basolateral membrane in 1˚ cell, 
but not in 2˚ cells at early 1-cell stage. B. DIC image of early 1-cell stage. C. The 
LIN-45::mNG starts to be degraded in 1˚ cell at late 1-cell stage. However, the 
signal of LIN-45::mNG is maintained in 2˚ cells at late 1-cell stage. D. DIC image 
of late 1-cell stage. E. The LIN-45::mNG is degraded in the daughters of 1˚ cell 
while expressing in the daughters of 2˚ cells at 2-cell stage. F. DIC image of 2-cell 
stage. G. The LIN-45::mNG is not expressed in the daughters of 1˚ cell at 4-cell 
stage. However, the LIN-45::mNG is still expressed in the daughters of 2˚ cells at 
4-cell stage. H. DIC image of 4-cell stage.  
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the size of the AC (Figs. 4.1A-B). Thus, the observed LIN-45::mNG signal is likely 
to be in the VPC, and not the nearby AC. This issue can be resolved in the future 
with conditional and VPC-specific degradation of LET-60, and perhaps the use of 
super-resolution confocal microscopy. 
LIN-45::mNG started to disappear from the 1˚ cell at late Pn.p stage, 1-cell 
stage (Figs. 4. 1C-D). At the 2-cell and 4-cell stage when VPC fate patterning is 
completed, LIN-45::mNG is degraded in the daughters of P6.p, 1˚ cell (Figs. 4. 
1E-H). This observation validates the published expression pattern of LIN-45 
reporter, Plin-31::YFP::LIN-45, which described targeted degradation of LIN-45 
after initial induction (de la Cova and Greenwald, 2012). There, YFP::LIN-45 was 
not expressed in the daughters of presumptive 1˚ cell at 2-cell stage. It has been 
proposed that SEL-10/FBW7 negatively regulates LIN-45 in P6.p, 1˚ cell, through 
ubiquitination and degradation (de la Cova and Greenwald, 2012). Yet in this 
study, exogenously expressed YFP::LIN-45 was not observed to be recruited to 
the basolateral plasma membrane. We speculate that over-expression of 
signaling proteins can drown out the signal of sub-populations of protein that might 
be relocalized to specific subcellular compartments. Consequently, we will 
continue to use CRISPR-dependent tagging of endogenous proteins to track 





RGL-1/RalGEF was recruited apically in 2˚ cells, but not in 1˚ cell at late 1-cell 
stage.  
 
Mammalian RalGEF is also shown to be recruited to the plasma membrane 
in cell culture system (Matsubara et al., 1999). And, activated RalGEF can be 
generated by adding the C-terminal membrane-targeting HVR+CAAX (hyper-
variable region, Cys-Aliphatic-Aliphatic-any amino acid) from Ras to the C-
terminus of RalGEF (Linnemann et al., 2002; Matsubara et al., 1999; Wolthuis et 
al., 1997). The membrane localization of RalGEF, like other Ras effectors, is 
important for its functional activity in mammalian cells. In C. elegans, LET-60/Ras-
RGL-1/RalGEF-RAL-1/Ral is a modulatory signaling cascade for inducing 2˚ fate 
in VPC fate patterning (Zand et al., 2011). We tagged the endogenous RGL-1 with 
mNG and 3xFlag by CRISPR-Cas9 knock-in to examine potential subcellular 
localization of RGL-1 in the VPCs (Shin et al., 2018 submitted). mNG::RGL-1 is 
expressed in the cytoplasm in all cells of the animal, including vulval lineages (Figs. 
4. 2A-B). We observed mNG::RGL-1 to be recruited to the apical plasma 
membrane in presumptive 2˚ cells, but not in 1˚ cells, at the late Pn.p stage prior 
to cell division (Figs. 4. 2C-D). mNG::RGL-1 is also localized to the apical plasma 
membrane in both 1˚ and 2˚ lineages at 2-cell and 4-cell stages (Figs. 4. 2E-H).  
Based on the observation of mNG::RGL-1 localization in early vs. late Pn.p 
stage, we did blind tests with ~60 randomly captured images. Since there are no 




Figure 4. 2 Subcellular localization of mNG::RGL-1 in VPCs at different 
stages. A. mNG::RGL-1 is expressed in the cytoplasm of VPCs and the AC at 
early Pn.p,1-cell, stage. B. DIC image of early 1-cell stage. C. The mNG::RGL-1 
is expressed in cytoplasm of 1˚ and 2˚ cells with enrichment at the apical 
membrane in 2˚ cells, but not in 1˚ cell. D. DIC image of late 1-cell stage showing 
that 1˚ cell is dividing. E. mNG::RGL-1 is expressed in the cytoplasm with apical 
enrichment in the daughters of 1˚ and 2˚ cells. F. DIC image of 2-cell stage. G. 
mNG::RGL-1 is expressed in cytoplasm and localized at the apical membrane and 





the AC, we correlated before/after induction based on the length of gonad by DIC-
based examination of the migration of distal tip cells (DTCs), at the leading point 
of each gonad arm, relative to VPC nuclei. If the DTCs were positioned between 
P3.p and P8.p, we inferred this to be early Pn.p stage, and before induction. If the 
DTCs had migrated further, we inferred this to be late Pn.p stage, and hence after 
induction. VPCs that had divided to yield two Pn.px cells were known to be post-
induction. We divided the images into “no apical”, “apical”, and “uncertain” groups 
without knowing the stage of animals as assessed by DTC position, which is not 
visible in these confocal fluorescence images. 
From the blind test, we found that most of the animals have no apical signal 
in the 1˚ and 2˚ cells, P5.p-P7.p, at early Pn.p stage, before induction (Figs. 4. 3A-
C). However, at the late Pn.p stage, after induction, the apical localization of RGL-
1 significantly increased in 2˚ cells, P5.p and P7.p, from ~10% to ~60%, but not 
in the 1˚ cell, P6.p (Figs. 4. 3D-F). We concluded that RGL-1 is apically localized 
in the 2˚ cells after LIN-3/EGF induction. 
The RGL-1 apical localization is LET-60/Ras-dependent. 
To validate the observed phenomenon of spatially and temporally dependent 
mNG::RGL-1 apical localization, tested whether this localization depended on 
functional LET-60/Ras. Since RalGEF binds to Ras through RA domain, we tested 




Figure 4. 3 mNG::RGL-1 is localized to the apical membrane in presumptive 
2˚ but not 1˚ cells, and in late but not early VPCs. Each pie graph shows 
percentage of apical vs. no apical signal of mNG::RGL-1 in each VPCs. We 
divided the images into three groups, apical, no apical, and uncertain. The 
“uncertain” group means the image is not clear to say it is apical or no apical. A-
C. mNG::RGL-1 in P5.p, P6.p, and P7.p at early L3 stage. Around 10% of animal 
show apical localization of mNG::RGL-1 in the presumptive 2˚ cells, P5.p and P7.p 
while the mNG::RGL-1 is in the cytoplasm with no apical localization in the 
presumptive 1˚ cell, P6.p. D-F. The apical localization of mNG::RGL-1 is increased 
in the 2˚ cells, P5.p and P7.p. Around 60% of animal show apical localization of 
mNG::RGL-1 in the 2˚ cells at late L3 stage while the mNG::RGL-1 is not localized 






let-60(dx16) confers severe sterility and lethality defects with a subset of 
homozygous larvae escaping lethality. Consequently, we had difficulty obtaining 
properly staged L3 animals from heterozygous let-60(dx16)/nT1g mothers (the 
balancing chromosome is GFP-tagged). Therefore, we used Pn.px (2-cell) stage 
animals, when mNG::RGL-1 was uniformly recruited to the apical plasma 
membrane (Figs. 4. 4A-B), to assess dependency of recruitment on LET-60 
function. We observed that apical localization of mNG::RGL-1 was abolished in 




Figure 4. 4 The validation of mNG::RGL-1 apical localization system by 
using LET-60 null mutant. A. mNG::RGL-1 is in the cytoplasm with localization 
to the apical membrane in the daughters of 1˚ and 2˚ cells at 2-cell stage. B. DIC 
image of the mNG::RGL-1 at 2-cell stage. C. The apical localization of mNG::RGL-
1 is abolished by LET-60 null mutant, let-60(dx16), at 2-cell stage. D. DIC image 





consistent with mNG::RGL-1 localization being dependent on LET-60. Thus, we 
hypothesize that the apical and 2˚-specific recruitment of endogenous 




Figure 4. 5 mNG::RGL-1 co-localizes with LET-23::mK2 at the plasma 
membrane.  
A. zhIs35 [let-23::GFP + unc-119(+)] from Dr. Hajnal lab. LET-23::GFP is 
expressed at the plasma membrane in 1˚ and 2˚ cells at 1-cell, Pn.p, stage. The 
expression of LET-23::GFP is highly elevated in the 1˚ cell. B. let-23(re202[let-
23::mKate2^3xFlag]) generated by Dr. Tam Duong. The expression pattern is 
similar to the zhIs35. LET-23::mKate2 is mostly at the plasma membrane in 1˚ 
and 2˚ cells with stronger expression in 1˚ cell at L3 stage. C-E. Images of let-
23(re202[let-23::mKate2^3xFlag]); rgl-1(re179[mNG^3xFlag::rgl-1]) at 1-cell 
stage.  C. LET-23::mKate2 is localized at the plasma membrane in VPCs with 
elevated expression level in the 1˚ cell. D. mNG::RGL-1 is expressed in the 
cytoplasm with apical membrane localization in 2˚ cells, not in 1˚ cell. E. merged 




mNG::RGL-1 co-localizes with LET-23::mK2 at the plasma membrane. 
 
LET-23/EGFR is localized at the plasma membrane in VPCs. zhIs35 [let-
23::GFP + unc-119(+)], low copy number of LET-23::GFP, was expressed at the 
plasma membrane with higher expression in 1˚ cell (Haag et al., 2014; Fig. 4. 5A; 
image captured by Hanna Shin). Our lab generated endogenous tagged LET-23 
with mKate2 and 3xFlag, let-23(re202[let-23::mKate2^3xFlag]), by CRISPR 
knock-in using Self-Excising Cassette (SEC) (Dickinson et al., 2015; kindly 
provided by T. Duong). We found that the expression pattern of endogenous 
tagged LET-23 is similar to LET-23::GFP. The LET-23 is mostly at the plasma 
membrane with high level of expression in 1˚ cell (Fig. 4. 5B). We generated 
double of LET-23::mKate2 and mNG::RGL-1 to see whether they are co-localized 
at the plasma membrane in VPCs. The LET-23::mKate2 and mNG::RGL-1 is at 
the plasma membrane in the 2˚ cells at 1-cell stage (Figs. 4. 5C-E).  
 
mNG::RGL-1 apical localization may be functional.  
 
The positioning of LET-23 to the basolateral membrane in 1˚ cell is an 
important mechanism of LET-23 functional activity to induce 1˚ fate (Kaech et al., 
1998; Simske et al., 1996; Whitfield et al., 1999). Basolateral localization of LET-
23 is regulated by LIN-2/-7/-10 protein complex (Kaech et al., 1998; Simske et al., 
1996; Whitfield et al., 1999). Consequently, in the mutants of LIN-2/-7/-10, LET-
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23 is mislocalized only at the apical membrane in all VPCs (Kaech et al., 1998). 
let-23(sy1), which deletes the last six amino acids, shows LET-23 localized only 
at the apical membrane in VPCs, suggesting that the C-terminus of LET-23 is 
important for interaction with LIN-2/-7/-10 protein complex, probably via the PDZ 
domain of LIN-7 recognizing the PDZ recognition sequence at the C-terminus of 
LET-23 (Kaech et al., 1998). Both LIN-2/-7/-10 mutant and let-23(sy1) has 
vulvaless phenotype because of failing to 1˚ fate induction (Kaech et al., 1998; 




Figure 4. 6 mNG::RGL-1 is localized to the apical membrane in VPCs in let-
23(sy1) background. A. mNG::RGL-1 is expressed in the cytoplasm with 
enrichment at the apical membrane in VPCs in the let-23(sy1) background at late 
1-cell, Pn.p, stage. B. DIC image of mNG::RGL-1 in let-23(sy1) at late 1-cell stage.  
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We evaluated mNG::RGL-1 localization in the let-23(sy1) mutant. We 
observed that mNG::RGL-1 was localized to the apical plasma membrane in P5.p-
P7.p, consistent with the apical mis-localization of LET-23 in VPCs as a 
consequence of the sy1 mutation (Figs. 4. 6A-B). In a wild-type background, these 
VPCs typically assume the 2˚-1˚-2˚ pattern. But in the absence of successful 
induction of 1˚ fate in the let-23(sy1) background, P6.p, presumptive 1˚ cell, 
permits the recruitment of a putative 2˚-promoting signal. These results suggest 
that let-23(sy1) mutant receptor retains the ability to recruit RGL-1 to the apical 
plasma membrane, despite let-23(sy1) being insufficient to promote 1˚ fate. These 
results also suggest that an induced 1˚ cell enacts some mechanism to block the 
theorized 2˚-promoting recruitment of RGL-1 to the apical plasma membrane. 





We found that LET-60/Ras effectors that function to promote different VPC 
fates are recruited to different subcellular locations in VPCs. LIN-45/Raf is 
localized to the basolateral membrane in 1˚ VPCs at the Pn.p (1-cell) stage, while 
RGL-1/RalGEF is recruited to the apical membrane in 2˚ VPCs at the Pn.p stage. 
Preliminary results suggest that recruitment of the two different effectors is 
temporally distinct, with LIN-45 recruited earlier than RGL-1. This asynchrony of 
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recruitment may represent a spatial representation of the morphogen gradient, 
but more data analysis will be needed to confirm this observation. Here, we 
discuss about validation and functional activity of RGL-1 recruitment to the 
membrane, improvement of our tools/systems technically, and potential 
mechanisms.  
 
LIN-45 localization at the basolateral membrane in 1˚ cell and LIN-45 expression 
pattern in VPCs.  
 
LIN-45::mNG is present in the cytoplasm of presumptive 1˚ and 2˚ cells with 
enrichment at the basolateral membrane only in 1˚ cell, but not in 2˚ cells. LIN-
45::mNG started to disappear in the presumptive 1˚ VPC after basolateral 
recruitment, and was mostly absent by the Pn.px (2-cell) stage. This putative post-
induction degradation of LIN-45 from 1˚ cell is governed by SEL-10/FBW7-
mediated ubiquitination and degradation (de la Cova and Greenwald, 2012). The 
degradation of LIN-45 was hypothesized to be a negative feedback loop of 1˚-
promoting signal in VPC fate patterning.  
Fluorescent signal from mNG::RGL-1 and LIN-45::mNG l was relatively weak 
even when using a confocal microscope. Therefore, we will attempt to improve 
our tools with two strategies to improve signal-to-noise ratio. First, we will tag 
endogenous LIN-45 and RGL-1 with mNG::mNG double tag to get stronger signal 
of these effectors. Second, we will tag downstream signaling partners in case the 
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signal is amplified downstream. Downstream of LIN-45 is the MEK-2/MAPK2 and 
the Raf-MEK scaffold protein KSR-1 (Kornfeld et al., 1995b; Sundaram and Han, 
1995), either of which might both be recruited and provided a stronger signal. For 
LIN-45::mNG, via CRISPR we will introduce the L429A/L431A mutations of the 
Cdc4 Phosphodegron (CPD) target of SEL-10/FBW7, which in ectopically 
expressed protein stabilized LIN-45 (de la Cova and Greenwald, 2012). As an 
alternative, we will work in a sel-10 mutant background, with the caveat that SEL-
10 also represses LIN-12/Notch signaling, and thus could disrupt the signaling 
network (Deng and Greenwald, 2016a; Hubbard et al., 1997). Downstream of 
RGL-1 we will tag RLBP-1 (RalBP1; reviewed in Gentry et al., 2014), a 
conventional target of RAL-1 that may provide a stronger and less variable 
reporter for spatial activation of LET-60-RGL-1 activation. Each new tag will be 
subjected to validation. For example, localization of tagged RLBP-1 should be 
abrogated by a mutation in ral-1. 
 
mNG::RGL-1 is localized to the apical membrane in 2˚ cells, not in 1˚ cell, at late 
1-cell stage, and daughters of 1˚ and 2˚ cells at 2-cell stage.  
 
We did not expect to see that plasma membrane recruitment of RGL-1 is 
polarized to the apical surface of presumptive 2˚ VPCs. We propose that the 
spatial regulation of LIN-45 vs. RGL-1 recruitment represents a major mechanism 
of Ras effector switching. We hypothesize that the regulators or scaffold proteins 
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between LET-60 and RGL-1 are polarized so that the RGL-1 is recruited to the 
membrane-bound LET-60 at the apical surface of 2˚ cells. We will further discuss 
hypothesis below in Discussion.  
We also observed that RGL-1 is apically localized in daughters of both 1˚ and 
2˚ cells at the Pn.px (2-cell) and Pn.pxx (4-cell) stage. The VPC fate patterning 
occurs during the second half of the Pn.p (1-cell) stage, though even after the first 
cell division ectopic EGF/LIN-3 induction can reverse cell fate induction. The 
reason why we see the apical localization of RGL-1 at the Pn.px (2-cell) stage 
may be that RGL-1 functions in defining sub-lineages and morphogenesis later in 
vulva development. Another explanation would be RGL-1 maintains 2˚-promoting 
signal in the daughters of 2˚ cells after VPC fate patterning for fidelity of fate 
decision. The apical localization of RGL-1 in the daughters of 1˚ cell may not 
function as a 2˚-promoting signal because of the negative regulators of LET-60-
RGL-1-RAL-1-GCK-2-PMK-1 signaling cascade, such as RalGAP or PMK-1/p38 
phosphatase, so this activity may be quenched or signal through another, non-2˚-
promoting effector of RAL-1.   
 
Validation of the RGL-1 recruitment system. 
 
RGL-1 is also apically localized in the daughters of 1˚ and 2˚ cells at 2-cell 
stage. As we expected, this apical localization of RGL-1 is abrogated by LET-60 
null mutant, let-60(dx16). Because few dx16 mutant animals survive to the L3 
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stage and the time window of 2˚-specific mNG::RGL-1 recruitment is short, we 
were not be able to validate RGL-1 localization system at 1-cell stage. Therefore, 
we will generate conditional LET-60 knock-out by using Auxin-Inducible 
Degradation (AID) system to validate RGL-1 recruitment system (Zhang et al., 
2015). By using AID system, degron tagged target protein can be degraded by a 
TIR1 protein, which is modified from Arabidopsis protein, in the presence of auxin 
(Zhang et al., 2015). We are tagging endogenous LET-60 with degron by CRISPR 
knock-in in the TIR1-expressing animals. Since LET-60 is critical for development 
prior to the L1 stage, we will delete LET-60 conditionally post-embryonically by 
treating auxin at L1 or L2 stage. We will use this tool to conclusively validate RGL-
1 recruitment to the membrane in VPCs. 
In addition, RGL-1 recruitment to the plasma membrane will be validated by 
RA dead mutation in RGL-1. RalGEF was identified by screening of Ras 
interacting proteins (Hofer et al., 1994; Kikuchi et al., 1994; Spaargaren and 
Bischoff, 1994), and RalGEF interacts with Ras through the RA (Ras Association) 
domain (Kishida et al., 1997; Matsubara et al., 1999; reviewed in Feig et al., 1996). 
Missense RA mutations have been shown to abrogate mammalian Ras interaction 
with RalGEF (Huang et al., 1998; Linnemann et al., 2002; Vetter et al., 1999). 
Therefore, the RA dead mutation is expected to disrupt RGL-1 recruitment to the 
plasma membrane in VPCs. We will generate RA dead mutation in the 
mNG::RGL-1 by CRISPR knock-in. 
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Does RGL-1 apical localization mean it is functionally active? 
 
In let-23(sy1) mutant and LIN-2/-7/-10 mutants, LET-23 is mislocalized to the 
apical membrane in VPCs, and no longer can be found at the basolateral surface 
(Kaech et al., 1998). The LET-23 and LIN-2/-7/-10 mutants have a vulvaless 
phenotype, suggesting that basolateral localization of LET-23 is important for 1˚ 
fate induction and that let-23(sy1) is non-functional (Kaech et al., 1998; Simske et 
al., 1996; Whitfield et al., 1999). We observed RGL-1 is localized to the apical 
membrane of VPCs in let-23(sy1) mutant background, but now in P5-7.p, 
suggesting the 1˚ fate is necessary to prevent RGL-1 recruitment in P6.p. We will 
use let-23(sy1) to test whether apical localization of RGL-1 results in a functional 
2˚-promoting signal. We will test whether let-23(sy1) has 2˚-promoting activity in 
the genetically sensitized background. We previously used lin-12(n379d); lin-
15(n765ts) as a sensitized background to control EGF-dependent 2˚-promoting 
signal (Shin et al., 2018; Zand et al., 2011). We will test whether the let-23(sy1) 
abolishes induction of ectopic 2˚s in the lin-12(n379d); lin-15(n765ts) background. 
If not, we will test in the lin-12(n379d); let-23(sy1); lin-15(n765ts) triple mutant 
whether increased ectopic secondaries are RGL-1-dependent by using RNAi of 
rgl-1 or RGL-1 deletion mutants. We hypothesize that apical localization of RGL-
1 functions to promote 2˚ fate, which also argues that let-23(sy1) still transduces 
the 2˚-promoting signal but just fails to transduce the 1˚-promoting signal for 1˚ 
fate induction. We will further test whether LIN-2/-7/-10 mutation shows RGL-1 
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Figure 4. 7 Three axes of Ras effectors recruitment to the membrane. A. LET-
60/Ras effectors are segregated in VPCs. LET-60/Ras (purple) is probably at the 
plasma membrane in 1˚ and 2˚ cells. LET-23/EGFR (green) is also at the plasma 
membrane in VPCs. LIN-45/Raf (light blue) recruitment has been shown to be at 
the apical membrane in 1˚ cell while RGL-1/RalGEF (pink) is recruited to the apical 
membrane in 2˚ cells. B. Three dimensional axes of LET-60/Ras effector 
recruitment. Three axes show differential factors that affect LET-60/Ras effector 
recruitment to the membrane. LIN-45/Raf and RGL-1/RalGEF are segregated 
based on subcellular portion (basolateral membrane vs. apical membrane), time 








Potential mechanisms of effector segregation.  
 
Here we discuss potential mechanisms of LET-60/Ras effector switching. 
There are three axes that make different LET-60 effectors to be recruited to the 
membrane differently (Figs. 4. 7A-B). First axis is different cells, 1˚ cell versus 2˚ 
cell (Fig. 4. 7B). LIN-45/Raf is recruited to the plasma membrane in the 1˚ cell 
while RGL-1/RalGEF is recruited to the plasma membrane in the 2˚ cells. LET-60-
LIN-45 is a 1˚-promoting signal while LET-60-RGL-1 is a 2˚-promoting signal in 
VPC fate patterning. We hypothesize that phosphorylation of RGL-1 regulates 
recruitment to the plasma membrane. RalGEF has REM domain, CDC25 domain, 
and RA domain, which protein sequences are conserved between species. The 
RA domain is highly conserved between mammals, Drosophila, and C. elegans 
(Fig. 4. 8). There is a potential phosphorylation site, Serine-Proline (SP), right after 
the RA domain in the C. elegans RGL-1 protein sequence (Fig. 4. 8) in the 
“phosphopep” database (http://www.unipep.org/phosphopep/index.php). And, the 
potential phosphorylation site “SP” is conserved between human RGL3 and C. 
elegans RGL-1. The Serine-Proline sequence has been shown as a consensus 
phosphorylation site for CDKs or MAPKs (Scansite 3). The LET-60/Ras-LIN-
45/Raf-MEK-2/MEK-MPK-1/ERK is activated in presumptive 1˚ cell to promote 1˚ 
fate. However, the 1˚-promoting MPK-1/ERK is inhibited by ERK phosphatase 
LIP-1/MKP in the presumptive 2˚ cells to prevent the presumptive 2˚ cells from 




Figure 4. 8 RGL-1/RalGEF RA domain is conserved between species. The 
identity of RA domain sequences of four human RalGEF, RalGDS, RGL1, RGL2, 
and RGL3, two Drosophila RalGEFs, RGL and RGL2 (Isoform E), and single C. 
elegans RalGEF, RGL1, are determined by CLUSTALW multiple sequence 
alignment. Green box shows RA domain. The lysine (K) residue in read box is 
identical between species. The serine-proline (SP) residues are a potential 
phosphorylation site for CDKs and MAPKs and conserved between human RGL3 
and C. elegans RGL-1.  
 
 
1 in the 1˚ cell. The phosphorylated RGL-1 may not be able to bind to membrane-
bound LET-60 in the 1˚ cell. However, the phosphorylation event on RGL-1 may 
be abolished by 1˚-antagonizing LIP-1, MPK-1/ERK phosphatase, function in the 
2˚ cells. Therefore, the un-phosphorylated RGL-1 could be recruited to the plasma 
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membrane in 2˚ cells. We will test whether phospho-mimetic or phospho-defective 
mutation in RGL-1 by CRISPR knock-in affects the localization of RGL-1 at the 
apical membrane in VPCs. We will also test whether the potential kinase, MPK-1, 
or phosphatase, LIP-1, regulates localization of RGL-1 in VPCs cell biologically. 
Second, LET-60/Ras effectors are recruited to different subcellular location 
in presumptive 1˚ vs. presumptive 2˚ VPCs (Fig. 4. 7B). Ras is known to have 
variable interactions with effectors in cancer (Yuan et al., 2018). Ras interacts with 
effectors through Ras Binding or Ras Association domain (RBD or RA domain) 
(McCormick and Wittinghofer, 1996). The scaffold protein between Ras and Ras 
effectors may spatially regulate the interaction between Ras and Ras effectors. C. 
elegans SOC-2/SUR-8 functions downstream of or parallel to LET-60/Ras 
genetically (Li et al., 2000; Sieburth et al., 1998). Mammalian Shoc2, an ortholog 
of C. elegans SOC-2/SUR-8, functions as a scaffold protein between Ras and Raf 
(Li et al., 2000; Sieburth et al., 1998). Thus, recruitment of LIN-45 to the 
basolateral membrane in 1˚ cell could be mediated by the scaffold protein SOC-
2/SUR-8, or that SOC-2/SUR-8 excludes RGL-1 recruitment to the basolateral 
compartment.  
We hypothesize that RGL-1 2˚-specific apical recruitment by LET-60 is 
regulated by LET-413, an ortholog of mammalian Erbin and Drosophila Scribble. 
Erbin/Scribble shares remarkable sequence identity with Shoc2/SOC-2/SUR-8 
through their LRR (Leucine-rich repeats) domains, which in human shoc2 forms 
the binding interface with Ras and Raf (Jang and Galperin, 2016). Erbin down-
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regulates ERK activation by Ras-Raf (Huang et al., 2003). Erbin has been shown 
to be a negative regulator of Shoc2 scaffolding of Ras and Raf in mammalian cells, 
interacting with GTP-bound Ras to sequester interaction of Ras with Raf through 
Shoc2 (Dai et al., 2006). However, RalGEF interaction with Erbin has not been 
tested in any system. An interesting model is that these two antagonistic LRR-
domain proteins, SOC-2/SUR-8/Shoc2 vs. LET-413/Scribble/Erbin, function to 
restrict LET-60/Ras interactions with its two antagonistic effectors, LIN-45 and 
RGL-1. We will test whether the apical recruitment of RGL-1 and basolateral 
recruitment of LIN-45 is mediated by LET-413. We will use VPC-specific RNAi 
depletion of LET-413 to assess disruption of apical vs. basolateral recruitment 
events. We will additionally use VPC-specific RNAi to determine whether LET-413 
has 2˚-promoting activity in genetically sensitized background. We will use 
CRISPR to tag endogenous LET-413 with Auxin-inducible degron, fluorescent 
protein, and an epitope tag, combined with VPC-specific expression of the TIR1 
co-factor, to degrade LET-413 specifically in VPCs just prior to induction. 
Other scaffold proteins or regulators may control segregation of LET-60 
effectors. Therefore, we will use co-immunoprecipitation followed by mass 
spectrometry (IP-mass spec) to proteins that come down with both tagged LET-
60 and tagged RGL-1. Though IP-mass spec is notoriously promiscuous, we 
propose that the set of proteins Iped as coincident partners of both LET-60 and 
RGL-1 is very small. We will genetically test whether the candidates show 2˚-
promoting activity in genetically sensitized background and whether the mutant or 
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RNAi of candidates abolishes apical localization of RGL-1 in VPCs cell biologically. 
Yet identification of partners that impose polarity on effector usage, while 
important, probably still leaves open the question of what system imposes polarity 
on those partners. The obvious candidates would be the PAR genes, which 
control cell polarity throughout metazoans, but were discovered in C. elegans 
(Kemphues, 2000; Thompson, 2013). Yet little is known of VPC polarity. Depletion 
of PAR-1 results in disrupted vulval morphogenesis, and PAR-1 is localized to the 
adherens junctions of VPCs prior to induction (Hurd and Kemphues, 2003). PAR-
1 is also thought to repress 1˚ induction at the level of LIN-45/Raf and KSR-1 
(Yoder et al., 2004). Yet the role of establishment and maintenance of polarity in 
VPCs has not been determined, nor has the PAR complex been visualized. We 
will consider whether the PAR complex plays an important role in establishing 
polarity of effector usage. By comparison to other epithelial systems, we would 
expect PAR-3, PAR-6 and aPKC to function apically, while PAR-1 could function 
basolaterally (Thompson, 2013). Interestingly, Scribble (LET-413 and Erbin) has 
been associated with PAR-1 and the basolateral cellular compartment in 
Drosophila (Bilder and Perrimon, 2000), counter to our model that LET-
413/Scribble would scaffold LET-60 and RGL-1 apical recruitment. In light of this 
connection, perhaps LET-413 functions to exclude RGL-1 from the basolateral 
compartment. Yet we will need to examine the consequences of RNAi depletion 
and localization of PAR components, including LET-413/Scribble, to inform further 
hypotheses and tests.  
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Third axis of polarized effector segregation is time (Fig. 4. 7B). Different LET-
60 effectors are recruited to the plasma membrane at different time points. Based 
on preliminary data, we think LIN-45 is recruited to the basolateral membrane at 
early 1-cell stage while RGL-1 is recruited to the apical membrane at late 1-cell 
stage. We hypothesize that LET-60 effector segregation at different times is 
regulated by the time at which inductive signal starts to signal through LET-60-
LIN-45 for 1˚ fate or LET-60-RGL-1 for 2˚ fate. In other words, the different times 
of LIN-45 vs. RGL-1 effector recruitment reflect the sequential induction model, 
suggesting that some consequence of LIN-12/Notch lateral signal is necessary to 
permit recruitment of RGL-1 to the apical compartment in presumptive 2˚ cells. 
We will test this idea by observing RGL-1 recruitment in the LIN-12 null mutant 
background.  
 
Materials and Methods  
 
C. elegans handling and genetics.  
 
All strains used are shown in Table 4. 1. The strains were derived from the 
N2 wild type. Nomenclature was used as described (Horvitz et al., 1979). Animals 
were cultured at 20˚C using standard conditions on OP50 bacteria on NGM agar 




CRISPR/Cas9-mediated genome engineering.  
 
The RGL-1 CRISPR knock-in to tag endogenous RGL-1 with mNG and 
3xFlag was described in the Chapter 3 (Shin et al., 2018, submitted). To tag 
endogenous LIN-45 with mNG and 3xFlag and endogenous LET-23 with mKate2 
and 3xFlag, Self Excising Cassette (SEC) strategy was used (Dickinson et al., 
2015). The sgRNA targeting sites were selected by using MIT-CRISPR web-site 
(http://crispr.mit.edu/) based on the sgRNA score and off target effect. Two sgRNA 
sites were used for both LIN-45 and LET-23 CRISPR (LIN-45 sgRNA targeting 
sequences: #1 GTATGCCTTCTTGTTAGCAGCGG, #2 
TATCGGGATGGGTGATGAGGGGG and LET-23 sgRNA targeting sequences: 
#1 TGGTTCATTGTAATATCCAGAGG, #2 TGTATGAGATGAATGGCAACGGG). 
The sgRNA sequences were inserted into the Cas9-sgRNA plasmid, pJW1236, 
by Q5 site-Directed Mutagenesis (NEB) (Ward, 2015). And, the repair template 
plasmid was generated by amplifying ~500 bp of homology arms from N2 genomic 
DNA (NEB Q5 polymerase), digesting of the target SEC vector, pDD268, and 
Gibson Assembly (NEB) directed by homologous ends. The primers used for 
amplification of homology arms in the repair template are listed in Table 4. 2. The 
mNG^3xFlag::LIN-45 was generated by microinjection of sgRNA-Cas9 #1 (50 
ng/µl), sgRNA-Cas9 #2 (50 ng/µl), repair template (10 ng/µl), and injection marker 
Pmyo-3::gfp (10 ng/µl) into N2 animals. And, the LET-23::mKate2^3xFlag was 
generated by microinjection of sgRNA-Cas9 #1 (43.5 ng/µl), sgRNA-Cas9 #2 
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(11.8 ng/µl), repair template (10 ng/µl), and injection marker Pmyo-2::gfp (10 ng/µl) 
into N2 animals. Animals were picked, treated with 5 mg/ml hygromycin, and heat-
shocked followed by the protocol from Dickinson et al., 2015. The CRISPR knock-
in results were confirmed by genotyping PCR using Taq PCR Master Mix 
(QIAGEN). The lin-45(re208[mNG^3xFlag::lin-45]) and let-23(re202[let-
23::mKate2^3xFlag]) sequences were confirmed by sanger sequencing 
(Genewiz).   
 
Imaging with fluorescent microscope.  
 
Early L2 to late L3 stage animals were mounted in 5 mM sodium azide/M9 
buffer on slides with 3% agar pad. The images were captured by A1si Confocal 
Laser Microscope (Nikon) using NIS Elements Advanced Research, Version 4.40 











Table 4. 1 Strains for effector switching mechanism study 
Strain Genotype Used in Figures 
DV3312 rgl-1(re179[mNG^3xFlag::rgl-1]) X Fig. 4. 2A-H, 4. 4A-B 




Fig. 4. 4C-D 
AH1747 
unc-119(ed3) III; zhIs35 [Plet-23::LET-
23::GFP; unc-119(+)] 
Fig. 4. 5A 








Fig. 4. 6A-B 
 
 
Table 4. 2 Primers for effector switching mechanism study 












primer for mNG:: 
3xFlag::LIN-45 






primer for mNG:: 
3xFlag::LIN-45 






Primer for amplifying 
upstream homology 
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Primer for amplifying 
upstream homology 








Primer for amplifying 
downstream homology 








Primer for amplifying 
downstream homology 




NR145 5’ -TGAGAAGCCAAATGCTTTCC- 3’ 
lin-45(re208) 
genotyping 
NR146 5’ -GAAGTCGACTCCGTTGATGG- 3’ 
lin-45(re208) 
genotyping 







primer for LET-23:: 
mKate2^3xFlag 






primer for LET-23:: 
mKate2^3xFlag 





GATTGTAAG- 3’  
Primer for amplifying 
upstream homology 
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Primer for amplifying 
upstream homology 








Primer for amplifying 
downstream 









Primer for amplifying 
downstream 










TD244 5’ -CCTCCATGTAGAGCTTCATATGC- 3’ 
let-23(re202) 
genotyping 












CONCLUSIONS AND REMARKS 
The LET-60/Ras-RGL-1/RalGEF-RAL-1/Ral modulatory signaling cascade 
induces 2˚ fate in support of LIN-12/Notch in C. elegans VPC fate patterning (Zand 
et al., 2011). The mechanism how LIN-3/EGF morphogen gradient induces 2˚ fate 
in support of LIN-12 was an interesting question for a long time (Kenyon, 1995). 
This system provides a framework for studying downstream Ral signal 
transduction, mechanisms of effector switching, and principles of network 
orchestration in a live animal (Reiner, 2011). 
We explored the cascade downstream of 2˚-promoting RAL-1 signaling. 
EXOC-8/Exo84, an inessential component of the exocyst complex, mediates the 
RAL-1 2˚-promoting signal in VPC fate patterning. GCK-2, a CNH-containing 
MAP4 kinase, functioned downstream of RAL-1-EXOC-8 to signal through PMK-
1/p38 MAP kinase to promote 2˚ fate in support of LIN-12. Constitutively activated 
RAL-1 was sufficient to induce ectopic 2˚ cells in a genetically sensitized 
background. Genetic perturbation of GCK-2, EXOC-8, and PMK-1 phenocopied 
the loss of RAL-1 function and blocked the phenotype of mutationally activated 
RAL-1. Endogenous GCK-2 and PMK-1 tagging with fluorescent protein revealed 
expression in the VPCs. RAL-1 and GCK-2 function cell autonomously in the 
VPCs. EXOC-8 and GCK-2 function as atypical effectors of RAL-1: unlike most 
effectors, GCK-2 is not recruited to the membrane-bound RAL-1 in VPCs. We 
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hypothesize that RAL-1, along with potentially hundreds of other proteins, 
interacts with EXOC-8 in the cell. Consequently, RAL-1 downstream signaling 
partners, like GCK-2, may be activated via coincident localization and/or co-
activating kinases.  
Our discovery of a RAL-1 downstream signaling cascade is useful in three 
ways. First, we have extended the RAL-1 2˚-promoting signal through a p38 MAP 
kinase cascade, thus providing interesting perspective on how the EGF gradient 
signal is transduced. Of equal interest is extending our knowledge of this cascade 
to its mechanistic output. Second, Identification of a p38 cascade downstream of 
Ral, which has not been done in any other system, provides potential 
phosphorylated biomarkers that could be screened in Ral-positive human tumors, 
starting with Ras-positive tumors. We draw a comparison with phospho-Akt and 
Phospho-ERK, which are routinely surveyed for activated effector status in Ras-
positive tumors. Third, if this p38 cascade was validated in tumors, it would 
provide a four-kinase cascade of potential druggable targets downstream of Ral. 
Additionally, our development of the constitutively active endogenous RAL-1 has 
identified other RAL-1-mediated functions outside of VPCs that appear to be 
independent of GCK-2 (data not shown). We propose that we identified an area 
of signaling richness that has not previously suspected. 
Mutational analysis of RGL-1 reveals two unexpected pictures of RalGEF. 
First, RGL-1 is not essential, while RAL-1 is essential. RAL-1 appears to be a key 
component of the exocyst complex: deletion of RAL-1 reveals function in cell 
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polarity, embryonic development and germline activity (Armenti et al., 2014). In 
contrast, multiple deletions of RGL-1 are superficially wild type. Given the 
exclusive relationship between RalGEF and Ral in other systems (Camonis and 
White, 2005), RAL-1 activation is expected to depend solely on RGL-1. Therefore, 
we hypothesize that the proposed function of RAL-1 as a core component of the 
exocyst complex is independent of its GDP/GTP bound state. This observation is 
supported by previous analysis from our lab that shows that perturbation of the 
heterodimeric RalGAP also results in healthy animals. However, we cannot rule 
out the possibility that there exist other Ral-specific GAPs in the genome. 
We additionally found that RGL-1 performs RAL-1-dependent and RAL-1-
independent functions in VPC fate patterning. These two functions are genetically 
separable. RAL-1 and RGL-1 also showed non-equivalence in VPC fate 
patterning. RAL-1 performs a single known function downstream of LET-60-RGL-
1 to promote 2˚ fate, and thus deletion, RNAi depletion, or a hypomorphic point 
mutation in ral-1 all confer the same phenotype: reduced 2˚-promoting signal. In 
contrast, null mutations in RGL-1 show no phenotypic changes in the balance 
between 1˚ and 2˚ signals. We showed both 1˚-promoting and 2˚-promoting 
signaling activities of RGL-1 can be separated genetically by using GEF-specific 
mutations and genetic bypass experiments. Mammalian RalGEF physically 
interacts with PDK and Akt as a scaffold protein. C. elegans PDK-1 was previously 
shown to promote 1˚ fate (Nakdimon et al., 2012). Our genetic analysis is 
consistent with RGL-1 also functioning as a scaffold protein for PDK-1/PDK and 
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AKT-1/Akt to promote 1˚ fate in the AGE-1/PI3K mediated 1˚-promoting 
modulatory cascade. RGL-1 mutants showed 15-fold higher error rate in VPC fate 
patterning than the wild type. This observation indicates that the opposing 
activities of RGL-1 for 1˚- and 2˚-promoting modulatory signaling cascade in AGE-
1-PDK-1-AKT-1 and LET-60-RGL-1-RAL-1, respectively, are controlled in order 
to decrease signaling noise and mis-patterning of VPC fate. From our study of 
opposing RGL-1 activities, we hypothesize that RGL-1 functions as a “balanced 
switch” to reinforce precise VPC fate patterning and hence contribute to fidelity of 
vulva development. 
While we showed that LET-60/Ras switches effectors during VPC fate 
patterning, we know nothing in any system about how different effector use is 
regulated. We find that LET-60/Ras effectors are segregated within a VPC and 
between VPCs at different time points. The 1˚-promoting LIN-45/Raf is recruited 
to the basolateral membrane in 1˚ cell, but not in 2˚ cells, at early Pn.p (1-cell) 
stage. In contrast, 2˚-promoting RGL-1/RalGEF is localized to the apical 
membrane in 2˚ cells, but not in 1˚ cell, at late Pn.p (1-cell) stage. The Ras effector 
recruitment to the plasma membrane has been shown in mammalian cell culture 
system. However, interestingly LET-60/Ras effectors are polarized in the C. 
elegans, in vivo system. We validated RGL-1 recruitment to the plasma 
membrane in VPCs by LET-60/Ras null mutant. The RGL-1 recruitment to the 
apical membrane is also shown in the LET-23 mutant, which expression of LET-
23 is only at the apical membrane in all VPCs. We will test the functional activity 
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of apically localized RGL-1 by using the LET-23 mutant in the genetically 
sensitized background. We will further study mechanism of LET-60 effector 
segregation using in vivo model system. We hypothesize that phosphorylation of 
RGL-1 regulates segregation of RGL-1 between 1˚ and 2˚ cells and the 
polarization of LET-60 effectors are mediated through regulators and scaffold 
proteins between LET-60 and its effectors. We observed that LIN-45 is recruited 
to the plasma membrane earlier than RGL-1 is. The “Sequential Induction Model” 
and “Morphogen Gradient Model” have not been reconciled for decades (Kenyon, 
1995). However, the two competing models were reconciled by LET-60 effector 
switching study done by Zand et al., 2011 genetically showing that the graded 
LIN-3/EGF mediates the activation of LET-60-RGL-1-RAL-1 signaling cascade in 
support of LIN-12/Notch. The observation of LET-60 effector segregation at 
different time supports the genetic study for reconciling the two models cell 
biologically. The study of Ras effector switching and segregation mechanism is 
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